Barclays PLC Interim Results Announcement 30 June 2022 -- 1 of 109 -- Results Announcement Page Notes 1 Performance Highlights 2 Group Finance Director’s Review 5 Results by Business • Barclays UK 8 • Barclays International 11 • Head Office 16 Quarterly Results Summary 17 Quarterly Results by Business 18 Performance Management • Margins and Balances 24 Risk Management • Risk Management and Principal Risks 25 • Credit Risk 27 • Market Risk 49 • Treasury and Capital Risk 50 Statement of Directors' Responsibilities 64 Independent Review Report to Barclays PLC 65 Condensed Consolidated Financial Statements 67 Financial Statement Notes 73 Appendix: Non-IFRS Performance Measures 101 Shareholder Information 107 BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839. Table of Contents Barclays PLC -- 2 of 109 -- This document contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended). The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the six months ended 30 June 2022 to the corresponding six months of 2021 and balance sheet analysis as at 30 June 2022 with comparatives relating to 31 December 2021 and 30 June 2021. The historical financial information used for the purposes of such analysis has been restated. Please refer to Note 1 to the condensed consolidated interim financial statements contained herein for further information. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions and thousands of millions of Euros respectively. There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time. Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary. The information in this announcement, which was approved by the Board of Directors on 27 July 2022, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2021, which contained an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006. These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC’s website at www.sec.gov. Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group. Non-IFRS performance measures Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 101 to 106 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures. Forward-looking statements This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward- looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial position, income levels, assets and liabilities, impairment charges, provisions, capital, leverage and other regulatory ratios, capital distributions (including dividend pay-out ratios and expected payment strategies), projected levels of growth in banking and financial markets, projected expenditures, costs or savings, any commitments and targets (including, without limitation, environmental, social and governance (ESG) commitments and targets), business strategy, plans and objectives for future operations, group structure, IFRS impacts and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulation and the interpretation thereof, the development of IFRS and other accounting standards, evolving practices with regard to the interpretation and application of accounting standards, emerging and developing ESG reporting standards, the outcome of current and future legal proceedings and regulatory investigations and any related impact on provisions, the policies and actions of governmental and regulatory authorities, the Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, environmental, social and geopolitical risks and incidents or similar events beyond the Group’s control, and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; changes in valuation of credit market exposures; changes in valuation of issued securities; changes in credit ratings of any entity within the Group or any securities issued by such entities; changes in counterparty risk; changes in consumer behaviour; the direct and indirect consequences of the Russia-Ukraine War on European and global macroeconomic conditions, political stability and financial markets; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK’s exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group’s reputation, business or operations; the Group’s ability to access funding; and the success of acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group’s control. As a result, the Group’s actual financial position, future results, capital distributions, capital, leverage or other regulatory ratios or other financial and non- financial metrics or performance measures or ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group’s forward-looking statements. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings with the SEC (including, without limitation, Barclays PLC’s Annual Report on Form 20-F, as amended, for the financial year ended 31 December 2021), which are available on the SEC’s website at www.sec.gov. Subject to Barclays’ obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Notes Barclays PLC 1 -- 3 of 109 -- Barclays delivered profit before tax of £3.7bn and return on tangible equity (RoTE) of 10.1%, with a half year dividend of 2.25p per share and intends to initiate a further share buyback of up to £500m C. S. Venkatakrishnan, Group Chief Executive, commented “This has been a strong first half with Group income up 17%1 to £13.2bn and a RoTE of 10.1%. The broad-based income growth that we achieved in the first quarter continued across all three operating businesses into the second quarter. Our performance in the first half shows the resilience and advantage that diversification at all levels brings, both across the bank and within our businesses. It also underlines the value of investment into our three strategic priorities in next generation consumer finance, sustainable growth across the Corporate and Investment Bank (CIB), and the transition to a low-carbon economy. Profit before tax was £3.7bn, and attributable profit was £2.5bn, after absorbing charges net of tax of £0.6bn relating to the Over-issuance of Securities. We are alert to the pressure that the rising cost of living will have on our customers and colleagues. We have a range of measures in place to help and are looking to do more. With our resilient income growth and balance sheet strength, we can provide that support while distributing excess capital, having announced a half year dividend of 2.25p per share and an intention to initiate a further share buyback of £500m.” Key financial metrics: Income Cost: income ratio Profit before tax Attributable profit RoTE EPS CET1 ratio TNAV per share Total capital return H122 £13.2bn 69% £3.7bn £2.5bn 10.1% 14.8p 13.6% 297p c.5.25p equivalent Q222 £6.7bn 75% £1.5bn £1.1bn 8.7% 6.4p H122 performance2: • Attributable profit was £2.5bn (H121: £3.8bn) and RoTE was 10.1% (H121: 16.1%) having reflected a £0.6bn net of tax impact for the Over-issuance of Securities in the US (Over-issuance of Securities3). Excluding this impact, RoTE was 12.5% – £0.6bn impact of Over-issuance of Securities is comprised of: – £0.4bn post tax expected net impact of the rescission offer losses, driven by £1.3bn of costs as a result of market movements and interest, substantially offset by £0.8bn of income from hedging arrangements – £0.2bn of costs relating to an estimated monetary penalty from the SEC – Excluding the impact of Over-issuance of Securities: – Group income was £12.4bn, up 10% year-on-year, driven by strong client activity in Markets, recovery in both Consumer, Cards and Payments (CC&P) and Barclays UK more than offsetting the impact of a weak fee pool in Investment Banking – Group costs were £7.7bn (H121: £7.2bn) including other litigation and conduct charges of £0.4bn (H121: £0.1bn), with operating costs (excluding litigation and conduct) up 2% year-on-year – On a statutory basis, including the impacts of Over-issuance of Securities: – Group income was £13.2bn, up 17% year-on-year, including the £0.8bn of income from hedging arrangements related to the Over-issuance of Securities – Credit impairment charges were £0.3bn (H121: £0.7bn net release) with provision levels broadly retained in light of an uncertain macroeconomic backdrop – Group costs were £9.1bn (H121: £7.3bn), including litigation and conduct charges of £1.9bn (H121: £0.2bn), including £1.5bn estimated impact of rescission offer losses in relation to the Over-Issuance of Securities and associated estimated monetary penalty from the SEC • Capital: Common Equity Tier 1 (CET1) ratio of 13.6% (December 2021: 15.1% and March 2022: 13.8%) and tangible net asset value (TNAV) per share of 297p (December 2021: 291p and March 2022: 294p) • Increased capital distributions: total capital return equivalent of c.5.25p per share, including a half year dividend of 2.25p per share. Intend to initiate a further share buyback of up to £0.5bn, which is expected to have a c.15bps CET1 ratio impact 1 Excluding the Q222 income benefit of £0.8bn from hedging arrangements related to the Over-issuance of Securities, Group income was up 10% to £12.4bn. 2 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. 3 Denotes the Over-issuance of Securities under Barclays Bank PLC’s US shelf registration statements on Form F-3 filed with the SEC in 2018 and 2019. Performance Highlights Barclays PLC 2 -- 4 of 109 -- Outlook: • Returns: Barclays continues to target a RoTE of greater than 10% in 2022 • Income: Barclays’ diversified income streams position the Group well for the current economic and market environment and rising interest rates • Costs: given £1.3bn of litigation and conduct charges in Q222 and the appreciation of average USD against GBP, Barclays now expects FY22 total operating expenses to be around £16.7bn1 versus previous outlook of £15.0bn2 • Impairment: while acknowledging macroeconomic uncertainty, the impairment charge is expected to remain below pre-pandemic levels in coming quarters given reduced unsecured lending balances and existing coverage ratios • Capital: Barclays continues to target a CET1 ratio within the range of 13-14% • Capital returns: Barclays' capital distribution policy incorporates a progressive ordinary dividend, supplemented with buybacks as appropriate. Dividends will continue to be paid semi-annually, with the half year dividend expected to represent, under normal circumstances, around one-third of the total dividend for the year 1 Group cost outlook is based on an average USD/GBP FX rate of 1.23 across H222 and subject to foreign currency movements. 2 Previous FY22 Group cost outlook was based on an average USD/GBP FX rate of 1.31 throughout 2022. Performance Highlights Barclays PLC 3 -- 5 of 109 -- Barclays Group results for the half year ended 30.06.22 Restated1 30.06.21 £m £m % Change Net interest income 4,763 3,903 22 Net fee, commission and other income 8,441 7,412 14 Total income 13,204 11,315 17 Credit impairment (charges)/releases (341) 742 Net operating income 12,863 12,057 7 Operating costs (7,270) (7,132) (2) Litigation and conduct (1,857) (176) Total operating expenses (9,127) (7,308) (25) Other net (expenses)/ income (3) 153 Profit before tax 3,733 4,902 (24) Tax charge (823) (742) (11) Profit after tax 2,910 4,160 (30) Non-controlling interests (21) (19) (11) Other equity instrument holders (414) (389) (6) Attributable profit 2,475 3,752 (34) Performance measures Return on average tangible shareholders' equity 10.1% 16.1% Average tangible shareholders' equity (£bn) 48.9 46.5 Cost: income ratio 69% 65% Loan loss rate (bps) 17 — Basic earnings per share 14.8p 21.9p Dividend per share 2.25p 2.0p Share buyback announced (£m) 500 500 Total payout equivalent per share c.5.25p 4.9p Basic weighted average number of shares (m) 16,684 17,140 (3) Period end number of shares (m) 16,531 16,998 (3) As at 30.06.22 Restated1 As at 31.12.21 Restated1 As at 30.06.21 Balance sheet and capital management2 £bn £bn £bn Loans and advances at amortised cost 395.8 361.5 348.5 Loans and advances at amortised cost impairment coverage ratio 1.4% 1.6% 1.8% Total assets 1,589.2 1,384.3 1,376.3 Deposits at amortised cost 568.7 519.4 500.9 Tangible net asset value per share 297p 291p 280p Common equity tier 1 ratio 13.6% 15.1% 15.0% Common equity tier 1 capital 46.7 47.3 46.2 Risk weighted assets 344.5 314.1 307.4 UK leverage ratio 5.1% 5.2% 5.0% UK leverage exposure 1,151.2 1,137.9 1,154.9 Average UK leverage ratio 4.7% 4.9% 4.8% Average UK leverage exposure 1,233.5 1,229.0 1,192.7 Funding and liquidity Group liquidity pool (£bn) 343 291 291 Liquidity coverage ratio 156% 168% 162% Loan: deposit ratio 70% 70% 70% 1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. 2 Refer to pages 55 to 62 for further information on how capital, Risk Weighted Assets (RWAs) and leverage are calculated. Performance Highlights Barclays PLC 4 -- 6 of 109 -- Group performance1, 2 • Barclays' diversified model delivered a profit before tax of £3,733m (H121: £4,902m), RoTE of 10.1% (H121: 16.1%), and earnings per share (EPS) of 14.8p (H121: 21.9p) • Total income increased to £13,204m (H121: £11,315m). Barclays UK income increased 5%. Barclays International income increased 21%, with CIB income up 21% and CC&P income up 20%. Excluding the income benefit of £758m from hedging arrangements related to the Over-issuance of Securities, total Group income was £12,446m, up 10% year- on-year, Barclays International income was £9,182m, up 12% year-on-year and CIB income was £7,213m, up 10% year- on-year • Credit impairment charges were £341m (H121: £742m net release) reflecting low flows to delinquency and an improved UK employment outlook, partially offset by a day one charge relating to the acquisition of the GAP Inc. US credit card portfolio (the GAP portfolio). Expert judgement post-model adjustments have been maintained to incorporate customer affordability and inflationary headwinds • Total operating expenses increased to £9,127m (H121: £7,308m). Operating costs increased 2% to £7,270m, reflecting continued investment and business growth, the impact of inflation and the appreciation of average USD against GBP, partially offset by efficiency savings and the non-recurrence of structural cost actions, primarily relating to the real estate review in June 2021. Litigation and conduct charges were £1,857m (H121: £176m) including £1,304m estimated impact of rescission offer losses in relation to the Over-Issuance of Securities and £165m associated estimated monetary penalty from the SEC, £181m of customer remediation costs relating to a legacy loan portfolio in CC&P and £165m related to settlements in principle in respect of industry-wide devices investigations by the SEC and the Commodity Futures Trading Commission (CFTC)3. This resulted in a cost: income ratio of 69% (H121: 65%) • The effective tax rate (ETR) was 22.0% (H121: 15.1%). The tax charge included a £346m charge recognised for the re- measurement of the Group’s UK deferred tax assets (DTAs) due to the enactment of legislation in Q122 which will result in the UK banking surcharge rate being reduced from 8% to 3% effective from 1 April 2023. The ETR excluding the impact of this downward re-measurement of UK DTAs was 12.8% which included a 5.8% benefit relating to adjustments in respect of prior years • Attributable profit was £2,475m (H121: £3,752m) including the net impact of the Over-issuance of Securities net of tax, of £581m, of which £341m was in Q222 • Total assets increased to £1,589bn (December 2021: £1,384bn) primarily due to an increase in client and trading activity, and growth in the liquidity pool • TNAV per share increased to 297p (December 2021: 291p) primarily reflecting 14.8p of EPS, partially offset by net negative reserve movements driven by higher interest rates Group capital and leverage1 • The CET1 ratio decreased by c.150bps to 13.6% (December 2021: 15.1%) as capital decreased by £0.6bn to £46.7bn and RWAs increased by £30.4bn to £344.5bn – c.80bps reduction to the CET1 ratio due to the expected impact of regulatory change on 1 January 2022 as CET1 capital decreased £1.7bn and RWAs increased £6.6bn – c.30bps reduction due to the £1bn buyback announced with FY21 results, which is well progressed – c.40bps reduction due to the impact of the Over-issuance of Securities. c.20bps due to the £0.6bn net of tax impact reducing CET1 capital and c.20bps due to a £4.5bn temporary increase in RWAs reflecting the hedging arrangements designed to manage the risk of the rescission offer. The hedging related RWAs are expected to reverse after the rescission offer is completed in Q322 – Excluding the impacts above, an increase in CET1 capital of £2.7bn was offset by a £19.3bn increase in RWAs: – The £2.7bn increase in CET1 capital reflects profits and an increase in the currency translation reserve, offset by an accrual toward a FY22 dividend, equity coupons paid, and a decrease in the fair value through other comprehensive income reserve – The £19.3bn increase in RWAs was primarily due to the appreciation of USD against GBP, increased client activity within CIB and higher CC&P balances mainly driven by the GAP portfolio acquisition. This was marginally offset by the partial disposal of Barclays' equity stake in Absa Group Limited (Absa) in April 2022 • The UK leverage ratio decreased to 5.1% (December 2021: 5.2%) primarily due to an increase in the leverage exposure of £13.3bn to £1,151.2bn 1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. 2 The 6% appreciation of average USD against GBP positively impacted income and profits and adversely impacted credit impairment charges and total operating expenses. 3 See 'Other matters' on page 6 for further details. Group Finance Director's Review Barclays PLC 5 -- 7 of 109 -- Group funding and liquidity • The liquidity pool was £343bn (December 2021: £291bn) and the liquidity coverage ratio (LCR) remained significantly above the 100% regulatory requirement at 156% (December 2021: 168%), equivalent to a surplus of £119bn (December 2021: £116bn). The increase in the liquidity pool was driven by deposit growth and an increase in wholesale funding, which were partly offset by an increase in business funding consumption • Wholesale funding outstanding, excluding repurchase agreements, was £181.5bn (December 2021: £167.5bn). The Group issued £3.5bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) in the year to date. The Group has a strong MREL position with a ratio of 30.9% of RWAs which is in excess of its regulatory requirement of 28.5%, excluding the confidential institution specific PRA buffer. The Group remains above its MREL regulatory requirement including the PRA buffer Other matters • Over-issuance of Securities: since 31 March 2022, the following developments should be noted with respect to the Over-issuance of Securities: – On 23 May 2022, Barclays PLC and Barclays Bank PLC filed amendments to their respective Annual Reports on Form 20-F to, among other matters, restate the financial statements for the financial year ended 31 December 2021 to reflect certain impacts of the Over-issuance of Securities – On 23 May 2022, Barclays Bank PLC filed a shelf registration statement on Form F-3 with the SEC, which was automatically effective and under which an unlimited amount of securities may be registered, on the basis that Barclays Bank PLC is a “well-known seasoned issuer” (the “2022 F-3”). Barclays PLC also has an automatic shelf registration statement on Form F-3 filed with the SEC on 1 March 2021 – On 1 August 2022, Barclays Bank PLC intends to launch an offer to rescind the purchase of securities that were issued in excess of Barclays Bank PLC’s shelf registration statement on Form F-3 declared effective by the SEC in 2019 (2019 F-3) and the predecessor US shelf registration statement filed in 2018 (Predecessor Shelf) by certain purchasers who purchased such securities in a distribution from Barclays Bank PLC during certain relevant periods (the rescission offer) – Following the launch of the rescission offer, Barclays Bank PLC is expected to resume issuances and sales of series of iPath ETNs that were not affected by the rescission offer. Barclays Bank PLC further expects to resume issuances and sales of the remaining series of iPath ETNs when the rescission offer has been completed and settlement of the rescission offer with respect to the relevant series has occurred – Barclays has recognised a H122 attributable profit impact of £581m relating to this matter net of tax, including a £1,304m charge recognised in costs, substantially offset by hedging arrangements which generated income of £758m, as well as an estimated monetary penalty from the SEC of £165m – The total balance sheet provision as at 30 June 2022 was £1,757m, of which: £1,592m relates to the estimated rescission offer losses and £165m relates to an estimated SEC monetary penalty. Barclays also expects temporary RWAs of £4.5bn, which translates to a c.20bps reduction in the CET1 ratio, from the hedging arrangements to reverse after the rescission offer has been completed in Q322 – Barclays also expects the Review (see pages 25-26 for more detail), assisted by external counsel, of the facts and circumstances related to this matter to conclude shortly and will continue to engage with regulators • SEC and CFTC devices investigation: in July 2022, Barclays Bank PLC and Barclays Capital Inc. (BCI) reached an agreement in principle with the staff of the SEC's Division of Enforcement and the staff of CFTC in connection with investigations by the SEC and the CFTC of Barclays Bank PLC, BCI and other financial institutions as part of a financial industry sweep regarding compliance with record-keeping obligations in connection with business-related communications sent over unapproved electronic messaging platforms (the Devices Settlements In Principle). The SEC and the CFTC found that Barclays Bank PLC and BCI failed to comply with their respective record keeping and supervisory obligations, where such communications were sent or received by employees over electronic messaging channels that had not been approved by the bank for business use by employees. The proposed resolution with the SEC and the CFTC will include Barclays Bank PLC and BCI paying a combined $125m civil monetary penalty to the SEC and a $75m civil monetary penalty to the CFTC. Subject to final agreement of the terms of the settlements and related documentation, as well as the SEC's and CFTC's approval, the civil monetary penalties are expected to be paid during the third quarter of 2022 • GAP portfolio acquisition: on 21 June 2022, Barclays completed the acquisition of a US credit card portfolio of $3.3bn of receivables, in partnership with GAP Inc. The acquisition reduced the Group CET1 ratio by approximately 15bps. The partnership broadens Barclays product offering in the retail sector and store cards, advancing our strategy and growth ambitions in the United States • Kensington Mortgage Company acquisition: on 24 June 2022 Barclays PLC announced that Barclays Bank UK PLC has agreed to acquire UK specialist mortgage lender Kensington Mortgage Company Limited, thereby broadening Barclays' capabilities and product offering in the UK mortgage market. The transaction is subject to regulatory approval and is expected to complete in late Q422 or early Q123 Group Finance Director's Review Barclays PLC 6 -- 8 of 109 -- Other matters (continued) • Legacy Loan Portfolio: a customer remediation provision of £181m was recognised in Q122 in relation to a legacy timeshare loan portfolio brokered by Azure Services Limited (ASL). The provision represents the best estimate as at 30 June 2022. Barclays continues to review complaints regarding legacy partner finance loans, however it is not currently possible to predict the outcome of this review • Absa sale: on 21 April 2022, Barclays sold 63m ordinary shares in Absa (7.4% of Absa’s issued share capital) at a price of ZAR 164.0 per share, raising aggregate gross sale proceeds of ZAR 10.3bn (£516m1) • Pensions: during 2019 and 2020, the UK Retirement Fund (UKRF), the Group’s main pension scheme, subscribed for non-transferable listed senior fixed rate notes for £1.25bn. Following the PRA's statement on 13 April 2022, Barclays is planning to unwind these transactions, which would result in a c.30bps reduction to the CET1 ratio, being accelerated to Q422 from 2023, 2024 and 2025. For more details, see note 16 on page 89 Capital distributions • Barclays is committed to maintaining an appropriate balance between delivering attractive total cash returns to shareholders, investment in the business and maintaining a strong capital position. Barclays pays a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. The Board will also continue to supplement the ordinary dividends as appropriate, including with share buybacks • Announced a half year dividend of 2.25p per share and intention to initiate a further share buyback of up to £500m • Dividends will continue to be paid semi-annually, with the half year dividend expected to represent, under normal circumstances, around one-third of the total dividend for the year • The £1.0bn buyback programme announced in FY21 results is expected to complete before the end of September 2022 Group targets Barclays continues to target the following over the medium term: • Returns: RoTE of greater than 10% • Cost efficiency: cost: income ratio below 60% • Capital adequacy: CET1 ratio in the range of 13-14% Anna Cross, Group Finance Director 1 Exchange rate GBP/ZAR 20.04 as of 21 April 2022. Group Finance Director's Review Barclays PLC 7 -- 9 of 109 -- Barclays UK Half year ended Half year ended 30.06.22 30.06.21 Income statement information £m £m % Change Net interest income 2,732 2,586 6 Net fee, commission and other income 641 613 5 Total income 3,373 3,199 5 Credit impairment (charges)/releases (48) 443 Net operating income 3,325 3,642 (9) Operating costs (2,083) (2,114) 1 Litigation and conduct (25) (22) (14) Total operating expenses (2,108) (2,136) 1 Other net income — — Profit before tax 1,217 1,506 (19) Attributable profit 854 1,019 (16) As at 30.06.22 As at 31.12.21 As at 30.06.21 Balance sheet information £bn £bn £bn Loans and advances to customers at amortised cost 205.9 208.8 207.8 Total assets 318.8 321.2 311.2 Customer deposits at amortised cost 261.5 260.6 255.5 Loan: deposit ratio 85% 85% 87% Risk weighted assets 72.2 72.3 72.2 Period end allocated tangible equity 9.9 10.0 9.9 Half year ended Half year ended Key facts 30.06.22 30.06.21 Average loan to value of mortgage portfolio1 51% 51% Average loan to value of new mortgage lending1 69% 69% Number of branches 593 755 Mobile banking active customers 10.1m 9.4m 30 day arrears rate - Barclaycard Consumer UK 1.0% 1.4% Performance measures Return on average allocated tangible equity 17.0% 20.6% Average allocated tangible equity (£bn) 10.0 9.9 Cost: income ratio 62% 67% Loan loss rate (bps) 4 — Net interest margin 2.67% 2.54% 1 Average loan to value of mortgages is balance weighted and reflects both residential and buy-to-let mortgage portfolios within the Home Loans portfolio. Results by Business Barclays PLC 8 -- 10 of 109 -- Analysis of Barclays UK Half year ended Half year ended 30.06.22 30.06.21 Analysis of total income £m £m % Change Personal Banking 2,099 1,910 10 Barclaycard Consumer UK 541 605 (11) Business Banking 733 684 7 Total income 3,373 3,199 5 Analysis of credit impairment (charges)/releases Personal Banking (21) 50 Barclaycard Consumer UK 40 398 (90) Business Banking (67) (5) Total credit impairment (charges)/releases (48) 443 As at 30.06.22 As at 31.12.21 As at 30.06.21 Analysis of loans and advances to customers at amortised cost £bn £bn £bn Personal Banking 167.1 165.4 162.4 Barclaycard Consumer UK 8.8 8.7 8.8 Business Banking 30.0 34.7 36.6 Total loans and advances to customers at amortised cost 205.9 208.8 207.8 Analysis of customer deposits at amortised cost Personal Banking 197.0 196.4 191.0 Barclaycard Consumer UK — — 0.1 Business Banking 64.5 64.2 64.4 Total customer deposits at amortised cost 261.5 260.6 255.5 Results by Business Barclays PLC 9 -- 11 of 109 -- Barclays UK delivered a RoTE of 17.0% (H121: 20.6%), and a lower cost: income ratio of 62% (H121: 67%), reflecting improved income performance across Personal Banking and Business Banking, alongside reduced total operating expenses, while impairment returned to a charge following a net release in H121. Barclays UK remains well positioned, with a strong focus on supporting customers in an increasingly difficult and uncertain environment. Income statement - H122 compared to H121 • Profit before tax decreased to £1,217m (H121: £1,506m). RoTE was 17.0% (H121: 20.6%) reflecting the non-recurrence of a prior year credit impairment release, partially offset by the rising rate environment in the UK • Total income increased 5% to £3,373m. Net interest income increased 6% to £2,732m with a net interest margin (NIM) of 2.67% (H121: 2.54%) primarily driven by the rising interest rate environment in the UK. Net fee, commission and other income increased 5% to £641m – Personal Banking income increased 10% to £2,099m, driven by rising interest rates and the benefit of strong mortgage origination in 2021, partially offset by mortgage margin compression – Barclaycard Consumer UK income decreased 11% to £541m as higher transaction based revenues from improved customer spend volumes were more than offset by lower interest earning lending (IEL) balances. Lower IEL balances were impacted by higher customer repayments and reduced borrowing – Business Banking income increased 7% to £733m driven by rising interest rates alongside improved transaction based revenues, partially offset by lower government scheme lending income as repayments continue • Credit impairment charge of £48m (H121: £443m net release) driven by low flows to delinquency, improved UK employment data and reduced uncertainty around the possible effects of COVID-19, offset by increased concerns around customers' vulnerability to high inflation. As at 30 June 2022, 30 and 90 day arrears rates in UK cards were 1.0% (H121: 1.4%) and 0.2% (H121: 0.6%) respectively. The credit card and consumer loan businesses maintain appropriate provision levels in light of affordability headwinds, as reflected in a total coverage ratio of 9.2% (December 2021: 10.9%) • Total operating expenses decreased 1% to £2,108m driven by lower operational costs and efficiency savings, partially offset by increased investment spend and the impact of inflation Balance sheet - 30 June 2022 compared to 31 December 2021 • Loans and advances to customers at amortised cost decreased 1% to £205.9bn as £1.5bn of mortgage growth was more than offset by a £4.7bn decrease in Business Banking balances due to the repayment of government scheme lending and the yield curve impact from rising interest rates on the Education, Social Housing and Local Authority portfolio carrying value • Customer deposits at amortised cost remained broadly stable at £261.5bn, maintaining a strong loan: deposit ratio of 85% (December 2021: 85%) • RWAs remained stable at £72.2bn (December 2021: £72.3bn) Results by Business Barclays PLC 10 -- 12 of 109 -- Barclays International Half year ended Restated1 Half year ended 30.06.22 30.06.21 Income statement information £m £m % Change Net interest income 1,965 1,559 26 Net trading income 5,212 3,389 54 Net fee, commission and other income 2,763 3,270 (16) Total income 9,940 8,218 21 Credit impairment (charges)/releases (310) 293 Net operating income 9,630 8,511 13 Operating costs (5,042) (4,606) (9) Litigation and conduct (1,832) (161) Total operating expenses (6,874) (4,767) (44) Other net income 13 22 (41) Profit before tax 2,769 3,766 (26) Attributable profit 2,083 2,638 (21) As at 30.06.22 As at 31.12.21 As at 30.06.21 Balance sheet information £bn £bn £bn Loans and advances at amortised cost 167.3 133.8 121.9 Trading portfolio assets 126.9 146.9 147.1 Derivative financial instrument assets 343.5 261.5 255.4 Financial assets at fair value through the income statement 209.3 188.2 190.4 Cash collateral and settlement balances 128.5 88.1 108.5 Other assets 275.1 225.6 223.5 Total assets 1,250.6 1,044.1 1,046.8 Deposits at amortised cost 307.4 258.8 245.4 Derivative financial instrument liabilities 321.2 256.4 246.9 Loan: deposit ratio 54% 52% 50% Risk weighted assets 263.8 230.9 223.2 Period end allocated tangible equity 38.0 33.2 31.8 Half year ended Restated1 Half year ended Performance measures 30.06.22 30.06.21 Return on average allocated tangible equity 11.5% 16.3% Average allocated tangible equity (£bn) 36.2 32.3 Cost: income ratio 69% 58% Loan loss rate (bps) 37 — Net interest margin 4.34% 3.95% 1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. Results by Business Barclays PLC 11 -- 13 of 109 -- Analysis of Barclays International Corporate and Investment Bank Half year ended Restated1 Half year ended 30.06.22 30.06.21 Income statement information £m £m % Change Net interest income 795 640 24 Net trading income 5,188 3,411 52 Net fee, commission and other income 1,988 2,522 (21) Total income 7,971 6,573 21 Credit impairment (charges)/releases (32) 272 Net operating income 7,939 6,845 16 Operating costs (3,791) (3,509) (8) Litigation and conduct (1,632) (79) Total operating expenses (5,423) (3,588) (51) Other net income — 1 Profit before tax 2,516 3,258 (23) Attributable profit 1,895 2,252 (16) As at 30.06.22 As at 31.12.21 As at 30.06.21 Balance sheet information £bn £bn £bn Loans and advances at amortised cost 125.8 100.0 91.0 Trading portfolio assets 126.7 146.7 147.0 Derivative financial instrument assets 343.4 261.5 255.3 Financial assets at fair value through the income statement 209.2 188.1 190.3 Cash collateral and settlement balances 127.7 87.2 107.7 Other assets 237.2 195.8 192.5 Total assets 1,170.0 979.3 983.8 Deposits at amortised cost 229.5 189.4 178.2 Derivative financial instrument liabilities 321.2 256.4 246.8 Risk weighted assets 227.6 200.7 194.3 Half year ended Restated1 Half year ended Performance measures 30.06.22 30.06.21 Return on average allocated tangible equity 11.9% 15.9% Average allocated tangible equity (£bn) 31.8 28.3 Cost: income ratio 68% 55% Analysis of total income £m £m % Change FICC 3,173 2,099 51 Equities 2,463 1,709 44 Global Markets 5,636 3,808 48 Advisory 421 381 10 Equity capital markets 84 469 (82) Debt capital markets 697 882 (21) Investment Banking fees 1,202 1,732 (31) Corporate lending 78 244 (68) Transaction banking 1,055 789 34 Corporate 1,133 1,033 10 Total income 7,971 6,573 21 1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. Results by Business Barclays PLC 12 -- 14 of 109 -- Analysis of Barclays International Consumer, Cards and Payments Half year ended Half year ended 30.06.22 30.06.21 Income statement information £m £m % Change Net interest income 1,170 919 27 Net fee, commission, trading and other income 799 726 10 Total income 1,969 1,645 20 Credit impairment (charges)/releases (278) 21 Net operating income 1,691 1,666 2 Operating costs (1,251) (1,097) (14) Litigation and conduct (200) (82) Total operating expenses (1,451) (1,179) (23) Other net income 13 21 (38) Profit before tax 253 508 (50) Attributable profit 188 386 (51) As at 30.06.22 As at 31.12.21 As at 30.06.21 Balance sheet information £bn £bn £bn Loans and advances at amortised cost 41.5 33.8 30.9 Total assets 80.6 64.8 63.0 Deposits at amortised cost 77.9 69.4 67.2 Risk weighted assets 36.2 30.2 29.0 Half year ended Half year ended Key facts 30.06.22 30.06.21 30 day arrears rate – Barclaycard US 1.4% 1.6% US cards customer FICO score distribution <660 10% 10% >660 90% 90% Total number of Barclaycard payments clients c.391,000 c.372,000 Value of payments processed (£bn)1 190 160 Performance measures Return on average allocated tangible equity 8.5% 19.1% Average allocated tangible equity (£bn) 4.4 4.0 Cost: income ratio 74% 72% Loan loss rate (bps) 128 — Analysis of total income £m £m % Change International Cards and Consumer Bank 1,229 1,050 17 Private Bank 459 393 17 Payments 281 202 39 Total income 1,969 1,645 20 1 Includes £145bn (H121: £129bn) of merchant acquiring payments. Results by Business Barclays PLC 13 -- 15 of 109 -- Barclays International delivered a RoTE of 11.5% reflecting the benefits of being a diversified business. CIB delivered a RoTE of 11.9% reflecting a strong performance in FICC, partially offset by a decrease in Investment Banking fees, against a strong prior year comparative, and provisions for litigation and conduct. CC&P RoTE decreased to 8.5% as an increase in income was offset by a provision for higher customer remediation costs relating to a legacy loan portfolio and continued investment in the business. Income statement - H122 compared to H1211 • Profit before tax decreased 26% to £2,769m with a RoTE of 11.5% (H121: 16.3%), reflecting a RoTE of 11.9% (H121: 15.9%) in CIB and 8.5% (H121: 19.1%) in CC&P • The 6% appreciation of average USD against GBP positively impacted income and profits and adversely impacted impairment charges and total operating expenses • Total income increased to £9,940m (H121: £8,218m) – CIB income increased 21% to £7,971m reflecting the benefit of a diversified business model and impact of hedging arrangements – Global Markets income increased 48% to £5,636m. FICC income increased 51% to £3,173m, mainly in macro, reflecting higher levels of activity as we supported our clients through a period of market volatility. Equities income increased £754m to £2,463m including £758m of income related to hedging arrangements in relation to managing the risks from the rescission offer to be launched by Barclays Bank PLC in relation to the Over-issuance of Securities – Investment Banking fees income decreased 31% to £1,202m due to the reduced fee pool, particularly in Equity capital markets2, and a strong prior year comparative – Within Corporate, Transaction banking income increased 34% to £1,055m driven by deposit balance growth, improved margins and higher payments volumes. Corporate lending income decreased 68% to £78m due to losses on certain fair value lending positions and higher costs of hedging and credit protection, partially offset by the non-recurrence of a prior year fair value loan write-off on a single name – CC&P income increased 20% to £1,969m – International Cards and Consumer Bank income increased 17% to £1,229m as higher average cards balances were partially offset by higher customer acquisition costs – Private Bank income increased 17% to £459m, reflecting client balance growth and improved margins partially offset by the non-recurrence of a gain on a property sale in the prior year – Payments income increased 39% to £281m driven by turnover growth following the easing of lockdown restrictions in the past year • Credit impairment charges were £310m (H121: £293m net release) – CIB credit impairment charge of £32m (H121: £272m net release) was driven by a net increase in modelled impairment whilst there continue to be limited material single name wholesale loan charges, with the prior year including a net release resulting from an improved macroeconomic outlook scenario refresh – CC&P credit impairment charges increased to £278m (H121: £21m net release) driven by higher balances in US cards, including the day one impact of acquiring the GAP portfolio, partially offset by lower provisions held for uncertainty. As at 30 June 2022, 30 and 90 day arrears in US cards were 1.4% (H121: 1.6%) and 0.7% (H121: 0.9%) respectively. The US cards business continues to maintain appropriate provision levels in light of affordability headwinds • Total operating expenses increased 44% to £6,874m – CIB total operating expenses increased 51% to £5,423m. Operating costs increased 8% to £3,791m driven by investment in talent, systems and technology, and the impact of inflation. Litigation and conduct charges were £1,632m (H121: £79m) including £1,304m estimated impact of rescission offer losses in relation to the Over- Issuance of Securities and £165m associated estimated monetary penalty from the SEC, and £165m provision relating to the Devices Settlements in Principle – CC&P total operating expenses increased 23% to £1,451m primarily driven by £200m of litigation and conduct costs, including a provision for higher customer remediation costs relating to a legacy loan portfolio. Operating costs increased 14% driven by higher investment spend reflecting an increase in marketing and costs for existing and new partnerships 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. 2 Data source: Dealogic for the period covering 1 January to 30 June 2022. Results by Business Barclays PLC 14 -- 16 of 109 -- Balance sheet - 30 June 2022 compared to 31 December 2021 • Loans and advances at amortised cost increased £33.5bn to £167.3bn due to increased lending across CIB and CC&P, inclusive of the £2.7bn GAP portfolio acquisition and appreciation of USD against GBP, and increased investment in debt securities • Trading portfolio assets decreased £20.0bn to £126.9bn due to a reduction in equity securities driven by facilitation of client activity, partially offset by increased trading activity in debt securities • Derivative assets and liabilities increased £82.0bn and £64.8bn respectively to £343.5bn and £321.2bn driven by market volatility and increased activity in FICC and Equities • Financial assets at fair value through the income statement increased £21.1bn to £209.3bn driven by increased secured lending • Deposits at amortised cost increased £48.6bn to £307.4bn primarily due to an increase in short-term money market deposits and growth in Corporate deposits • RWAs increased to £263.8bn (December 2021: £230.9bn) resulting from the impact of the appreciation of USD against GBP, regulatory changes that took effect from 1 January 2022, increased client activity within CIB, an increase in respect of hedging arrangements designed to manage the risks of the rescission offer relating to the Over-issuance of Securities and higher CC&P balances driven mainly by the GAP portfolio acquisition Results by Business Barclays PLC 15 -- 17 of 109 -- Head Office Half year ended Half year ended 30.06.22 30.06.21 Income statement information £m £m % Change Net interest income 66 (242) Net fee, commission and other income (175) 140 Total income (109) (102) (7) Credit impairment releases 17 6 Net operating income (92) (96) 4 Operating costs (145) (412) 65 Litigation and conduct — 7 Total operating expenses (145) (405) 64 Other net (expenses)/income (16) 131 Loss before tax (253) (370) 32 Attributable (loss)/profit (462) 95 As at 30.06.22 Restated1 As at 31.12.21 Restated1 As at 30.06.21 Balance sheet information £bn £bn £bn Total assets 19.8 19.0 18.3 Risk weighted assets 8.6 11.0 12.0 Period end allocated tangible equity 1.1 5.5 5.9 Half year ended Half year ended Performance measures 30.06.22 30.06.21 Average allocated tangible equity (£bn) 2.7 4.3 Income statement - H122 compared to H121 • Loss before tax was £253m (H121: £370m) • Total income was an expense of £109m (H121: £102m expense) which primarily reflected hedge accounting, funding costs on legacy capital instruments, treasury items as well as a £42m loss on sale from the partial disposal of Barclays’ equity stake in Absa in April 2022. This was partially offset by a one-off gain of £86m from the sale and leaseback of UK data centres and the recognition of dividends on Barclays’ equity stake in Absa • Total operating expenses reduced to £145m (H121: £405m) reflecting the non-recurrence of the £266m charge related to structural cost actions taken as part of the real estate review in June 2021 • Other net income was an expense of £16m (H121: £131m income) driven by a fair value loss in Barclays associate investment holding in the Business Growth Fund Balance sheet - 30 June 2022 compared to 31 December 2021 • RWAs reduced to £8.6bn (December 2021: £11.0bn) reflecting the partial sale of Barclays' equity stake in Absa in April 2022. The sale resulted in an increase to Barclays' CET1 ratio of c.10bps 1 2021 financial and capital metrics have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. Results by Business Barclays PLC 16 -- 18 of 109 -- Barclays Group Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320 Income statement information £m £m £m £m £m £m £m £m Net interest income 2,422 2,341 2,230 1,940 2,052 1,851 1,845 2,055 Net fee, commission and other income 4,286 4,155 2,930 3,525 3,363 4,049 3,096 3,149 Total income 6,708 6,496 5,160 5,465 5,415 5,900 4,941 5,204 Credit impairment (charges)/releases (200) (141) 31 (120) 797 (55) (492) (608) Net operating income 6,508 6,355 5,191 5,345 6,212 5,845 4,449 4,596 Operating costs (3,682) (3,588) (3,514) (3,446) (3,587) (3,545) (3,480) (3,391) UK bank levy — — (170) — — — (299) — Litigation and conduct (1,334) (523) (92) (129) (143) (33) (47) (76) Total operating expenses (5,016) (4,111) (3,776) (3,575) (3,730) (3,578) (3,826) (3,467) Other net income/(expenses) 7 (10) 13 94 21 132 23 18 Profit before tax 1,499 2,234 1,428 1,864 2,503 2,399 646 1,147 Tax charge (209) (614) (104) (292) (246) (496) (163) (328) Profit after tax 1,290 1,620 1,324 1,572 2,257 1,903 483 819 Non-controlling interests (20) (1) (27) (1) (15) (4) (37) (4) Other equity instrument holders (199) (215) (218) (197) (194) (195) (226) (204) Attributable profit 1,071 1,404 1,079 1,374 2,048 1,704 220 611 Performance measures Return on average tangible shareholders' equity 8.7% 11.5% 9.0% 11.4% 17.6% 14.7% 1.8% 5.1% Average tangible shareholders' equity (£bn) 49.0 48.8 48.0 48.3 46.5 46.5 47.6 48.3 Cost: income ratio 75% 63% 73% 65% 69% 61% 77% 67% Loan loss rate (bps) 20 15 — 13 — 6 56 69 Basic earnings per share 6.4p 8.4p 6.4p 8.0p 11.9p 9.9p 1.3p 3.5p Basic weighted average number of shares (m) 16,684 16,682 16,985 17,062 17,140 17,293 17,300 17,298 Period end number of shares (m) 16,531 16,762 16,752 16,851 16,998 17,223 17,359 17,353 Balance sheet and capital management2 £bn £bn £bn £bn £bn £bn £bn £bn Loans and advances at amortised cost 395.8 371.7 361.5 353.0 348.5 345.8 342.6 344.4 Loans and advances at amortised cost impairment coverage ratio 1.4% 1.5% 1.6% 1.7% 1.8% 2.2% 2.4% 2.5% Total assets 1,589.2 1,496.1 1,384.3 1,406.5 1,376.3 1,379.7 1,349.5 1,421.7 Deposits at amortised cost 568.7 546.5 519.4 510.2 500.9 498.8 481.0 494.6 Tangible net asset value per share 297p 294p 291p 286p 280p 267p 269p 275p Common equity tier 1 ratio 13.6% 13.8% 15.1% 15.3% 15.0% 14.6% 15.1% 14.6% Common equity tier 1 capital 46.7 45.3 47.3 47.2 46.2 45.9 46.3 45.5 Risk weighted assets 344.5 328.8 314.1 307.7 307.4 313.4 306.2 310.7 UK leverage ratio 5.1% 5.0% 5.2% 5.1% 5.0% 5.0% 5.3% 5.2% UK leverage exposure 1,151.2 1,123.5 1,137.9 1,162.7 1,154.9 1,145.4 1,090.9 1,095.1 Average UK leverage ratio 4.7% 4.8% 4.9% 4.9% 4.8% 4.9% 5.0% 5.1% Average UK leverage exposure 1,233.5 1,179.4 1,229.0 1,201.1 1,192.7 1,174.9 1,146.9 1,111.1 Funding and liquidity Group liquidity pool (£bn) 343 320 291 293 291 290 266 327 Liquidity coverage ratio 156% 159% 168% 161% 162% 161% 162% 181% Loan: deposit ratio 70% 68% 70% 69% 70% 69% 71% 70% 1 The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. 2 Refer to pages 55 to 62 for further information on how capital, RWAs and leverage are calculated. Quarterly Results Summary Barclays PLC 17 -- 19 of 109 -- Barclays UK Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320 Income statement information £m £m £m £m £m £m £m £m Net interest income 1,393 1,339 1,313 1,303 1,305 1,281 1,317 1,280 Net fee, commission and other income 331 310 386 335 318 295 309 270 Total income 1,724 1,649 1,699 1,638 1,623 1,576 1,626 1,550 Credit impairment (charges)/releases — (48) 59 (137) 520 (77) (170) (233) Net operating income 1,724 1,601 1,758 1,501 2,143 1,499 1,456 1,317 Operating costs (1,085) (998) (1,202) (1,041) (1,078) (1,036) (1,134) (1,095) UK bank levy — — (36) — — — (50) — Litigation and conduct (16) (9) (5) (10) (19) (3) 4 (25) Total operating expenses (1,101) (1,007) (1,243) (1,051) (1,097) (1,039) (1,180) (1,120) Other net (expenses)/income — — (1) 1 — — 6 (1) Profit before tax 623 594 514 451 1,046 460 282 196 Attributable profit 458 396 420 317 721 298 160 113 Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn Loans and advances to customers at amortised cost 205.9 207.3 208.8 208.6 207.8 205.7 205.4 203.9 Total assets 318.8 317.2 321.2 312.1 311.2 309.1 289.1 294.5 Customer deposits at amortised cost 261.5 260.3 260.6 256.8 255.5 247.5 240.5 232.0 Loan: deposit ratio 85% 85% 85% 86% 87% 88% 89% 91% Risk weighted assets 72.2 72.7 72.3 73.2 72.2 72.7 73.7 76.2 Period end allocated tangible equity 9.9 10.1 10.0 10.0 9.9 10.0 9.7 10.0 Performance measures Return on average allocated tangible equity 18.4% 15.6% 16.8% 12.7% 29.1% 12.0% 6.5% 4.5% Average allocated tangible equity (£bn) 10.0 10.1 10.0 10.0 9.9 9.9 9.8 10.1 Cost: income ratio 64% 61% 73% 64% 68% 66% 73% 72% Loan loss rate (bps) — 9 — 24 — 14 31 43 Net interest margin 2.71% 2.62% 2.49% 2.49% 2.55% 2.54% 2.56% 2.51% Quarterly Results by Business Barclays PLC 18 -- 20 of 109 -- Analysis of Barclays UK Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320 Analysis of total income £m £m £m £m £m £m £m £m Personal Banking 1,077 1,022 983 990 987 923 895 833 Barclaycard Consumer UK 265 276 352 293 290 315 354 362 Business Banking 382 351 364 355 346 338 377 355 Total income 1,724 1,649 1,699 1,638 1,623 1,576 1,626 1,550 Analysis of credit impairment (charges)/releases Personal Banking (42) 21 8 (30) 72 (22) (68) (48) Barclaycard Consumer UK 84 (44) 114 (108) 434 (36) (78) (106) Business Banking (42) (25) (63) 1 14 (19) (24) (79) Total credit impairment (charges)/releases — (48) 59 (137) 520 (77) (170) (233) Analysis of loans and advances to customers at amortised cost £bn £bn £bn £bn £bn £bn £bn £bn Personal Banking 167.1 166.5 165.4 164.6 162.4 160.4 157.3 155.7 Barclaycard Consumer UK 8.8 8.4 8.7 8.6 8.8 8.7 9.9 10.7 Business Banking 30.0 32.4 34.7 35.4 36.6 36.6 38.2 37.5 Total loans and advances to customers at amortised cost 205.9 207.3 208.8 208.6 207.8 205.7 205.4 203.9 Analysis of customer deposits at amortised cost Personal Banking 197.0 196.6 196.4 193.3 191.0 186.0 179.7 173.2 Barclaycard Consumer UK — — — — 0.1 0.1 0.1 0.1 Business Banking 64.5 63.7 64.2 63.5 64.4 61.4 60.7 58.7 Total customer deposits at amortised cost 261.5 260.3 260.6 256.8 255.5 247.5 240.5 232.0 Quarterly Results by Business Barclays PLC 19 -- 21 of 109 -- Barclays International Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320 Income statement information £m £m £m £m £m £m £m £m Net interest income 1,029 936 955 749 811 748 614 823 Net trading income 2,766 2,446 789 1,515 1,455 1,934 1,372 1,528 Net fee, commission and other income 1,321 1,442 1,766 1,673 1,553 1,717 1,500 1,430 Total income 5,116 4,824 3,510 3,937 3,819 4,399 3,486 3,781 Credit impairment (charges)/releases (209) (101) (23) 18 271 22 (291) (370) Net operating income 4,907 4,723 3,487 3,955 4,090 4,421 3,195 3,411 Operating costs (2,537) (2,505) (2,160) (2,310) (2,168) (2,438) (2,133) (2,227) UK bank levy — — (134) — — — (240) — Litigation and conduct (1,319) (513) (84) (100) (140) (21) (9) (28) Total operating expenses (3,856) (3,018) (2,378) (2,410) (2,308) (2,459) (2,382) (2,255) Other net income 5 8 3 15 13 9 9 9 Profit before tax 1,056 1,713 1,112 1,560 1,795 1,971 822 1,165 Attributable profit 783 1,300 818 1,191 1,207 1,431 441 782 Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn Loans and advances at amortised cost 167.3 144.8 133.8 125.9 121.9 123.5 122.7 128.0 Trading portfolio assets 126.9 134.1 146.9 144.8 147.1 131.1 127.7 122.3 Derivative financial instrument assets 343.5 288.8 261.5 257.0 255.4 269.4 301.8 295.9 Financial assets at fair value through the income statement 209.3 203.8 188.2 200.5 190.4 197.5 170.7 178.2 Cash collateral and settlement balances 128.5 132.0 88.1 115.9 108.5 109.7 97.5 121.8 Other assets 275.1 255.5 225.6 231.8 223.5 221.7 221.4 261.7 Total assets 1,250.6 1,159.0 1,044.1 1,075.9 1,046.8 1,052.9 1,041.8 1,107.9 Deposits at amortised cost 307.4 286.1 258.8 253.3 245.4 251.2 240.5 262.4 Derivative financial instrument liabilities 321.2 277.2 256.4 252.3 246.9 260.2 300.4 293.3 Loan: deposit ratio 54% 51% 52% 50% 50% 49% 51% 49% Risk weighted assets 263.8 245.1 230.9 222.7 223.2 230.0 222.3 224.7 Period end allocated tangible equity 38.0 35.6 33.2 31.8 31.8 32.7 30.2 30.5 Performance measures Return on average allocated tangible equity 8.4% 14.8% 9.9% 14.9% 14.9% 17.7% 5.8% 10.2% Average allocated tangible equity (£bn) 37.3 35.1 32.9 31.8 32.4 32.3 30.5 30.6 Cost: income ratio 75% 63% 68% 61% 60% 56% 68% 60% Loan loss rate (bps) 49 28 7 — — (7) 90 112 Net interest margin 4.52% 4.15% 4.14% 4.02% 3.96% 3.92% 3.41% 3.79% 1 The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. Quarterly Results by Business Barclays PLC 20 -- 22 of 109 -- Analysis of Barclays International Corporate and Investment Bank Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320 Income statement information £m £m £m £m £m £m £m £m Net interest income 410 385 432 279 370 270 110 305 Net trading income 2,738 2,450 774 1,467 1,494 1,917 1,397 1,535 Net fee, commission and other income 885 1,103 1,426 1,383 1,115 1,407 1,131 1,065 Total income 4,033 3,938 2,632 3,129 2,979 3,594 2,638 2,905 Credit impairment (charges)/releases (65) 33 73 128 229 43 (52) (187) Net operating income 3,968 3,971 2,705 3,257 3,208 3,637 2,586 2,718 Operating costs (1,870) (1,921) (1,562) (1,747) (1,623) (1,886) (1,603) (1,716) UK bank levy — — (128) — — — (226) — Litigation and conduct (1,314) (318) (59) (99) (78) (1) 2 (3) Total operating expenses (3,184) (2,239) (1,749) (1,846) (1,701) (1,887) (1,827) (1,719) Other net income — — 1 — — 1 2 1 Profit before tax 784 1,732 957 1,411 1,507 1,751 761 1,000 Attributable profit 579 1,316 695 1,085 989 1,263 413 627 Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn Loans and advances at amortised cost 125.8 109.6 100.0 93.8 91.0 94.3 92.4 96.8 Trading portfolio assets 126.7 134.0 146.7 144.7 147.0 130.9 127.5 122.2 Derivative financial instruments assets 343.4 288.7 261.5 256.9 255.3 269.4 301.7 295.9 Financial assets at fair value through the income statement 209.2 203.8 188.1 200.4 190.3 197.3 170.4 177.9 Cash collateral and settlement balances 127.7 131.2 87.2 115.1 107.7 108.8 96.7 121.0 Other assets 237.2 222.5 195.8 200.4 192.5 190.8 194.9 228.9 Total assets 1,170.0 1,089.8 979.3 1,011.3 983.8 991.5 983.6 1,042.7 Deposits at amortised cost 229.5 214.7 189.4 185.8 178.2 185.2 175.2 195.6 Derivative financial instrument liabilities 321.2 277.1 256.4 252.2 246.8 260.2 300.3 293.2 Risk weighted assets 227.6 213.5 200.7 192.5 194.3 201.3 192.2 193.3 Performance measures Return on average allocated tangible equity 7.1% 17.1% 9.7% 15.6% 14.0% 17.9% 6.3% 9.5% Average allocated tangible equity (£bn) 32.7 30.8 28.7 27.8 28.4 28.2 26.3 26.4 Cost: income ratio 79% 57% 66% 59% 57% 53% 69% 59% Analysis of total income £m £m £m £m £m £m £m £m FICC 1,529 1,644 546 803 895 1,204 812 1,000 Equities 1,411 1,052 501 757 777 932 542 691 Global Markets 2,940 2,696 1,047 1,560 1,672 2,136 1,354 1,691 Advisory 236 185 287 253 218 163 232 90 Equity capital markets 37 47 158 186 226 243 104 122 Debt capital markets 281 416 511 532 429 453 418 398 Investment Banking fees 554 648 956 971 873 859 754 610 Corporate lending (47) 125 176 168 38 206 186 232 Transaction banking 586 469 453 430 396 393 344 372 Corporate 539 594 629 598 434 599 530 604 Total income 4,033 3,938 2,632 3,129 2,979 3,594 2,638 2,905 1 The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. Quarterly Results by Business Barclays PLC 21 -- 23 of 109 -- Analysis of Barclays International Consumer, Cards and Payments Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320 Income statement information £m £m £m £m £m £m £m £m Net interest income 619 551 522 471 441 478 504 518 Net fee, commission, trading and other income 464 335 356 337 399 327 344 358 Total income 1,083 886 878 808 840 805 848 876 Credit impairment (charges)/releases (144) (134) (96) (110) 42 (21) (239) (183) Net operating income 939 752 782 698 882 784 609 693 Operating costs (667) (584) (598) (563) (545) (552) (530) (511) UK bank levy — — (6) — — — (14) — Litigation and conduct (5) (195) (25) (1) (62) (20) (11) (25) Total operating expenses (672) (779) (629) (564) (607) (572) (555) (536) Other net income 5 8 2 15 13 8 7 8 Profit/(loss) before tax 272 (19) 155 149 288 220 61 165 Attributable profit/(loss) 204 (16) 123 106 218 168 28 155 Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn Loans and advances at amortised cost 41.5 35.2 33.8 32.1 30.9 29.2 30.3 31.2 Total assets 80.6 69.2 64.8 64.6 63.0 61.4 58.2 65.2 Deposits at amortised cost 77.9 71.4 69.4 67.5 67.2 66.0 65.3 66.8 Risk weighted assets 36.2 31.6 30.2 30.2 29.0 28.8 30.1 31.4 Performance measures Return on average allocated tangible equity 17.8% (1.5)% 11.7% 10.5% 21.8% 16.5% 2.7% 14.7% Average allocated tangible equity (£bn) 4.6 4.3 4.2 4.0 4.0 4.1 4.2 4.2 Cost: income ratio 62% 88% 72% 70% 72% 71% 65% 61% Loan loss rate (bps) 132 145 105 127 — 27 286 211 Analysis of total income £m £m £m £m £m £m £m £m International Cards and Consumer Bank 691 538 552 490 517 533 576 600 Private Bank 245 214 200 188 214 179 174 171 Payments 147 134 126 130 109 93 98 105 Total income 1,083 886 878 808 840 805 848 876 Quarterly Results by Business Barclays PLC 22 -- 24 of 109 -- Head Office Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320 Income statement information £m £m £m £m £m £m £m £m Net interest income — 66 (38) (112) (64) (178) (86) (48) Net fee, commission and other income (132) (43) (11) 2 37 103 (85) (79) Total income (132) 23 (49) (110) (27) (75) (171) (127) Credit impairment releases/(charges) 9 8 (5) (1) 6 — (31) (5) Net operating expenses (123) 31 (54) (111) (21) (75) (202) (132) Operating costs (60) (85) (152) (95) (341) (71) (213) (69) UK bank levy — — — — — — (9) — Litigation and conduct 1 (1) (3) (19) 16 (9) (42) (23) Total operating expenses (59) (86) (155) (114) (325) (80) (264) (92) Other net income/(expenses) 2 (18) 11 78 8 123 8 10 Loss before tax (180) (73) (198) (147) (338) (32) (458) (214) Attributable (loss)/profit (170) (292) (159) (134) 120 (25) (381) (284) Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn Total assets 19.8 19.9 19.0 18.5 18.3 17.7 18.6 19.3 Risk weighted assets1 8.6 11.0 11.0 11.8 12.0 10.7 10.2 9.8 Period end allocated tangible equity1 1.1 3.6 5.5 6.3 5.9 3.3 6.8 7.1 Performance measures1 Average allocated tangible equity (£bn) 1.7 3.6 5.1 6.5 4.2 4.3 7.3 7.6 1 The comparative capital and financial metrics relating to Q221 - Q421 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 and Restatement of financial statements (Note 1) on page 73 for more information. Quarterly Results by Business Barclays PLC 23 -- 25 of 109 -- Margins and balances Half year ended 30.06.22 Half year ended 30.06.21 Net interest income Average customer assets Net interest margin Net interest income Average customer assets Net interest margin £m £m % £m £m % Barclays UK 2,732 206,524 2.67 2,586 204,930 2.54 Barclays International1 1,883 88,607 4.29 1,518 77,413 3.95 Total Barclays UK and Barclays International 4,615 295,131 3.15 4,104 282,343 2.93 Other2 148 (201) Total Barclays Group 4,763 3,903 1 Barclays International margins include the lending related investment bank business. 2 Other includes Head Office and the non-lending related investment bank businesses not included in Barclays International margins. The Group’s combined product and equity structural hedge notional as at 30 June 2022 was £256bn (30 June 2021: £198bn), with an average duration of close to 3 years (2021: average duration close to 3 years). Gross structural hedge contributions of £879m (H121: £689m) and net structural hedge contributions of £83m (H121: £592m) are included in Group net interest income. Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates. Quarterly analysis for Barclays UK and Barclays International Net interest income Average customer assets Net interest margin Three months ended 30.06.22 £m £m % Barclays UK 1,393 205,834 2.71 Barclays International1 1,016 92,371 4.41 Total Barclays UK and Barclays International 2,409 298,205 3.24 Three months ended 31.03.22 Barclays UK 1,339 207,607 2.62 Barclays International1 867 84,838 4.15 Total Barclays UK and Barclays International 2,206 292,445 3.06 Three months ended 31.12.21 Barclays UK 1,313 209,064 2.49 Barclays International1 848 81,244 4.14 Total Barclays UK and Barclays International 2,161 290,308 2.95 Three months ended 30.09.21 Barclays UK 1,303 207,692 2.49 Barclays International1 783 77,364 4.02 Total Barclays UK and Barclays International 2,086 285,056 2.90 Three months ended 30.06.21 Barclays UK 1,305 205,168 2.55 Barclays International1 763 77,330 3.96 Total Barclays UK and Barclays International 2,068 282,498 2.94 1 Barclays International margins include the lending related investment bank business. Performance Management Barclays PLC 24 -- 26 of 109 -- Risk management and principal risks The roles and responsibilities of the business groups, Risk and Compliance in the management of risk in the Group are defined in the Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the Group, the process by which the Group sets its appetite for these risks in its business activities, and the consequent limits which it places on related risk taking. The framework identifies nine principal risks: credit risk, market risk, treasury and capital risk, climate risk, operational risk, model risk, conduct risk, reputation risk and legal risk. Further detail on the Group’s principal risks and previously identified material existing and emerging risks and how such risks are managed is available in the Barclays PLC Annual Report 2021 (pages 202 to 223), or online at home.barclays/annualreport. There have been no significant changes to these principal risks or previously identified material existing and emerging risks in the period other than as set out below. Material existing and emerging risks Set out below are details of two additional material risks identified in H122 which potentially impact one or more principal risks. Internal control over financial reporting and disclosure controls and procedures The Group is subject to requirements under the Sarbanes-Oxley Act of 2002, as amended, to perform system and process evaluation and testing of its internal control over financial reporting to allow management to assess the effectiveness of its internal controls. In connection with the offer and sale of securities by Barclays Bank PLC in excess of the amounts registered under the 2019 F-3 and Predecessor Shelf (see “Over-issuance of US securities under Barclays Bank PLC's US shelf registration statements” below), management has concluded that the Group had a material weakness in relation to certain aspects of its internal control environment and that, as a consequence, its internal control over financial reporting as at 31 December 2021 was not effective under the applicable Committee of Sponsoring Organizations Framework and its disclosure controls and procedures were not effective as at such date. The material weakness that has been identified relates to a weakness in controls over the identification of external regulatory limits related to securities issuance and monitoring against these limits. As a result of this weakness, Barclays Bank PLC issued securities in excess of the amounts under the US shelf registration statements referred to above. Remediation efforts have begun and the Group is taking steps to strengthen internal controls relating to securities issuance to address the material weakness. However, internal control systems (no matter how well designed) have inherent limitations and may not prevent or detect further misstatements or errors (whether of a similar or different character to the foregoing). If the Group fails to maintain an effective internal control environment or its disclosure controls and procedures are not effective, the Group could suffer material misstatements in its financial statements and fail to meet its reporting obligations, which could cause investors to lose confidence in the Group's reported financial information. This could in turn limit the Group's access to capital markets, negatively impact its results of operations, and lead to a negative impact on the trading price of its securities. Additionally, ineffective internal control over financial reporting could expose the Group to increased risk of fraud or misuse of corporate assets and subject it to potential regulatory investigations and civil or criminal sanctions. Any of the foregoing could have a material adverse effect on Barclays Bank PLC’s and the Group's business, financial condition, results of operations and reputation as a frequent issuer in the securities markets. Over-issuance of US securities under Barclays Bank PLC's US shelf registration statements The Group may be subject to claims for rescission or damages and regulatory enforcement actions in connection with certain sales of securities issued by Barclays Bank PLC materially in excess of the amounts set forth in prior registration statements as set out under “Internal control over financial reporting and disclosure controls and procedures” above. The securities that were issued in excess of these amounts comprise structured notes and exchange traded notes (ETNs). As such, certain offers and sales were not made in compliance with the US Securities Act of 1933, as amended (Securities Act), giving rise to rights of rescission for certain purchasers of the securities. As a result, Barclays Bank PLC has elected to make a rescission offer (Rescission Offer) to eligible purchasers of the relevant affected securities, which it intends to launch on 1 August 2022. As previously disclosed, the Group is conducting a review (the Review), assisted by external counsel, of the facts and circumstances relating to the sale of the relevant affected securities in excess of amounts registered under such US shelf registration statements and, among other things, the control environment related to such sales. The Review is at an advanced stage and reports on its progress have been made to the Group’s management team, the Group Board, and regulators, including the SEC Divisions of Enforcement and Corporation Finance. Such reports have included, among other things: (i) an assessment that the issuance of securities in excess of the maximum aggregate offering price for BBPLC’s 2019 US Shelf resulted from a failure to monitor issuances during the period in which Barclays Bank PLC’s status changed from a Risk Management Barclays PLC 25 -- 27 of 109 -- “well-known seasoned issuer” to an “ineligible issuer” for US securities law purposes, which required Barclays Bank PLC to pre-register a set amount of securities to be issued under its US Shelf with the SEC; (ii) confirmation that the Review has not identified any evidence of intentional misconduct; and (iii) the discovery that, while the vast majority of the over-issuance occurred under the 2019 US Shelf, a small portion of the over-issuance also occurred under the Predecessor Shelf. The Group is also conducting an internal review involving a five-year look-back at limits in other issuance programmes. Management has assessed as remote the risk of material financial impact associated with issuance limits other than where pre-registration of securities is required; therefore the focus of the review has been on programmes with external regulatory limits related to securities issuance. This review has not identified any other breach of an external regulatory limit in any issuance programme used by a member of the Group. Management has identified an instance where a limit imposed solely for internal governance reasons was exceeded when taking into account a large security held on the Group's own balance sheet issued under a non-SEC registered debt issuance programme which did not have an external limit, although the breach of the internal limit did not give rise to any rights on the part of investors and did not constitute a material weakness. Nevertheless, there can be no assurance that the ongoing internal or external counsel reviews will not identify additional facts and information that could be material to an evaluation of this aspect of the Group's control environment. Under Section 12(a)(1) of the Securities Act, certain purchasers of unregistered securities have a right to recover, upon the tender of such security, the consideration paid for such security with interest, less the amount of any income received, or damages if the purchaser no longer owns the security (Rescission Price). Pursuant to the Rescission Offer, Barclays Bank PLC will offer to repurchase the relevant affected securities at the Rescission Price. Although the Rescission Offer is expected to reduce liability with respect to potential private civil claims, it will not necessarily prevent such claims from being asserted against Barclays Bank PLC and/or its affiliates, including claims under applicable US federal securities laws. Further, the Rescission Offer does not bar the SEC or other authorities from pursuing enforcement actions against Barclays Bank PLC and its affiliates, which are expected to result in fines, penalties and/or other sanctions. The Group is engaged with, and responding to inquiries and requests for information from, various regulators, including the SEC. The SEC’s investigation into this matter is at an advanced stage and the Group has had preliminary discussions with the staff of the SEC’s Division of Enforcement about resolving this matter. As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation to this matter, out of which £1,592m (December 2021: £220m) relates to the over-issuance of structured notes and £165m (December 2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential SEC resolution. A contingent liability exists in relation to the over-issuance of ETNs due to evidentiary challenges and the high level of trading in the securities. A contingent liability also exists in relation to any potential civil claims or enforcement actions taken against Barclays Bank PLC and its affiliates but Barclays Bank PLC is unable to assess the likelihood of liabilities that may arise out of such claims or actions, there is currently no indication of the exact timing for resolution and it is not practicable to provide an estimate of the financial effects. The final cost of the Rescission Offer will be impacted by a number of factors, including prevailing market conditions. Prior to the completion of the Rescission Offer, the amount of the provision in relation to the over-issuance of structured notes will fluctuate, perhaps materially, due, in part, to the volatility of the market prices for the structured notes subject to the Rescission Offer. While Barclays Bank PLC and/or its affiliates have entered into hedging arrangements designed to minimise the volatility, such arrangements cannot by their very nature completely hedge the exposures, which may mean the final impact of the Rescission Offer may materially differ from the £1,592m provision reflected as at 30 June 2022. In addition, the hedging arrangements may be modified, may not prove effective (in existing or modified form), may expire prior to the end of the Rescission Offer and do not cover any other losses arising out of potential private civil claims or enforcement actions. The provision of £165m in relation to the potential SEC resolution may also be impacted by the ultimate outcome of the ongoing discussions. Any of the foregoing could result in material additional losses for the Group. Any liabilities, claims or actions in connection with the over-issuance of securities under the 2019 F-3 and the Predecessor Shelf could have a material adverse effect on Barclays Bank PLC's and the Group's business, financial condition, results of operations and reputation as a frequent issuer in the securities markets. Management has concluded that, by virtue of the fact that there was a weakness in controls over the identification of external regulatory limits related to securities issuance and monitoring against these limits, the Group had a material weakness in relation to certain aspects of its internal control environment and, as a consequence, its internal control over financial reporting and disclosure controls and procedures as at 31 December 2021 were not effective. Further details on such material weakness are set out under “Internal control over financial reporting and disclosure controls and procedures” above. Risk Management Barclays PLC 26 -- 28 of 109 -- Loans and advances at amortised cost by stage The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio by stage allocation and business segment as at 30 June 2022. Also included are off- balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio by stage allocation as at 30 June 2022. Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as expected credit loss (ECL) is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision. Gross exposure Impairment allowance Net exposure Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 30.06.22 £m £m £m £m £m £m £m £m £m Barclays UK 160,110 23,805 3,012 186,927 218 780 753 1,751 185,176 Barclays International 32,053 3,251 1,674 36,978 679 821 826 2,326 34,652 Head Office 3,852 215 688 4,755 2 16 346 364 4,391 Total Barclays Group retail 196,015 27,271 5,374 228,660 899 1,617 1,925 4,441 224,219 Barclays UK 35,915 2,267 862 39,044 131 49 117 297 38,747 Barclays International 120,470 11,916 1,022 133,408 254 198 287 739 132,669 Head Office 186 1 23 210 — — 21 21 189 Total Barclays Group wholesale1 156,571 14,184 1,907 172,662 385 247 425 1,057 171,605 Total loans and advances at amortised cost 352,586 41,455 7,281 401,322 1,284 1,864 2,350 5,498 395,824 Off-balance sheet loan commitments and financial guarantee contracts2 373,544 24,429 1,146 399,119 275 233 17 525 398,594 Total3 726,130 65,884 8,427 800,441 1,559 2,097 2,367 6,023 794,418 As at 30.06.22 Half year ended 30.06.22 Coverage ratio Loan impairment charge/(release) and loan loss rate Stage 1 Stage 2 Stage 3 Total Loan impairment charge/(release) Loan loss rate % % % % £m bps Barclays UK 0.1 3.3 25.0 0.9 14 2 Barclays International 2.1 25.3 49.3 6.3 253 138 Head Office 0.1 7.4 50.3 7.7 (18) — Total Barclays Group retail 0.5 5.9 35.8 1.9 249 22 Barclays UK 0.4 2.2 13.6 0.8 36 19 Barclays International 0.2 1.7 28.1 0.6 75 11 Head Office — — 91.3 10.0 — — Total Barclays Group wholesale1 0.2 1.7 22.3 0.6 111 13 Total loans and advances at amortised cost 0.4 4.5 32.3 1.4 360 18 Off-balance sheet loan commitments and financial guarantee contracts2 0.1 1.0 1.5 0.1 (42) Other financial assets subject to impairment3 23 Total4 0.2 3.2 28.1 0.8 341 1 Includes Wealth UK and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures, including lending under the government backed Bounce Back Loan Scheme (BBLS) of £8.1bn that are managed on a collective basis and reported within BUK Retail. The net impact is a difference in total exposure of £4.3bn of balances reported as wholesale loans on page 29 in the Loans and advances at amortised cost by product disclosure. 2 Excludes loan commitments and financial guarantees of £21.1bn carried at fair value. 3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.3bn and impairment allowance of £149m. This comprises £11m ECL on £195.0bn Stage 1 assets, £2m on £2.1bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £136m on £143m Stage 3 other assets. 4 The loan loss rate is 17bps after applying the total impairment charge of £341m. Credit Risk Barclays PLC 27 -- 29 of 109 -- Gross exposure Impairment allowance Net exposure Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 31.12.21 £m £m £m £m £m £m £m £m £m Barclays UK 160,695 22,779 2,915 186,389 261 949 728 1,938 184,451 Barclays International 25,981 2,691 1,566 30,238 603 795 858 2,256 27,982 Head Office 3,735 429 705 4,869 2 36 347 385 4,484 Total Barclays Group retail 190,411 25,899 5,186 221,496 866 1,780 1,933 4,579 216,917 Barclays UK 35,571 1,917 969 38,457 153 43 111 307 38,150 Barclays International 92,341 13,275 1,059 106,675 187 192 458 837 105,838 Head Office 542 2 21 565 — — 19 19 546 Total Barclays Group wholesale1 128,454 15,194 2,049 145,697 340 235 588 1,163 144,534 Total loans and advances at amortised cost 318,865 41,093 7,235 367,193 1,206 2,015 2,521 5,742 361,451 Off-balance sheet loan commitments and financial guarantee contracts2 312,142 34,815 1,298 348,255 217 302 23 542 347,713 Total3 631,007 75,908 8,533 715,448 1,423 2,317 2,544 6,284 709,164 As at 31.12.21 Half year ended 31.12.21 Coverage ratio Loan impairment charge/(release) and loan loss rate Stage 1 Stage 2 Stage 3 Total Loan impairment charge/(release) Loan loss rate % % % % £m bps Barclays UK 0.2 4.2 25.0 1.0 (227) — Barclays International 2.3 29.5 54.8 7.5 181 60 Head Office 0.1 8.4 49.2 7.9 — — Total Barclays Group retail 0.5 6.9 37.3 2.1 (46) — Barclays UK 0.4 2.2 11.5 0.8 122 32 Barclays International 0.2 1.4 43.2 0.8 (197) — Head Office — — 90.5 3.4 — — Total Barclays Group wholesale1 0.3 1.5 28.7 0.8 (75) — Total loans and advances at amortised cost 0.4 4.9 34.8 1.6 (121) — Off-balance sheet loan commitments and financial guarantee contracts2 0.1 0.9 1.8 0.2 (514) Other financial assets subject to impairment3 (18) Total 0.2 3.1 29.8 0.9 (653) 1 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures, including BBLS of £9.4bn that are managed on a collective basis and reported within Barclays UK Retail. The net impact is a difference in total exposure of £6.0bn of balances reported as wholesale loans on page 29 in the Loans and advances at amortised cost by product disclosure. 2 Excludes loan commitments and financial guarantees of £18.8bn carried at fair value. 3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £155.2bn and impairment allowance of £114m. This comprises £6m ECL on £154.9bn Stage 1 assets, £1m on £157.0bn Stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances and £107m on £110m Stage 3 other assets. Credit Risk Barclays PLC 28 -- 30 of 109 -- Loans and advances at amortised cost by product The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification. Stage 2 As at 30.06.22 Stage 1 Not past due <=30 days past due >30 days past due Total Stage 3 Total Gross exposure £m £m £m £m £m £m £m Home loans 150,883 16,269 1,700 765 18,734 2,110 171,727 Credit cards, unsecured loans and other retail lending 43,628 5,918 303 273 6,494 2,510 52,632 Wholesale loans 158,075 15,814 84 329 16,227 2,661 176,963 Total 352,586 38,001 2,087 1,367 41,455 7,281 401,322 Impairment allowance Home loans 19 29 6 6 41 398 458 Credit cards, unsecured loans and other retail lending 860 1,329 100 126 1,555 1,448 3,863 Wholesale loans 405 264 2 2 268 504 1,177 Total 1,284 1,622 108 134 1,864 2,350 5,498 Net exposure Home loans 150,864 16,240 1,694 759 18,693 1,712 171,269 Credit cards, unsecured loans and other retail lending 42,768 4,589 203 147 4,939 1,062 48,769 Wholesale loans 157,670 15,550 82 327 15,959 2,157 175,786 Total 351,302 36,379 1,979 1,233 39,591 4,931 395,824 Coverage ratio % % % % % % % Home loans — 0.2 0.4 0.8 0.2 18.9 0.3 Credit cards, unsecured loans and other retail lending 2.0 22.5 33.0 46.2 23.9 57.7 7.3 Wholesale loans 0.3 1.7 2.4 0.6 1.7 18.9 0.7 Total 0.4 4.3 5.2 9.8 4.5 32.3 1.4 As at 31.12.21 Gross exposure £m £m £m £m £m £m £m Home loans 148,058 17,133 1,660 707 19,500 2,122 169,680 Credit cards, unsecured loans and other retail lending 37,840 5,102 300 248 5,650 2,332 45,822 Wholesale loans 132,967 15,246 306 391 15,943 2,781 151,691 Total 318,865 37,481 2,266 1,346 41,093 7,235 367,193 Impairment allowance Home loans 19 46 6 7 59 397 475 Credit cards, unsecured loans and other retail lending 824 1,493 85 123 1,701 1,504 4,029 Wholesale loans 363 248 4 3 255 620 1,238 Total 1,206 1,787 95 133 2,015 2,521 5,742 Net exposure Home loans 148,039 17,087 1,654 700 19,441 1,725 169,205 Credit cards, unsecured loans and other retail lending 37,016 3,609 215 125 3,949 828 41,793 Wholesale loans 132,604 14,998 302 388 15,688 2,161 150,453 Total 317,659 35,694 2,171 1,213 39,078 4,714 361,451 Coverage ratio % % % % % % % Home loans — 0.3 0.4 1.0 0.3 18.7 0.3 Credit cards, unsecured loans and other retail lending 2.2 29.3 28.3 49.6 30.1 64.5 8.8 Wholesale loans 0.3 1.6 1.3 0.8 1.6 22.3 0.8 Total 0.4 4.8 4.2 9.9 4.9 34.8 1.6 Credit Risk Barclays PLC 29 -- 31 of 109 -- Loans and advances at amortised cost by selected sectors The table below presents a breakdown of drawn exposure and impairment allowance for loans and advances at amortised cost with stage allocation for selected industry sectors within the wholesale loans portfolio. As the nature of macroeconomic uncertainty has evolved from the COVID-19 pandemic towards high inflation, supply chain constraints and consumer demand headwinds, so has the selected population under management focus. The gross loans and advances to selected sectors have remained stable over the year. The small increase in provisions is informed by the improved macroeconomic outlook used in the Q222 scenario refresh, offset by management judgments to reflect the risk of uncertainty still prevailing within these sectors. The wholesale portfolio also benefits from a hedge protection programme that enables effective risk management against credit losses. An additional £0.1bn (December 2021: £0.1bn) impairment allowance has been applied to the undrawn exposures not included in the table below. Gross exposure Impairment allowance Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 30.06.22 £m £m £m £m £m £m £m £m Autos 914 370 2 1,286 10 5 — 15 Consumer manufacture 3,498 1,587 215 5,300 45 27 47 119 Discretionary retail and wholesale 5,811 1,311 240 7,362 34 21 45 100 Hospitality and leisure 3,817 1,755 352 5,924 33 35 41 109 Passenger travel 807 318 107 1,232 11 5 12 28 Real estate 14,001 2,509 550 17,060 89 45 107 241 Steel and aluminium manufacturers 610 75 7 692 6 1 1 8 Total 29,458 7,925 1,473 38,856 228 139 253 620 Total of wholesale exposures (%) 19% 49% 55% 22% 56% 52% 50% 53% Gross exposure Impairment allowance Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total As at 31.12.21 £m £m £m £m £m £m £m £m Autos 656 295 2 953 3 3 — 6 Consumer manufacture 3,904 1,304 211 5,419 18 22 43 83 Discretionary retail and wholesale 5,413 1,197 230 6,840 47 20 54 121 Hospitality and leisure 4,348 1,613 384 6,345 28 33 44 105 Passenger travel 856 285 143 1,284 30 8 40 78 Real estate 13,620 3,314 518 17,452 65 53 93 211 Steel and aluminium manufacturers 415 75 6 496 2 3 1 6 Total 29,212 8,083 1,494 38,789 193 142 275 610 Total of wholesale exposures (%) 22% 51% 54% 26% 53% 56% 44% 49% UK Commercial real estate exposure continues to remain well collateralised, however it has been included within the latest selected sector scoping as the broader real estate sector remains under pressure due to pricing and affordability concerns, as well as construction input costs and supply chain issues adding to the uncertainty, in particular across non-investment grade exposures. The coverage ratio for selected sectors has broadly remained consistent at 1.6% as at 30 June 2022. Non-default coverage has marginally increased from 0.9% as at 31 December 2021 to 1.0% as at 30 June 2022. Credit Risk Barclays PLC 30 -- 32 of 109 -- Movement in gross exposures and impairment allowance including provisions for loan commitments and financial guarantees The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An explanation of the methodology used to determine credit impairment provisions is included in the Barclays PLC Annual Report 2021 (Page 348). Transfers between stages in the table have been reflected as if they had taken place at the beginning of the year. The movements are measured over a 6-month period. Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL Home loans £m £m £m £m £m £m £m £m As at 1 January 2022 148,058 19 19,500 59 2,122 397 169,680 475 Transfers from Stage 1 to Stage 2 (5,725) (1) 5,725 1 — — — — Transfers from Stage 2 to Stage 1 5,131 18 (5,131) (18) — — — — Transfers to Stage 3 (197) — (234) (5) 431 5 — — Transfers from Stage 3 19 1 133 3 (152) (4) — — Business activity in the period1 14,723 4 339 1 1 — 15,063 5 Refinements to models used for calculation — — — — — — — — Net drawdowns, repayments, net re- measurement and movement due to exposure and risk parameter changes (4,151) (22) (506) 2 (69) 16 (4,726) (4) Final repayments (6,975) — (1,092) (2) (210) (3) (8,277) (5) Disposals — — — — — — — — Write-offs2 — — — — (13) (13) (13) (13) As at 30 June 20223 150,883 19 18,734 41 2,110 398 171,727 458 Credit cards, unsecured loans and other retail lending As at 1 January 2022 37,840 824 5,650 1,701 2,332 1,504 45,822 4,029 Transfers from Stage 1 to Stage 2 (2,572) (67) 2,572 67 — — — — Transfers from Stage 2 to Stage 1 1,689 422 (1,689) (422) — — — — Transfers to Stage 3 (444) (11) (516) (222) 960 233 — — Transfers from Stage 3 30 13 49 9 (79) (22) — — Business activity in the period1 8,231 354 294 32 20 5 8,545 391 Refinements to models used for calculation4 — 43 — 187 — 96 — 326 Net drawdowns, repayments, net re- measurement and movement due to exposure and risk parameter changes5 1,678 (691) 413 240 94 285 2,185 (166) Final repayments (2,673) (23) (251) (27) (140) (29) (3,064) (79) Disposals6 (151) (4) (28) (10) (122) (69) (301) (83) Write-offs2 — — — — (555) (555) (555) (555) As at 30 June 20223 43,628 860 6,494 1,555 2,510 1,448 52,632 3,863 1 Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re- measurement and movements due to exposure and risk parameter changes'. Business activity reported within Credit cards, unsecured loans and other retail lending portfolio includes GAP portfolio acquisition in US cards of £2.7bn. 2 In H122, gross write-offs amounted to £768m (H121: £1,001m) and post write-off recoveries amounted to £36m (H121: £31m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £732m (H121: £970m). 3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.3bn (December 21: £155.2bn) and an impairment allowance of £149m (December 21: £114m). This comprises £11m ECL (December 21: £6m) on £195.0bn stage 1 assets (December 21: £154.9bn), £2m (December 21: £1m) on £2.1bn stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 21: £0.2bn) and £136m (FY21: £107m) on £143m stage 3 other assets (December 21: £110m). 4 Refinements to models used for calculation reported within Credit cards, unsecured loans and other retail lending portfolio include a £0.3bn movement in US cards. These reflect methodology changes made during the year. Barclays continually review the output of models to determine accuracy of the ECL calculation including review of model monitoring, external benchmarking and experience of model operation over an extended period of time. This ensures that the models used continue to reflect the risks inherent across the businesses. 5 Transfers and risk parameter changes include a £0.2bn (December 21: £0.3bn) net release in ECL arising from a reclassification of £1.4bn (December 21: £1.9bn) gross loans and advances from Stage 2 to Stage 1 in Credit cards, unsecured loans and other retail lending portfolio. The reclassification followed a review of back-testing of results which indicated that accuracy of origination probability of default characteristics required management adjustments to correct. The re-classification was first established in Q220. 6 The £0.3bn disposals reported within Credit cards, unsecured loans and other retail lending portfolio includes £0.2bn sale of NFL portfolio within US cards and £0.1bn of debt sales undertaken during the year. Credit Risk Barclays PLC 31 -- 33 of 109 -- Loans and advances at amortised cost Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL Wholesale loans £m £m £m £m £m £m £m £m As at 1 January 2022 132,967 363 15,943 255 2,781 620 151,691 1,238 Transfers from Stage 1 to Stage 2 (5,129) (29) 5,129 29 — — — — Transfers from Stage 2 to Stage 1 5,544 41 (5,544) (41) — — — — Transfers to Stage 3 (676) (3) (405) (6) 1,081 9 — — Transfers from Stage 3 114 9 200 17 (314) (26) — — Business activity in the period1 28,927 40 1,670 14 108 14 30,705 68 Refinements to models used for calculation2 — (66) — (42) — (374) — (482) Net drawdowns, repayments, net re- measurement and movement due to exposure and risk parameter changes3 12,529 79 1,048 70 (634) 555 12,943 704 Final repayments (16,201) (29) (1,783) (28) (115) (48) (18,099) (105) Disposals4 — — (31) — (46) (46) (77) (46) Write-offs5 — — — — (200) (200) (200) (200) As at 30 June 20226 158,075 405 16,227 268 2,661 504 176,963 1,177 Reconciliation of ECL movement to impairment charge/(release) for the period £m Home loans (4) Credit cards, unsecured loans and other retail lending 472 Wholesale loans 185 ECL movement excluding assets derecognised due to disposals and write-offs 653 Recoveries and reimbursements7 (47) Exchange and other adjustments8 (246) Impairment release on loan commitments and other financial guarantees (42) Impairment charge on other financial assets6 23 Income statement charge for the period 341 1 Business activity in the period does not include additional drawdowns on the existing facility which are reported under 'Net drawdowns, repayments, net re- measurement and movements due to exposure and risk parameter changes'. 2 Refinements to models used for calculation reported within Wholesale loans relates to a £0.5bn movement in Business Banking. This relates to an update in the underlying ECL model that now fully recognises the 100% government guarantee against Barclays Bounce Back Loans exposure. 3 "Net drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes" reported within Wholesale loans also include assets of £0.5bn de-recognised due to payment received on defaulted loans from government guarantees issued under government’s Bounce Back Loans Scheme. 4 The £0.1bn disposals reported within Wholesale loans relates to debt sales undertaken during the year. 5 In H122, gross write-offs amounted to £768m (H121: £1,001m) and post write-off recoveries amounted to £36m (H121: £31m). Net write-offs represent gross write-offs less post write-off recoveries and amounted to £732m (H121: £970m). 6 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £197.3bn (December 21: £155.2bn) and impairment allowance of £149m (December 21: £114m). This comprises £11m ECL (December 21: £6m) on £195.0bn stage 1 assets (December 21: £154.9bn), £2m (December 21: £1m) on £2.1bn stage 2 fair value through other comprehensive income assets, other assets and cash collateral and settlement balances (December 21: £157.0bn) and £136m (December 21: £107m) on £143m stage 3 other assets (December 21: £110m). 7 Recoveries and reimbursements includes a net gain in relation to reimbursements from financial guarantee contracts held with third parties of £11m (H121 loss: £216m) and post write off recoveries of £36m (H121: £31m). 8 Exchange and other adjustments includes foreign exchange and interest and fees in suspense. Credit Risk Barclays PLC 32 -- 34 of 109 -- Loan commitments and financial guarantees Stage 1 Stage 2 Stage 3 Total Gross exposure ECL Gross exposure ECL Gross exposure ECL Gross exposure ECL Home loans £m £m £m £m £m £m £m £m As at 1 January 2022 10,833 — 532 — 3 — 11,368 — Net transfers between stages 39 — (39) — — — — — Business activity in the period 8,146 — — — — — 8,146 — Net drawdowns, repayments, net re- measurement and movement due to exposure and risk parameter changes (6,354) — (12) — — — (6,366) — Limit management and final repayments (172) — (22) — — — (194) — As at 30 June 2022 12,492 — 459 — 3 — 12,954 — Credit cards, unsecured loans and other retail lending As at 1 January 2022 122,819 50 5,718 61 218 20 128,755 131 Net transfers between stages (1,277) 23 935 (18) 342 (5) — — Business activity in the period 26,892 1 212 — — — 27,104 1 Net drawdowns, repayments, net re- measurement and movement due to exposure and risk parameter changes 9,385 3 (1,267) 20 (288) 2 7,830 25 Limit management and final repayments (3,740) (1) (209) (3) (36) — (3,985) (4) As at 30 June 2022 154,079 76 5,389 60 236 17 159,704 153 Wholesale loans As at 1 January 2022 178,490 167 28,565 241 1,077 3 208,132 411 Net transfers between stages 9,775 36 (9,709) (37) (66) 1 — — Business activity in the period 37,358 19 2,864 24 1 — 40,223 43 Net drawdowns, repayments, net re- measurement and movement due to exposure and risk parameter changes 17,712 (9) 1,510 (22) 140 (5) 19,362 (36) Limit management and final repayments (36,362) (14) (4,649) (33) (245) 1 (41,256) (46) As at 30 June 2022 206,973 199 18,581 173 907 — 226,461 372 Credit Risk Barclays PLC 33 -- 35 of 109 -- Management adjustments to models for impairment Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy that are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period end. Management adjustments are reviewed and incorporated into future model development where applicable. Total management adjustments to impairment allowance are presented by product below: Overview of management adjustments to models for impairment allowance1 As at 30.06.22 As at 31.12.21 Management adjustments to impairment allowances Proportion of total impairment allowances Management adjustments to impairment allowances Proportion of total impairment allowances £m % £m % Home loans 76 16.6 103 21.7 Credit cards, unsecured loans and other retail lending 785 19.6 1,362 32.7 Wholesale loans2 426 27.5 21 1.3 Total 1,287 21.4 1,486 23.6 Management adjustments to models for impairment allowance1 Impairment allowance pre management adjustments3 Economic uncertainty adjustments Other adjustments Total Adjustments Total impairment allowance4 (a) (b) (a+b) As at 30.06.22 £m £m £m £m £m Home loans 382 43 33 76 458 Credit cards, unsecured loans and other retail lending 3,229 578 207 785 4,014 Wholesale loans 1,125 417 9 426 1,551 Total 4,736 1,038 249 1,287 6,023 As at 31.12.21 Home loans 372 72 31 103 475 Credit cards, unsecured loans and other retail lending 2,798 1,217 145 1,362 4,160 Wholesale loans 1,628 403 (382) 21 1,649 Total 4,798 1,692 (206) 1,486 6,284 1 Positive values reflect an increase in impairment allowance and negative values reflect a reduction in the impairment allowance. 2 Proportion of management adjustments to impairment allowances has increased in wholesale loans primarily driven by release of offsetting PMA to recognise BBLS government guarantees of £0.4bn; now captured through the model. Excluding this, proportion of management adjustments to impairment allowances remain materially stable compare to previous year. 3 Includes £4.1bn (December 2021: £4.1bn) of modelled ECL, £0.4bn (December 2021: £0.5bn) of individually assessed impairments and £0.2bn (December 2021: £0.2bn) ECL from non-modelled exposures. 4 Total impairment allowance consists of ECL stock on drawn and undrawn exposure. Economic uncertainty adjustments Throughout the COVID-19 pandemic in 2020 and 2021, macroeconomic forecasts anticipated lasting impacts to unemployment levels and customer and client stress. However, the most recent macroeconomic outlook suggests the concerns over the spread of COVID-19 in major economies has receded and normalisation of customer behaviour has been observed, but uncertainty persists: Russia’s invasion of Ukraine is affecting global energy markets and food prices; China’s ‘zero-COVID’ policy is putting pressure on stretched supply chains; and labour markets continue to generate inflationary pressures. Credit deterioration could still occur as emerging supply chain disruption and inflationary pressures challenge economic stability; and economic consensus may not capture the range of arising economic uncertainty. Given this backdrop, COVID-19 related expert judgements have been materially replaced by provisions for customers and clients considered most vulnerable to rising costs and supply chain disruption. This uncertainty continues to be captured in two distinct ways. Firstly, customer uncertainty: the identification of customers and clients who may be more vulnerable to the emerging economic instability; and secondly, model uncertainty: to capture the impact from model limitations and sensitivities to specific macroeconomic parameters which are applied at a portfolio level. Credit Risk Barclays PLC 34 -- 36 of 109 -- The economic uncertainty adjustments of £1.0bn (FY21: £1.7bn) include customer and client uncertainty provisions of £0.8bn (FY21: £1.5bn) and model uncertainty provisions of £0.2bn (FY21: £0.2bn). Customer and client uncertainty provisions include an adjustment of £0.8bn (FY21: £1.5bn) which has been applied to customers and clients considered potentially vulnerable to the emerging economic instability in light of inflationary and supply chain concerns. This adjustment is split between credit cards, unsecured loans and other retail lending £0.5bn (FY21: £0.8bn) and wholesale loans £0.3bn (FY21: £0.3bn). The reduction in the credit cards, unsecured loans and other retail lending-related adjustment is due to unwinding of COVID-19 related expert judgements partially offset by provisions booked for customers and clients considered more vulnerable to rising costs and slowing consumer demand. Furthermore, a previously held 2021 adjustment of £0.4bn to amend probabilities of default (PDs), informed by pre COVID-19 levels, is no longer required as the normalisation of customer behaviour is now captured within the modelled output. Model uncertainty provisions £0.2bn (2021: £0.2bn) informed by modelled provisions following the updated Q222 scenario. Other adjustments Other adjustments are operational in nature and are expected to remain in place until they can be corrected in the underlying models. These adjustments result from data limitations and model performance related issues identified through established governance processes. The quantum of adjustments has reduced in response to the macroeconomic variable refresh in Q222 as well as model enhancements made during H122. Material adjustments comprise the following: Home loans: The low average loan to value (LTV) nature of the UK Home Loans portfolio means that modelled ECL estimates are low. An adjustment is made to maintain an appropriate level of ECL informed by model monitoring. Credit cards, unsecured loans and other retail lending: Includes the estimated ECL impact from adoption of the new definition of default under the Capital Requirements Regulation, the Day 1 provision for the GAP portfolio acquisition in US cards, an annual update to the qualitative measures used in high risk account management (HRAM) and adjustments for model inaccuracies informed by model monitoring; partially offset by a reclassification of loans and advances from Stage 2 to Stage 1 in credit cards. The reclassification followed a review of back-testing results which indicated that accuracy of origination probability of default characteristics requires management adjustments to correct and was first established in Q220. This adjustment has been reduced, driven by the improved macroeconomic scenarios in Q222. Wholesale loans: Management adjustments of £(0.4)bn within wholesale loans in 2021 principally comprised an adjustment applied on bounce back loans of £(0.4)bn to reverse out the modelled charge which did not consider the government guarantee when calculating the ECL. This adjustment is no longer needed due to model enhancements. Credit Risk Barclays PLC 35 -- 37 of 109 -- Measurement uncertainty Management has applied economic uncertainty and other adjustments to modelled ECL outputs. Economic uncertainty adjustments have been applied to customers and clients considered most vulnerable to rising costs and supply chain disruption. As a result, ECL is higher than would be the case if it were based on forecast economic scenarios alone. The measurement of modelled ECL involves complexity and judgement, including estimation of probabilities of default (PD), loss given default (LGD), a range of unbiased future economic scenarios, estimation of expected lives, estimation of exposures at default (EAD) and assessing significant increases in credit risk. The Group uses a five-scenario model to calculate ECL. An external consensus forecast is assembled from key sources, including HM Treasury (short and medium term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House Prices), which forms the Baseline scenario. In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are derived, with associated probability weightings. The adverse scenarios are calibrated to a broadly similar severity to Barclays’ internal stress tests and stress scenarios provided by regulators whilst also considering IFRS 9 specific sensitivities and non-linearity. The favourable scenarios are designed to reflect plausible upside risks to the Baseline scenario which are broadly consistent with the economic narrative approved by the Senior Scenario Review Committee. All scenarios are regenerated at a minimum semi-annually. The scenarios include key economic variables, (including GDP, unemployment, House Price Index (HPI) and base rates in both the UK and US markets), and expanded variables using statistical models based on historical correlations. The upside and downside shocks are designed to evolve over a five-year stress horizon, with all five scenarios converging to a steady state after approximately seven years. Scenarios used to calculate the Group’s ECL charge were refreshed in Q222. The current Baseline scenario reflects the latest consensus economic forecasts. Unemployment rates remain low, close to current levels. As inflation expectations drift higher, central banks tighten monetary policy sharply. In 2023, the UK Bank Rate reaches 2.75%, while the US Federal Funds Rate peaks at 3.25%. Rising borrowing charges and falling real wages subtract from growth through lower investment and household consumption. In the Downside 2 scenario, with inflation expectations rising, the central banks have to raise interest rates very sharply. The UK Bank Rate and the US Federal Funds Rate both reach 5.0% in Q223. Higher borrowing costs derail the economy and unemployment peaks in Q124 at 9.2% in the UK and 9.5% in the US. Given already stretched valuations, the sharp increase in mortgage servicing costs sees house prices decrease very sharply. In the Upside 2 scenario, supply disruptions get resolved, while the aggregate demand is supported by a release of household savings. GDP growth accelerates. Recovering labour force participation limits domestic inflationary pressures, while lower energy prices add some downward pressure on prices globally. The methodology for estimating probability weights used in calculating ECL involves simulating a range of future paths for UK and US GDP using historical data. The five scenarios are mapped against the distribution of these future paths, with the median centred around the Baseline such that scenarios further from the Baseline attract a lower weighting. A single set of five scenarios is used across all portfolios and all five weights are normalised to equate to 100%. The same scenarios and weights that are used in the ECL estimation are also used for Barclays’ internal planning purposes. The impacts across the portfolios are different because of the sensitivities of each of the portfolios to specific macroeconomic variables. For example, mortgages are highly sensitive to house prices; credit cards and unsecured consumer loans are highly sensitive to unemployment. The decrease in the Upside scenario weightings and increase in the Baseline weighting were driven by: (i) continued growth in UK/US GDP which resulted in a narrower fan of future GDP paths; and (ii) generally less favourable GDP projections across scenarios, increasing the distance between Upside 2 and Baseline scenario paths. For further details see page 40. COVID-19 related expert judgements have been materially replaced by provisions for customers and clients considered most vulnerable to rising costs and supply chain disruption. The economic uncertainty adjustments of £1.0bn (FY21: £1.7bn) have been applied as overlays to the modelled ECL output. These adjustments consist of a customer and client uncertainty provision of £0.8bn (FY21: £1.5bn) and a model uncertainty provision of £0.2bn (FY21: £0.2bn). For further details, see pages 34 to 35. The tables below show the key consensus macroeconomic variables used in the scenarios (5-year annual paths), the probability weights applied to each scenario and the macroeconomic variables by scenario using ‘specific bases’ i.e. the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios and the lowest unemployment for upside scenarios. The 5-year average table provides additional transparency. Credit Risk Barclays PLC 36 -- 38 of 109 -- Baseline average macroeconomic variables used in the calculation of ECL 2022 2023 2024 2025 2026 As at 30.06.22 % % % % % UK GDP1 3.9 1.7 1.6 1.6 1.6 UK unemployment2 4.0 4.1 3.9 3.9 3.9 UK HPI3 4.3 1.0 2.2 2.5 2.8 UK bank rate 1.5 2.7 2.4 2.1 2.0 US GDP1 3.3 2.2 2.1 2.1 2.1 US unemployment4 3.6 3.5 3.5 3.5 3.5 US HPI5 4.1 3.4 3.4 3.4 3.4 US federal funds rate 1.5 3.2 2.9 2.7 2.5 2021 2022 2023 2024 2025 As at 31.12.21 % % % % % UK GDP1 6.2 4.9 2.3 1.9 1.7 UK unemployment2 4.8 4.7 4.5 4.3 4.2 UK HPI3 4.7 1.0 1.9 1.9 2.3 UK bank rate 0.1 0.8 1.0 1.0 0.8 US GDP1 5.5 3.9 2.6 2.4 2.4 US unemployment4 5.5 4.2 3.6 3.6 3.6 US HPI5 11.8 4.5 5.2 4.9 5.0 US federal funds rate 0.2 0.3 0.9 1.2 1.3 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in year end US HPI = FHFA House Price Index, relative to prior year end. Credit Risk Barclays PLC 37 -- 39 of 109 -- Downside 2 average economic variables used in the calculation of ECL 2022 2023 2024 2025 2026 As at 30.06.22 % % % % % UK GDP1 3.1 (4.8) (0.4) 4.3 3.6 UK unemployment2 5.2 8.4 8.6 6.8 5.9 UK HPI3 0.2 (26.2) (3.6) 17.9 10.2 UK bank rate 1.8 4.7 4.3 2.6 2.3 US GDP1 2.4 (4.1) (0.2) 3.4 2.7 US unemployment4 4.6 8.0 9.0 7.1 5.8 US HPI5 (0.2) (11.7) (0.2) 5.5 3.5 US federal funds rate 1.8 4.8 4.6 3.6 3.0 2021 2022 2023 2024 2025 As at 31.12.21 % % % % % UK GDP1 6.2 0.2 (4.0) 2.8 4.3 UK unemployment2 4.8 7.2 9.0 7.6 6.3 UK HPI3 4.7 (14.3) (21.8) 11.9 15.2 UK bank rate 0.1 2.2 3.9 3.1 2.2 US GDP1 5.5 (0.8) (3.5) 2.5 3.2 US unemployment4 5.5 6.4 9.1 8.1 6.4 US HPI5 11.8 (6.6) (9.0) 5.9 6.7 US federal funds rate 0.2 2.1 3.4 2.6 2.0 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in year end US HPI = FHFA House Price Index, relative to prior year end. Downside 1 average economic variables used in the calculation of ECL 2022 2023 2024 2025 2026 As at 30.06.22 % % % % % UK GDP1 3.5 (1.6) 0.6 3.0 2.6 UK unemployment2 4.6 6.2 6.2 5.3 4.9 UK HPI3 2.3 (13.2) (0.8) 10.0 6.5 UK bank rate 1.6 3.8 3.4 2.4 2.0 US GDP1 2.7 (1.0) 1.1 2.9 2.5 US unemployment4 4.1 5.7 6.2 5.3 4.6 US HPI5 1.9 (4.4) 1.6 4.4 3.4 US federal funds rate 1.7 3.9 3.8 3.2 2.8 2021 2022 2023 2024 2025 As at 31.12.21 % % % % % UK GDP1 6.2 2.8 (0.7) 2.3 2.9 UK unemployment2 4.8 6.2 6.8 6.0 5.3 UK HPI3 4.7 (6.8) (10.5) 6.9 8.6 UK bank rate 0.1 1.6 2.7 2.3 1.6 US GDP1 5.5 1.6 (0.4) 2.4 2.7 US unemployment4 5.5 5.4 6.6 6.1 5.2 US HPI5 11.8 (1.2) (2.1) 4.8 5.2 US federal funds rate 0.2 1.3 2.3 2.1 1.8 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in year end US HPI = FHFA House Price Index, relative to prior year end. Credit Risk Barclays PLC 38 -- 40 of 109 -- Upside 2 average economic variables used in the calculation of ECL 2022 2023 2024 2025 2026 As at 30.06.22 % % % % % UK GDP1 5.0 5.2 3.1 2.4 2.0 UK unemployment2 3.8 3.7 3.6 3.6 3.6 UK HPI3 6.5 11.2 6.2 4.7 3.7 UK bank rate 1.2 1.5 1.4 1.3 1.3 US GDP1 4.0 4.9 3.6 3.4 3.4 US unemployment4 3.4 3.0 3.1 3.1 3.1 US HPI5 5.4 5.5 4.6 4.5 4.5 US federal funds rate 1.1 2.2 1.9 1.7 1.5 2021 2022 2023 2024 2025 As at 31.12.21 % % % % % UK GDP1 6.2 7.2 4.0 2.7 2.1 UK unemployment2 4.8 4.5 4.1 4.0 4.0 UK HPI3 4.7 8.5 9.0 5.2 4.2 UK bank rate 0.1 0.2 0.5 0.5 0.3 US GDP1 5.5 5.3 4.1 3.5 3.4 US unemployment4 5.5 3.9 3.4 3.3 3.3 US HPI5 11.8 10.6 8.5 7.2 6.6 US federal funds rate 0.2 0.3 0.4 0.7 1.0 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in year end US HPI = FHFA House Price Index, relative to prior year end. Upside 1 average economic variables used in the calculation of ECL 2022 2023 2024 2025 2026 As at 30.06.22 % % % % % UK GDP1 4.5 3.5 2.4 2.0 1.8 UK unemployment2 3.9 3.8 3.8 3.8 3.8 UK HPI3 5.4 6.3 4.1 3.6 3.2 UK bank rate 1.3 2.0 1.6 1.5 1.5 US GDP1 3.7 3.7 3.0 2.9 2.9 US unemployment4 3.5 3.2 3.3 3.3 3.3 US HPI5 4.7 4.4 4.0 3.9 3.9 US federal funds rate 1.3 2.4 2.2 1.9 1.8 2021 2022 2023 2024 2025 As at 31.12.21 % % % % % UK GDP1 6.2 6.0 3.1 2.3 1.9 UK unemployment2 4.8 4.6 4.3 4.2 4.1 UK HPI3 4.7 5.0 5.0 3.9 3.3 UK bank rate 0.1 0.6 0.8 0.8 0.5 US GDP1 5.5 4.6 3.4 2.9 2.9 US unemployment4 5.5 4.0 3.5 3.5 3.5 US HPI5 11.8 8.3 7.0 6.0 5.7 US federal funds rate 0.2 0.3 0.6 1.0 1.1 1 Average Real GDP seasonally adjusted change in year. 2 Average UK unemployment rate 16-year+. 3 Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. 4 Average US civilian unemployment rate 16-year+. 5 Change in year end US HPI = FHFA House Price Index, relative to prior year end. Credit Risk Barclays PLC 39 -- 41 of 109 -- Scenario probability weighting Upside 2 Upside 1 Baseline Downside 1 Downside 2 % % % % % As at 30.06.22 Scenario probability weighting 14.0 25.6 37.8 15.2 7.4 As at 31.12.21 Scenario probability weighting 20.9 27.2 30.1 14.8 7.0 Specific bases show the most extreme position of each variable in the context of the scenario, for example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest unemployment for upside scenarios. GDP and HPI downside and upside scenario data represents the lowest and highest points relative to the start point in the 20 quarter period. Macroeconomic variables (specific bases)1 Upside 2 Upside 1 Baseline Downside 1 Downside 2 As at 30.06.22 % % % % % UK GDP2 16.8 12.8 2.1 (1.1) (5.9) UK unemployment3 3.6 3.8 4.0 6.6 9.2 UK HPI4 36.7 24.8 2.6 (13.6) (30.8) UK bank rate 0.8 0.8 2.1 4.0 5.0 US GDP2 20.2 16.1 2.4 (0.5) (5.0) US unemployment3 3.0 3.2 3.5 6.5 9.5 US HPI4 27.0 22.9 3.5 (2.6) (13.4) US federal funds rate 0.3 0.3 2.6 4.1 5.0 As at 31.12.21 UK GDP2 21.4 18.3 3.4 (1.6) (1.6) UK unemployment3 4.0 4.1 4.5 7.0 9.2 UK HPI4 35.7 23.8 2.4 (12.7) (29.9) UK bank rate 0.1 0.1 0.7 2.8 4.0 US GDP2 22.8 19.6 3.4 1.5 (1.3) US unemployment3 3.3 3.5 4.1 6.8 9.5 US HPI4 53.3 45.2 6.2 2.2 (5.0) US federal funds rate 0.1 0.1 0.8 2.3 3.5 1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 20 quarter period starts from Q122 (2021: Q121). 2 Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year yearly average Compound Annual Growth Rate (CAGR) in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios. 3 Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios. 4 Maximum growth relative to Q421 (2021: Q420), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline; minimum growth relative to Q421 (2021: Q420), based on 20 quarter period in Downside scenarios. Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly average and quarterly CAGRs respectively. Credit Risk Barclays PLC 40 -- 42 of 109 -- Macroeconomic variables (5-year averages)1 Upside 2 Upside 1 Baseline Downside 1 Downside 2 As at 30.06.22 % % % % % UK GDP2 3.5 2.8 2.1 1.6 1.1 UK unemployment3 3.7 3.8 4.0 5.5 7.0 UK HPI4 6.4 4.5 2.6 0.6 (1.5) UK bank rate 1.3 1.6 2.1 2.7 3.1 US GDP2 3.9 3.2 2.4 1.6 0.8 US unemployment3 3.1 3.3 3.5 5.2 6.9 US HPI4 4.9 4.2 3.5 1.4 (0.8) US federal funds rate 1.7 1.9 2.6 3.1 3.6 As at 31.12.21 UK GDP2 4.4 3.9 3.4 2.7 1.8 UK unemployment3 4.3 4.4 4.5 5.8 7.0 UK HPI4 6.3 4.4 2.4 0.3 (2.0) UK bank rate 0.3 0.5 0.7 1.7 2.3 US GDP2 4.4 3.9 3.4 2.4 1.3 US unemployment3 3.9 4.0 4.1 5.7 7.1 US HPI4 8.9 7.7 6.2 3.6 1.4 US federal funds rate 0.5 0.6 0.8 1.5 2.1 1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA House Price Index. 2 5-year yearly average CAGR, starting 2021 (2021: 2020). 3 5-year average. Period based on 20 quarters from Q122 (2021: Q121). 4 5-year quarter end CAGR, starting Q421 (2021: Q420). Credit Risk Barclays PLC 41 -- 43 of 109 -- ECL under 100% weighted scenarios for modelled portfolios The table below shows the ECL assuming scenarios have been 100% weighted. Model exposures are allocated to a stage based on the individual scenario rather than through a probability-weighted approach as required for Barclays reported impairment allowances. As a result, it is not possible to back solve to the final reported weighted ECL from the individual scenarios as a balance may be assigned to a different stage dependent on the scenario. Model exposure uses exposure at default (EAD) values and is not directly comparable to gross exposure used in prior disclosures. For Credit cards, unsecured loans and other retail lending, an average EAD measure is used (12-month or lifetime, depending on stage allocation in each scenario). Therefore, the model exposure movement into Stage 2 is higher than the corresponding Stage 1 reduction. All ECL using a model is included, with the exception of Treasury assets (£7.7m of ECL). Non-modelled exposures and management adjustments are excluded. Management adjustments can be found in the Management adjustments to models for impairment section. Model exposures allocated to Stage 3 do not change in any of the scenarios as the transition criteria relies only on observable evidence of default as at 30 June 2022 and not on macroeconomic scenarios. The Downside 2 scenario represents a severe global recession with substantial falls in both UK and US GDP. Unemployment in UK markets rises towards 9.2% and US markets rises towards 9.5% and there are substantial falls in asset prices including housing. Under the Downside 2 scenario, model exposure moves between stages as the economic environment weakens. This can be seen in the movement of £22.1bn of model exposure into Stage 2 between the Weighted and Downside 2 scenario. ECL increases in Stage 2 predominantly due to unsecured portfolios as economic conditions deteriorate. Credit Risk Barclays PLC 42 -- 44 of 109 -- Scenarios As at 30 June 2022 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2 Stage 1 Model Exposure (£m) Home loans 142,668 144,569 143,881 142,882 141,536 139,553 Credit cards, unsecured loans and other retail lending 46,225 46,906 46,692 46,446 45,324 44,057 Wholesale loans 183,356 189,252 187,709 183,570 178,233 167,303 Stage 1 Model ECL (£m) Home loans 3 2 2 2 4 10 Credit cards, unsecured loans and other retail lending 341 329 333 338 353 372 Wholesale loans 250 210 224 237 296 329 Stage 1 Coverage (%) Home loans — — — — — — Credit cards, unsecured loans and other retail lending 0.7 0.7 0.7 0.7 0.8 0.8 Wholesale loans 0.1 0.1 0.1 0.1 0.2 0.2 Stage 2 Model Exposure (£m) Home loans 18,684 16,783 17,471 18,470 19,815 21,799 Credit cards, unsecured loans and other retail lending 8,699 7,741 8,048 8,448 9,932 11,658 Wholesale loans 23,702 17,806 19,349 23,489 28,825 39,755 Stage 2 Model ECL (£m) Home loans 13 8 9 11 20 40 Credit cards, unsecured loans and other retail lending 1,531 1,306 1,378 1,468 1,840 2,318 Wholesale loans 463 348 382 438 604 1,091 Stage 2 Coverage (%) Home loans 0.1 — 0.1 0.1 0.1 0.2 Credit cards, unsecured loans and other retail lending 17.6 16.9 17.1 17.4 18.5 19.9 Wholesale loans 2.0 2.0 2.0 1.9 2.1 2.7 Stage 3 Model Exposure (£m) Home loans 1,631 1,631 1,631 1,631 1,631 1,631 Credit cards, unsecured loans and other retail lending 1,797 1,797 1,797 1,797 1,797 1,797 Wholesale loans1 2,431 2,431 2,431 2,431 2,431 2,431 Stage 3 Model ECL (£m) Home loans 313 301 305 309 328 357 Credit cards, unsecured loans and other retail lending 1,207 1,183 1,191 1,222 1,218 1,212 Wholesale loans1 61 56 58 60 66 73 Stage 3 Coverage (%) Home loans 19.2 18.5 18.7 18.9 20.1 21.9 Credit cards, unsecured loans and other retail lending 67.2 65.8 66.3 68.0 67.8 67.4 Wholesale loans1 2.5 2.3 2.4 2.5 2.7 3.0 Total Model ECL (£m) Home loans 329 311 316 322 352 407 Credit cards, unsecured loans and other retail lending 3,079 2,818 2,902 3,028 3,411 3,902 Wholesale loans1 774 614 664 735 966 1,493 Total Model ECL 4,182 3,743 3,882 4,085 4,729 5,802 1 Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £376m is reported as individually assessed impairments in the table below. Reconciliation to total ECL £m Total model ECL 4,182 ECL from individually assessed impairments 376 ECL from non-modelled and other management adjustments1 1,465 Total ECL 6,023 1 Includes £1.3bn post-model adjustments of which £0.1bn is included as part of total model ECL and £0.2bn ECL from non-modelled exposures. Credit Risk Barclays PLC 43 -- 45 of 109 -- The dispersion of results around the Baseline is an indication of uncertainty around the future projections. The disclosure highlights the results of the alternative scenarios enabling the reader to understand the extent of the impact on exposure and ECL from the upside/downside scenarios. Consequently, the use of five scenarios with associated weightings results in a total weighted ECL uplift from the Baseline ECL of 2.4%, largely driven by credit card losses which have more linear loss profiles than UK home loans and wholesale loan positions. Home loans: Total weighted ECL of £329m represents a 2.2% increase over the Baseline ECL (£322m), and coverage ratios remain steady across the Upside scenarios, Baseline and Downside 1 scenario. However, total ECL increases in the Downside 2 scenario to £407m, driven by a significant fall in UK HPI (30.8%) reflecting the non-linearity of the UK portfolio. Credit cards, unsecured loans and other retail lending: Total weighted ECL of £3,079m represents a 1.7% increase over the Baseline ECL (£3,028m) reflecting the range of economic scenarios used, mainly impacted by unemployment and other key retail variables. Total ECL increases to £3,902m under Downside 2 scenario, mainly driven by Stage 2, where coverage rates increase to 19.9% from a weighted scenario approach of 17.6% and circa £3.0bn increase in model exposure that meets the Significant Increase in Credit Risk criteria and transitions from Stage 1 to Stage 2. Wholesale loans: Total weighted ECL of £774m represents an 5.3% increase over the Baseline ECL (£735m) reflecting the range of economic scenarios used, with exposures in the Corporate and Investment Bank particularly sensitive to the Downside 2 scenario. Credit Risk Barclays PLC 44 -- 46 of 109 -- Scenarios As at 31 December 2021 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2 Stage 1 Model Exposure (£m) Home loans 137,279 139,117 138,424 137,563 135,544 133,042 Credit cards, unsecured loans and other retail lending 45,503 46,170 45,963 45,751 43,131 38,820 Wholesale loans 174,249 177,453 176,774 175,451 169,814 161,998 Stage 1 Model ECL (£m) Home loans 4 2 2 3 6 14 Credit cards, unsecured loans and other retail lending 324 266 272 279 350 418 Wholesale loans 290 240 262 286 327 350 Stage 1 Coverage (%) Home loans — — — — — — Credit cards, unsecured loans and other retail lending 0.7 0.6 0.6 0.6 0.8 1.1 Wholesale loans 0.2 0.1 0.1 0.2 0.2 0.2 Stage 2 Model Exposure (£m) Home loans 22,915 21,076 21,769 22,631 24,649 27,151 Credit cards, unsecured loans and other retail lending 7,200 6,260 6,521 6,795 9,708 14,290 Wholesale loans 32,256 29,052 29,732 31,054 36,692 44,507 Stage 2 Model ECL (£m) Home loans 15 10 11 12 22 47 Credit cards, unsecured loans and other retail lending 1,114 925 988 1,058 1,497 3,295 Wholesale loans 572 431 467 528 851 1,510 Stage 2 Coverage (%) Home loans 0.1 — 0.1 0.1 0.1 0.2 Credit cards, unsecured loans and other retail lending 15.5 14.8 15.2 15.6 15.4 23.1 Wholesale loans 1.8 1.5 1.6 1.7 2.3 3.4 Stage 3 Model Exposure (£m) Home loans 1,724 1,724 1,724 1,724 1,724 1,724 Credit cards, unsecured loans and other retail lending 1,922 1,922 1,922 1,922 1,922 1,922 Wholesale loans1 1,811 1,811 1,811 1,811 1,811 1,811 Stage 3 Model ECL (£m) Home loans 303 292 295 299 320 346 Credit cards, unsecured loans and other retail lending 1,255 1,236 1,245 1,255 1,277 1,297 Wholesale loans1 323 321 322 323 326 332 Stage 3 Coverage (%) Home loans 17.6 16.9 17.1 17.3 18.6 20.1 Credit cards, unsecured loans and other retail lending 65.3 64.3 64.8 65.3 66.4 67.5 Wholesale loans1 17.8 17.7 17.8 17.8 18.0 18.3 Total Model ECL (£m) Home loans 322 304 308 314 348 407 Credit cards, unsecured loans and other retail lending 2,693 2,427 2,505 2,592 3,124 5,010 Wholesale loans1 1,185 992 1,051 1,137 1,504 2,192 Total Model ECL 4,200 3,723 3,864 4,043 4,976 7,609 1 Material wholesale loan defaults are individually assessed across different recovery strategies. As a result, ECL of £524m is reported as individually assessed impairments in the table below. Reconciliation to total ECL1 £m Total model ECL 4,200 ECL from individually assessed impairments 524 ECL from non-modelled and other management adjustments 1,560 Total ECL 6,284 1 Includes £1.5bn of post-model adjustments and £0.2bn ECL from non-modelled exposures. Credit Risk Barclays PLC 45 -- 47 of 109 -- Analysis of specific portfolios and asset types Secured home loans The UK home loan portfolio primarily comprises first lien mortgages and accounts for 93% (December 2021: 93%) of the Group’s total home loans balance. Barclays UK Home loans principal portfolios As at 30.06.22 As at 31.12.21 Gross loans and advances (£m) 159,676 158,192 90 day arrears rate, excluding recovery book (%) 0.1 0.1 Annualised gross charge-off rates - 180 days past due (%) 0.5 0.5 Recovery book proportion of outstanding balances (%) 0.6 0.6 Recovery book impairment coverage ratio (%) 4.6 4.2 Average marked to market LTV Balance weighted % 50.8 50.7 Valuation weighted % 37.8 37.5 New lending Half year ended 30.06.22 Half year ended 30.06.21 New home loan bookings (£m) 14,117 19,120 New home loan proportion > 90% LTV (%) 2.6 0.9 Average LTV on new home loans: balance weighted (%) 68.6 68.7 Average LTV on new home loans: valuation weighted (%) 60.4 61.3 Home loans principal portfolios – distribution of balances by LTV1 Distribution of balances Distribution of impairment allowance Coverage ratio Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total Barclays UK % % % % % % % % % % % % As at 30.06.22 <=75% 79.2 10.9 0.6 90.7 6.7 17.3 34.5 58.5 — 0.1 2.9 — >75% and <=90% 8.2 0.5 — 8.7 4.2 10.8 12.2 27.2 — 1.2 29.1 0.2 >90% and <=100% 0.6 — — 0.6 0.4 0.6 2.2 3.2 — 2.5 72.9 0.3 >100% — — — — 0.1 1.5 9.5 11.1 0.4 20.7 100.0 23.1 As at 31.12.21 <=75% 77.2 11.3 0.7 89.2 8.3 17.7 31.9 57.9 — 0.1 2.4 — >75% and <=90% 9.3 0.6 — 9.9 4.8 10.7 11.7 27.2 — 1.0 22.6 0.1 >90% and <=100% 0.9 — — 0.9 0.9 1.0 2.9 4.8 0.1 1.9 87.5 0.3 >100% — — — — 0.2 1.0 8.9 10.1 0.4 6.4 100.0 14.1 1 Portfolio mark to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest HPI available as at 30 June 2022. New lending reduced to £14.1bn, a level more consistent with pre-COVID-19 periods, from £19.1bn in H121 when market dynamics drove high levels of new business due to stamp duty relief and property ownership led demand. The proportion of new lending with LTV >85% was 18%, more consistent with levels seen pre-COVID-19, compared to 7% in H121 when high LTV products were gradually being reintroduced following COVID-19 restrictions. Head Office: Italian home loans and advances at amortised cost reduced to £4.6bn (2021: £4.7bn). The portfolio is secured on residential property with an average balance weighted mark to market LTV of 59.0% (2021: 60.4%). 90 day arrears remained stable at 1.3% (2021: 1.3%), gross charge-off rates increased to 0.4% (2021: 0.3%). Credit Risk Barclays PLC 46 -- 48 of 109 -- Credit cards, unsecured loans and other retail lending The principal portfolios listed below accounted for 83% (December 2021: 82%) of the Group’s total credit cards, unsecured loans and other retail lending. Principal portfolios Gross exposure 30 day arrears rate, excluding recovery book 90 day arrears rate, excluding recovery book Annualised gross write- off rate Annualised net write-off rate As at 30.06.22 £m % % % % Barclays UK UK cards 9,901 1.0 0.2 2.4 2.3 UK personal loans 4,188 1.3 0.6 2.0 1.6 Barclays Partner Finance 2,459 0.5 0.2 0.8 0.8 Barclays International US cards 23,037 1.4 0.7 2.9 2.7 Germany consumer lending 3,993 1.5 0.7 0.7 0.7 As at 31.12.21 Barclays UK UK cards 9,933 1.0 0.2 4.1 4.0 UK personal loans 4,011 1.5 0.7 3.5 3.2 Barclays Partner Finance 2,471 0.4 0.2 1.4 1.4 Barclays International US cards 17,779 1.6 0.8 4.3 4.2 Germany consumer lending 3,559 1.5 0.7 0.9 0.8 UK cards: 30 and 90 day arrears rates remained stable at 1.0% and 0.2%, with balances flat at £9.9bn. Gross and net write- off rates returned to more stable levels of 2.4% and 2.3% following the higher rates in 2021 caused by the sharp reductions in overall balances through COVID-19 and heightened debt sale activity. UK personal loans: 30 and 90 day arrears rates reduced by 0.2% and 0.1% to 1.3% and 0.6% respectively. This marginal reduction was driven by the portfolio growing through new lending post the COVID-19 reductions, and these newer vintages performing better than the historical stock. Gross and net write-off rates returned to more stable levels of 2.0% and 1.6% following the higher rates in 2021 caused by the sharp reductions in overall balances through COVID-19 and heightened debt sale activity. Barclays Partner Finance: 30 and 90 day arrears rates remain stable and in line with December 2021. US cards: Balances increased due to the acquisition of the GAP portfolio in June 2022, movement in the USD/GBP exchange rate and core portfolio growth. 30 and 90 day arrears rates improved due to the GAP portfolio acquisition. Germany consumer lending: 30 and 90 day arrears rates were stable. 30 day arrears rates are below pre-COVID levels. Credit Risk Barclays PLC 47 -- 49 of 109 -- Government supported loans Throughout the COVID-19 pandemic Barclays has supported its customers and clients by participating in the UK government's Bounce Back Loan Scheme (BBLS), Coronavirus Business Interruption Loan Scheme (CBILS), Coronavirus Large Business Interruption Loan Scheme (CLBILS) and the Recovery Loan Scheme (RLS). Gross exposure Impairment allowance Impairment coverage Government guaranteed exposure Stage 1 Stage 2 Stage 3 Total Modelled impairment Management adjustment Impairment post- management adjustment Pre- management adjustment Post- management adjustment Total As at 30.06.22 £m £m £m £m £m £m £m % % £m Barclays UK BBLS 5,231 1,982 893 8,106 22 — 22 0.3 0.3 8,083 CBILS 606 234 54 894 18 (4) 14 2.1 1.6 715 RLS 17 2 1 20 — — — — — 16 Barclays International CBILS 458 145 7 610 3 — 3 0.5 0.5 488 CLBILS 96 79 6 181 1 — 1 0.6 0.6 145 RLS 16 4 1 21 — — — 0.5 0.5 16 Total 6,424 2,446 962 9,832 44 (4) 40 0.4 0.4 9,463 As at 31.12.21 Barclays UK BBLS 7,881 797 704 9,382 396 (380) 16 4.2 0.2 9,366 CBILS 900 110 47 1,057 12 (7) 5 1.1 0.5 845 RLS 11 — 1 12 — — — 2.7 2.7 10 Barclays International CBILS 619 146 6 771 5 — 5 0.6 0.6 617 CLBILS 163 56 2 221 1 — 1 0.4 0.4 177 RLS 1 — — 1 — — — 4.7 4.7 1 Total 9,575 1,109 760 11,444 414 (387) 27 3.6 0.2 11,016 The BBLS and CBILS schemes were launched to provide financial support to smaller and medium-sized businesses and CLBILS for larger businesses in the UK who may experience financial difficulties as a result of the COVID-19 outbreak. The RLS aims to help UK businesses access finance as they recover and grow following the COVID-19 pandemic. These loans are guaranteed by the government at 100% for BBLS and 80% for CBILS, CLBILS and RLS (70% for RLS issued post January 1, 2022) as at the balance sheet date. Management adjustment of £(380)m applied in December 2021 has been discontinued following an update in the underlying ECL model that now fully recognises the 100% government guarantee against BBLS exposure within BUK Business Banking. However, we continue to hold the £(4)m (December 2021: £7m) adjustment against CBILS as the 80% government guarantee is not fully recognised in the models. In instances where Barclays has assessed the BBLS exposure to have not met strict assessment criteria, no claim has been made against the government guarantee resulting in an impairment allowance against these loans of £22m (December 2021: £16m) as at the balance sheet date. Additionally, while the government supported loans are covered by guarantees, many BBLS customers have other financing arrangements with Barclays which are not covered by the government guarantee. Noting the elevated levels of delinquency across the BBLS population, Barclays has applied an adjustment of £0.1bn to the £2.6bn gross exposure to BBLS customers outside the scheme. Credit Risk Barclays PLC 48 -- 50 of 109 -- Analysis of management value at risk (VaR) The table below shows the total management VaR on a diversified basis by asset class. Total management VaR includes all trading positions in Barclays Bank Group and it is calculated with a one-day holding period. VaR limits are applied to total management VaR and by asset class. Additionally, the market risk management function applies VaR sub-limits to material businesses and trading desks. Management VaR (95%) by asset class Half year ended 30.06.22 Half year ended 31.12.21 Half year ended 30.06.21 Average High Low Average High Low Average High Low £m £m £m £m £m £m £m £m £m Credit risk 16 24 8 10 13 7 18 30 9 Interest rate risk 10 19 4 5 9 4 8 15 4 Equity risk 10 29 4 8 29 4 10 15 6 Basis risk 9 24 4 4 7 3 7 10 4 Spread risk 5 10 3 4 6 3 4 6 3 Foreign exchange risk 10 25 2 4 16 1 3 6 2 Commodity risk — 1 — — 1 — — 1 — Inflation risk 6 17 3 3 5 2 2 3 2 Diversification effect1 (39) n/a n/a (23) n/a n/a (30) n/a n/a Total management VaR 27 43 13 15 34 6 22 36 13 1 Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently, a diversification effect balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table. Average management VaR increased 80% to £27m (H221: £15m) driven by elevated market volatility and defensive risk positioning. Risk taking during the period remained within risk appetite. Market Risk Barclays PLC 49 -- 51 of 109 -- The Group has a comprehensive Key Risk Control Framework for managing its liquidity risk. The liquidity framework meets the PRA standards and is designed to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is appropriate to meet the Group’s Liquidity Risk Appetite (LRA). The liquidity framework is delivered via a combination of policy formation, review and governance, analysis, stress testing, limit setting and monitoring. Liquidity risk stress testing The liquidity risk stress assessment measures the potential contractual and contingent stress outflows under a range of scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-wide stress event and a 30 day combined scenario consisting of both a Barclays specific and market-wide stress event. The Group also runs a long-term liquidity stress test, which measures the anticipated outflows over a 12 month market-wide scenario. The LCR requirement takes into account the relative stability of different sources of funding and potential incremental funding requirements in a stress. The LCR is designed to promote short-term resilience of a bank’s liquidity risk profile by holding sufficient high quality liquid assets to survive an acute stress scenario lasting for 30 days. As at 30 June 2022, the Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and external regulatory requirements. Liquidity coverage ratio As at 30.06.22 As at 31.12.21 £bn £bn Eligible liquidity buffer 331 285 Net stress outflows (212) (169) Surplus 119 116 Liquidity coverage ratio 156% 168% The Group plans to maintain its surplus to the internal and regulatory stress requirements at an efficient level, while considering risks to market funding conditions and its liquidity position. The continuous reassessment of these risks may lead to execution of appropriate actions to resize the liquidity pool. Treasury and Capital Risk Barclays PLC 50 -- 52 of 109 -- Composition of the Group liquidity pool As at 30.06.22 As at 31.12.21 Liquidity pool Liquidity pool of which LCR eligible1 Liquidity pool Cash Level 1 Level 2A £bn £bn £bn £bn £bn Cash and deposits with central banks2 288 284 — — 245 Government bonds3 AAA to AA- 33 — 24 1 26 A+ to A- 5 — — 5 2 BBB+ to BBB- — — — — — Total government bonds 38 — 24 6 28 Other Government Guaranteed Issuers, PSEs and GSEs 8 — 6 1 6 International Organisations and MDBs 3 — 4 — 5 Covered bonds 4 — 2 2 6 Other 2 — — — 1 Total other 17 — 12 3 18 Total as at 30 June 2022 343 284 36 9 291 Total as at 31 December 2021 291 243 37 5 1 The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR as amended by CRR II qualifying assets that are not eligible under Barclays’ internal risk appetite. 2 Includes cash held at central banks and surplus cash at central banks related to payment schemes. 99% (December 2021: over 99%) was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank. 3 Of which over 81% (December 2021: over 82%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities. The Group liquidity pool increased to £343bn as at 30 June 2022 (December 2021: £291bn) driven by continued deposit growth and an increase in wholesale funding, which were partly offset by an increase in business funding consumption. During H122, the month-end liquidity pool ranged from £309bn to £343bn (H221: £290bn to £308bn), and the month-end average balance was £324bn (H221: £296bn). The liquidity pool is held unencumbered and is not used to support payment or clearing requirements. Such requirements are treated as part of our regular business funding. The liquidity pool is intended to offset stress outflows, and comprises the above cash and unencumbered assets. As at 30 June 2022, 64% (December 2021: 58%) of the liquidity pool was located in Barclays Bank PLC, 25% (December 2021: 30%) in Barclays Bank UK PLC and 6% (December 2021: 7%) in Barclays Bank Ireland PLC. The residual portion of the liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local regulatory requirements, it is assumed to be unavailable to the rest of the Group in calculating the LCR. The composition of the pool is subject to limits and controls set by the respective entity Boards and independent liquidity risk, credit risk and market risk functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type. Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed. Treasury and Capital Risk Barclays PLC 51 -- 53 of 109 -- Deposit funding As at 30.06.22 As at 31.12.21 Loans and advances at amortised cost Deposits at amortised cost Loan: deposit ratio1 Loan: deposit ratio1 Funding of loans and advances £bn £bn % % Barclays UK 224 262 85 85 Barclays International 167 307 54 52 Head Office 5 — Barclays Group 396 569 70 70 1 The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost. Funding structure and funding relationships The basis for liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an inability to meet funding obligations as they fall due. The Group’s overall funding strategy is to develop a diversified funding base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources, to provide protection against unexpected fluctuations, while minimising the cost of funding. Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched. A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to fund residual assets. These funding relationships as at 30 June 2022 are summarised below: Restated1 As at 30.06.22 As at 31.12.21 As at 30.06.22 As at 31.12.21 Assets £bn £bn Liabilities and equity £bn £bn Loans and advances at amortised cost2 381 358 Deposits at amortised cost 569 519 Group liquidity pool 343 291 <1 Year wholesale funding 84 67 >1 Year wholesale funding 97 101 Reverse repurchase agreements, trading portfolio assets, cash collateral and settlement balances 426 388 Repurchase agreements, trading portfolio liabilities, cash collateral and settlement balances 387 330 Derivative financial instruments 345 263 Derivative financial instruments 321 257 Other assets3 94 84 Other liabilities 60 40 Equity 71 70 Total assets 1,589 1,384 Total liabilities and equity 1,589 1,384 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. The contractual maturity profile of Senior unsecured (privately placed) has been restated to reflect the impact of the Over-issuance of Securities. 2 Adjusted for liquidity pool debt securities reported at amortised cost of £15bn (December 2021: £3bn). 3 Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories. Treasury and Capital Risk Barclays PLC 52 -- 54 of 109 -- Composition of wholesale funding Wholesale funding outstanding (excluding repurchase agreements) was £181.5bn (December 2021: £167.5bn). In H122, the Group issued £3.5bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and currencies. Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases. Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets. In addition, Barclays Bank UK PLC continued to issue in the shorter-term markets. Wholesale funding of £84.2bn (December 2021: £66.7bn1) matures in less than one year, representing 46% (December 2021: 40%1) of total wholesale funding outstanding. This includes £19.4bn (December 2021: £24.9bn1) related to term funding2. Maturity profile of wholesale funding2,3 <1 1-3 3-6 6-12 <1 1-2 2-3 3-4 4-5 >5 month months months months year years years years years years Total £bn £bn £bn £bn £bn £bn £bn £bn £bn £bn £bn Barclays PLC (the Parent company) Senior unsecured (public benchmark) — — — 0.2 0.2 6.9 7.7 5.5 3.5 14.0 37.8 Senior unsecured (privately placed) — — — — — 0.2 — — — 1.2 1.4 Subordinated liabilities — — — — — — 1.0 1.7 — 7.4 10.1 Barclays Bank PLC (including subsidiaries) Certificates of deposit and commercial paper 9.7 11.4 18.1 10.8 50.0 0.1 2.1 — — — 52.2 Asset backed commercial paper 3.7 4.5 0.2 0.2 8.6 — — — — — 8.6 Senior unsecured (public benchmark) — — — — — 0.6 — — — — 0.6 Senior unsecured (privately placed)4 7.6 1.8 1.9 3.9 15.2 6.3 7.5 2.1 3.2 20.3 54.6 Asset backed securities 0.6 — — 0.1 0.7 0.4 2.3 0.4 0.2 1.4 5.4 Subordinated liabilities — 0.1 1.2 0.2 1.5 0.1 0.1 — 0.1 — 1.8 Barclays Bank UK PLC (including subsidiaries) Certificates of deposit and commercial paper 6.1 0.1 — — 6.2 — — — — — 6.2 Senior unsecured (public benchmark) — — — — — — — — — 0.1 0.1 Covered Bonds — — — 1.8 1.8 — — — — 0.9 2.7 Total as at 30 June 2022 27.7 17.9 21.4 17.2 84.2 14.6 20.7 9.7 7.0 45.3 181.5 Of which secured 4.3 4.5 0.2 2.1 11.1 0.4 2.3 0.4 0.2 2.3 16.7 Of which unsecured 23.4 13.4 21.2 15.1 73.1 14.2 18.4 9.3 6.8 43.0 164.8 Total as at 31 December 20211 14.1 21.7 15.5 15.4 66.7 15.4 15.1 9.9 11.4 49.0 167.5 Of which secured 2.4 6.4 0.6 0.5 9.9 1.9 2.0 0.1 0.3 2.4 16.6 Of which unsecured 11.7 15.3 14.9 14.9 56.8 13.5 13.1 9.8 11.1 46.6 150.9 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. The contractual maturity profile of financial liabilities designated at fair value has been restated to reflect the impact of the Over- issuance of Securities. Securities issued by BBPLC in excess of the maximum aggregate offering price registered under Barclays Bank PLC's 2019 F-3 and Predecessor Shelf with a value of £6,997m have been classified as "on demand". 2 The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing. 3 Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt where the original maturity of the instrument is more than 1 year. 4 Includes structured notes of £45.9bn, of which £8.5bn matures within one year. Treasury and Capital Risk Barclays PLC 53 -- 55 of 109 -- Credit ratings In addition to monitoring and managing key metrics related to the financial strength of the Group, Barclays also solicits independent credit ratings from Standard & Poor’s Global (S&P), Moody’s, Fitch, and Rating and Investment Information (R&I). These ratings assess the creditworthiness of the Group, its subsidiaries and its branches, and are based on reviews of a broad range of business and financial attributes including capital strength, profitability, funding, liquidity, asset quality, strategy and governance. Barclays Bank PLC Standard & Poor's Moody's Fitch Long-term A / Positive A1 / Stable A+ / Stable Short-term A-1 P-1 F1 Barclays Bank UK PLC Long-term A / Positive A1 / Stable A+ / Stable Short-term A-1 P-1 F1 Barclays PLC Long-term BBB / Positive Baa2 /Positive A / Stable Short-term A-2 P-2 F1 As at 30 June 2022, all solicited ratings and outlooks with all agencies remained unchanged since 31 December 2021. In June 2021, S&P revised the outlooks of Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC to positive from stable, whilst affirming all ratings. The revisions reflect the view that Barclays is delivering a stronger, more consistent business profile and financial performance. In November 2021, Moody’s revised the outlook of Barclays PLC to positive from stable, whilst affirming all ratings. The revisions reflect Moody’s view that the level and stability of the Group’s earnings could further improve once global macroeconomic conditions normalise, recognising the balanced earnings streams and stable operating costs. In July 2021, Fitch revised the outlooks of Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC to stable from negative, whilst affirming all ratings. The revisions reflected improved expectations for economic recovery in Barclays’ key markets and the Group’s resilient performance through the pandemic. Barclays also solicits issuer ratings from R&I. In November 2021, R&I upgraded the issuer ratings of Barclays PLC and Barclays Bank PLC by one notch to A and A+ respectively. A credit rating downgrade could result in outflows to meet collateral requirements on existing contracts. Outflows related to credit rating downgrades are included in the LRA stress scenarios and a portion of the liquidity pool is held against this risk. Credit ratings downgrades could also result in reduced funding capacity and increased funding costs. The contractual collateral requirement following one- and two-notch long-term and associated short-term downgrades across all credit rating agencies, would result in outflows of £1bn and £3bn respectively, and are provided for in determining an appropriate liquidity pool size given the Group’s liquidity risk appetite. These numbers do not assume any management or restructuring actions that could be taken to reduce posting requirements. These outflows do not include the potential liquidity impact from loss of unsecured funding, such as from money market funds, or loss of secured funding capacity. However, unsecured and secured funding stresses are included in the LRA stress scenarios and a portion of the liquidity pool is held against these risks. Treasury and Capital Risk Barclays PLC 54 -- 56 of 109 -- Regulatory minimum requirements Capital The Group’s Overall Capital Requirement for CET1 is 10.9% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.4% Pillar 2A requirement and a 0% Countercyclical Capital Buffer (CCyB). The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11 March 2020, the Financial Policy Committee (FPC) set the CCyB rate for UK exposures at 0% with immediate effect. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.0% CCyB for the Group. On 13 December 2021, the FPC announced that a CCyB rate of 1% for UK exposures has been re- introduced and will be applicable from 13 December 2022. On 5 July 2022, the FPC announced that the UK CCyB rate will be increased from 1% to 2% and will be applicable from 5 July 2023. The Group’s Pillar 2A requirement as per the PRA’s Individual Capital Requirement was set as a nominal amount. When expressed as a percentage of RWAs this was 4.2% of which at least 56.25% needed to be met with CET1 capital, equating to approximately 2.4% of RWAs. The Pillar 2A requirement is subject to at least annual review and is based on a point in time assessment. The Group’s CET1 target ratio of 13-14% takes into account headroom above requirements which includes a confidential institution-specific PRA buffer. The Group remains above its minimum capital regulatory requirements including the PRA buffer. Leverage The Group is subject to a UK leverage ratio requirement of 3.8%. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer of 0.0%. Although the leverage ratio is expressed in terms of Tier 1 (T1) capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.0bn. The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter. MREL The Group is required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.2% Pillar 2A; and (ii) 6.75% of leverage exposures plus capital buffers, including the above mentioned confidential institution-specific PRA buffer. CET1 capital cannot be counted towards both MREL and the capital buffers, meaning that the buffers will effectively be applied above MREL requirements. Significant regulatory updates in the period Capital and RWAs On 1 January 2022 the PRA’s implementation of Basel III standards took effect including the re-introduction of the 100% CET1 capital deduction for qualifying software intangible assets and the introduction of the Standardised Approach for Counterparty Credit Risk (SA-CCR) which replaces the Current Exposure Method (CEM) for Standardised derivative exposures as a more risk sensitive approach. In addition, the PRA also implemented IRB roadmap changes which includes revisions to the criteria for definition of default, probability of default (PD) and loss given default (LGD) estimation to ensure supervisory consistency and increase transparency of IRB models. Leverage From 1 January 2022, UK banks became subject to a single UK leverage ratio requirement meaning that the CRR leverage ratio no longer applies. Central bank claims can be excluded from the UK leverage ratio measure as long as they are matched by qualifying liabilities (rather than deposits). References to CRR, as amended by CRR II mean, unless otherwise specified, CRR as amended by CRR II, as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018. On 31 March 2022, the temporary transitional powers (TTP) available to UK regulators to delay or phase in on-shoring of European Union legislation into UK law ended with full compliance of the on-shored regulations required from 1 April 2022. Treasury and Capital Risk Barclays PLC 55 -- 57 of 109 -- Impact of Over-issuance of Securities Basis of preparation In March 2022, the Group became aware that Barclays Bank PLC had issued securities in excess of the amount it had registered with the SEC under Barclays Bank PLC’s 2019 F-3 and subsequently became aware that securities had also been issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities issued in excess of the registered amount comprised structured products and exchange traded notes. As these securities were not issued in compliance with the Securities Act, a right of rescission has arisen for certain purchasers of the securities. A proportion of these costs associated with the right of rescission are attributable to the financial statements for the year ended 31 December 2021, resulting in the restatement of the 2021 figures in the disclosures below. Prior to the restatement, litigation and conduct charges in the income statement in relation to 2021 were under reported by £220m (pre-tax). This resulted in a CET1 capital decrease of £170m from £47,497m to £47,327m. Both the transitional and fully loaded CET1 ratios remained unchanged at 15.1% and 14.7% respectively. The T1 ratio moved from 19.2% to 19.1% and the total capital ratio moved from 22.3% to 22.2%. The leverage exposure increased £1.9bn to recognise on a regulatory basis, the potential commitment relating to the rescission offer (see 'Other matters' on page 6). This resulted in the UK leverage ratio moving from 5.3% to 5.2% whilst the average UK leverage ratio remained unchanged at 4.9%. Total own funds and eligible liabilities decreased £0.2bn to £108bn, which was in excess of a restated requirement to hold £94bn of own funds and eligible liabilities. Treasury and Capital Risk Barclays PLC 56 -- 58 of 109 -- Restated1 Capital ratios2,3,4 As at 30.06.22 As at 31.03.22 As at 31.12.21 CET1 13.6% 13.8% 15.1% T1 17.1% 17.1% 19.1% Total regulatory capital 19.9% 20.1% 22.2% Capital resources £m £m £m Total equity excluding non-controlling interests per the balance sheet 69,627 68,465 69,052 Less: other equity instruments (recognised as AT1 capital) (12,357) (11,119) (12,259) Adjustment to retained earnings for foreseeable ordinary share dividends (595) (968) (666) Adjustment to retained earnings for foreseeable repurchase of shares (568) (1,000) — Adjustment to retained earnings for foreseeable other equity coupons (32) (39) (32) Other regulatory adjustments and deductions Additional value adjustments (PVA) (1,810) (1,864) (1,585) Goodwill and intangible assets (8,232) (8,035) (6,804) Deferred tax assets that rely on future profitability excluding temporary differences (1,010) (938) (1,028) Fair value reserves related to gains or losses on cash flow hedges 4,673 3,343 852 Gains or losses on liabilities at fair value resulting from own credit (62) 4 892 Defined benefit pension fund assets (3,785) (3,225) (2,619) Direct and indirect holdings by an institution of own CET1 instruments (20) (20) (50) Adjustment under IFRS 9 transitional arrangements 642 601 1,229 Other regulatory adjustments 220 64 345 CET1 capital 46,691 45,269 47,327 AT1 capital Capital instruments and related share premium accounts 12,357 11,119 12,259 Qualifying AT1 capital (including minority interests) issued by subsidiaries — — 637 Other regulatory adjustments and deductions (60) (60) (80) AT1 capital 12,297 11,059 12,816 T1 capital 58,988 56,328 60,143 T2 capital Capital instruments and related share premium accounts 8,442 8,334 8,713 Qualifying T2 capital (including minority interests) issued by subsidiaries 1,277 1,540 1,113 Credit risk adjustments (excess of impairment over expected losses) 73 98 73 Other regulatory adjustments and deductions (160) (160) (160) Total regulatory capital 68,620 66,140 69,882 Total RWAs 344,516 328,830 314,136 1 Capital metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 for more information. The transitional CET1 ratio remains unchanged at 15.1%. 2 CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR II non-compliant capital instruments. December 2021 comparatives include the grandfathering of CRR non-compliant capital instruments. 3 The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.4%, with £46.0bn of CET1 capital and £344.3bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II. 4 The Group’s CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC 7.625% Contingent Capital Notes, was 13.6%. For this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR as amended by CRR II, including the IFRS 9 transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the implementation of CRD IV, expired in December 2017. Treasury and Capital Risk Barclays PLC 57 -- 59 of 109 -- Movement in CET1 capital Three months ended 30.06.22 Six months ended 30.06.22 £m £m Opening CET1 capital1 45,269 47,327 Profit for the period attributable to equity holders 1,270 2,889 Own credit relating to derivative liabilities (76) (97) Ordinary share dividends paid and foreseen (291) (593) Purchased and foreseeable share repurchase — (1,000) Other equity coupons paid and foreseen (192) (414) Increase in retained regulatory capital generated from earnings 711 785 Net impact of share schemes 132 (136) Fair value through other comprehensive income reserve (550) (759) Currency translation reserve 1,333 1,703 Other reserves 11 35 Increase in other qualifying reserves 926 843 Pension remeasurements within reserves 423 1,090 Defined benefit pension fund asset deduction (560) (1,166) Net impact of pensions (137) (76) Additional value adjustments (PVA) 54 (225) Goodwill and intangible assets (197) (1,428) Deferred tax assets that rely on future profitability excluding those arising from temporary differences (72) 18 Direct and indirect holdings by an institution of own CET1 instruments — 30 Adjustment under IFRS 9 transitional arrangements 41 (587) Other regulatory adjustments 96 4 Decrease in regulatory capital due to adjustments and deductions (78) (2,188) Closing CET1 capital 46,691 46,691 1 Opening balance as at 31 December 2021 has been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 for further details. CET1 capital decreased £0.6bn to £46.7bn (December 2021: £47.3bn). CET1 capital decreased by £1.7bn as a result of regulatory changes that took effect from 1 January 2022 including the re- introduction of the 100% CET1 capital deduction for qualifying software intangible assets and a reduction in IFRS9 transitional relief due to the relief applied to the pre-2020 impairment charge reducing to 25% in 2022 from 50% in 2021 and the relief applied to the post-2020 impairment charge reducing to 75% in 2022 from 100% in 2021. £2.9bn of capital generated from profits, after absorbing the £0.6bn net of tax impact of the Over-issuance of Securities, was partially offset by distributions of £2bn comprising: • £1bn for share buybacks announced with FY21 results • £0.6bn accrual towards a FY22 dividend • £0.4bn of equity coupons paid Other significant movements in the period were: • £0.8bn decrease in the fair value through other comprehensive income reserve primarily due to losses on bonds as a result of an increase in yields • £1.7bn increase in the currency translation reserves driven by the appreciation of period end USD against GBP Treasury and Capital Risk Barclays PLC 58 -- 60 of 109 -- RWAs by risk type and business Credit risk Counterparty credit risk Market Risk Operational risk Total RWAs STD IRB STD IRB Settlement Risk CVA STD IMA As at 30.06.22 £m £m £m £m £m £m £m £m £m £m Barclays UK 6,613 53,958 253 — — 76 236 — 11,047 72,183 Corporate and Investment Bank 40,055 71,737 18,739 22,099 440 3,357 17,466 28,423 25,296 227,612 Consumer, Cards and Payments 25,516 3,643 256 34 — 64 28 195 6,424 36,160 Barclays International 65,571 75,380 18,995 22,133 440 3,421 17,494 28,618 31,720 263,772 Head Office 3,488 6,069 — — — — — — (996) 8,561 Barclays Group 75,672 135,407 19,248 22,133 440 3,497 17,730 28,618 41,771 344,516 As at 31.03.22 Barclays UK 6,989 54,241 229 — — 57 155 — 11,047 72,718 Corporate and Investment Bank 35,325 70,831 16,422 21,047 268 3,675 17,068 23,551 25,296 213,483 Consumer, Cards and Payments 21,289 3,459 242 12 — 37 110 34 6,424 31,607 Barclays International 56,614 74,290 16,664 21,059 268 3,712 17,178 23,585 31,720 245,090 Head Office 5,532 6,486 — — — — — — (996) 11,022 Barclays Group 69,135 135,017 16,893 21,059 268 3,769 17,333 23,585 41,771 328,830 As at 31.12.21 Barclays UK 7,195 53,408 426 — — 138 100 — 11,022 72,289 Corporate and Investment Bank 29,420 64,416 15,223 19,238 105 2,289 17,306 27,308 25,359 200,664 Consumer, Cards and Payments 20,770 2,749 215 18 — 21 — 57 6,391 30,221 Barclays International 50,190 67,165 15,438 19,256 105 2,310 17,306 27,365 31,750 230,885 Head Office 4,733 7,254 — — — — — — (1,025) 10,962 Barclays Group 62,118 127,827 15,864 19,256 105 2,448 17,406 27,365 41,747 314,136 Movement analysis of RWAs Credit risk Counterparty credit risk Market risk Operational risk Total RWAs £m £m £m £m £m Opening RWAs (as at 31.12.21) 189,945 37,673 44,771 41,747 314,136 Book size 12,781 1,611 60 24 14,476 Acquisitions and disposals (209) — — — (209) Book quality (3,101) 117 — — (2,984) Model updates — — — — — Methodology and policy 3,458 3,352 — — 6,810 Foreign exchange movements1 8,205 2,565 1,517 — 12,287 Total RWA movements 21,134 7,645 1,577 24 30,380 Closing RWAs (as at 30.06.22) 211,079 45,318 46,348 41,771 344,516 1 Foreign exchange movements does not include foreign exchange for modelled market risk or operational risk. Overall RWAs increased £30.4bn to £344.5bn (December 2021: £314.1bn) Credit risk RWAs increased £21.1bn: • A £12.8bn increase in book size primarily driven by a £7.8bn increase in lending activities mainly within CIB and a £4.5bn temporary increase in RWAs reflecting the hedging arrangements designed to manage the risk of the rescission offer relating to the Over-issuance of Securities, which are expected to reverse after the rescission offer has been completed in Q322 • A £0.2bn decrease in acquisitions and disposals primarily driven by partial disposal of Barclays' equity stake in Absa in April 2022, offset by GAP portfolio acquisition • A £3.1bn decrease in book quality primarily driven by the benefit in mortgages from an increase in the House Price Index (HPI) • A £3.5bn increase in methodology and policy as a result of regulatory changes that took effect from 1 January 2022, relating to implementation of IRB roadmap changes partially offset by the reversal of the software intangibles benefit • A £8.2bn increase in FX primarily due to appreciation of period end USD against GBP Treasury and Capital Risk Barclays PLC 59 -- 61 of 109 -- Counterparty Credit risk RWAs increased £7.6bn: • A £1.6bn increase in book size primarily due to an increase in trading activities within SFTs and derivatives • A £3.4bn increase in methodology and policy as a result of regulatory changes that took effect from 1 January 2022, relating to the introduction of SA-CCR • A £2.6bn increase in FX primarily due to appreciation of period end USD against GBP Market risk RWAs increased £1.6bn: • A £0.1bn increase in book size primarily driven by a £8.4bn increase due to client and trading activities, offset by a £6.9bn decrease in Stressed Value at Risk (SVaR) model adjustment as a result of changes in portfolio composition and a £1.4bn reduction in Structural FX • A £1.5bn increase in FX primarily due to appreciation of period end USD against GBP Treasury and Capital Risk Barclays PLC 60 -- 62 of 109 -- Restated1 Leverage ratios2,3 As at 30.06.22 As at 31.03.22 As at 31.12.21 £m £m £m Average UK leverage ratio 4.7% 4.8% 4.9% Average T1 capital 57,689 56,701 59,739 Average UK leverage exposure 1,233,537 1,179,381 1,229,041 UK leverage ratio 5.1% 5.0% 5.2% CET1 capital 46,691 45,269 47,327 AT1 capital 12,297 11,059 12,179 T1 capital 58,988 56,328 59,506 UK leverage exposure 1,151,214 1,123,531 1,137,904 UK leverage exposure Accounting assets Derivative financial instruments 344,855 289,822 262,572 Derivative cash collateral 66,909 64,836 58,177 Securities financing transactions (SFTs) 193,682 186,417 170,853 Loans and advances and other assets 983,784 955,020 892,683 Total IFRS assets 1,589,230 1,496,095 1,384,285 Regulatory consolidation adjustments (3,546) (3,605) (3,665) Derivatives adjustments Derivatives netting (288,727) (235,071) (236,881) Adjustments to collateral (53,328) (52,181) (50,929) Net written credit protection 28,102 19,729 15,509 Potential future exposure (PFE) on derivatives 85,469 85,619 137,291 Total derivatives adjustments (228,484) (181,904) (135,010) SFTs adjustments 29,784 29,095 24,544 Regulatory deductions and other adjustments (22,758) (22,332) (20,219) Weighted off-balance sheet commitments 127,400 119,933 115,047 Qualifying central bank claims (294,477) (260,196) (210,134) Settlement netting (45,935) (53,555) (16,944) UK leverage exposure 1,151,214 1,123,531 1,137,904 1 Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 for further details. 2 Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II. 3 Fully loaded average UK leverage ratio was 4.6%, with £57.0bn of T1 capital and £1,232.9bn of leverage exposure. Fully loaded UK leverage ratio was 5.1%, with £58.3bn of T1 capital and £1,150.6bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II. The UK leverage ratio decreased to 5.1% (December 2021: 5.2%) primarily due to a £13.3bn increase in the leverage exposure. The UK leverage exposure increased to £1,151.2bn (December 2021: £1,137.9bn), due to the following significant movements: • £36.8bn increase in derivative financial instruments post additional regulatory netting and adjustments for cash collateral primarily driven by client and trading activity in CIB and the application of a 1.4 multiplier introduced under SA- CCR • £34.4bn increase in loans and advances at amortised cost primarily driven by increased lending • £28.1bn increase in SFTs primarily driven by client activity in CIB • £12.6bn increase in net written credit protection primarily driven by the inclusion of credit default swap options from 1 January 2022 Treasury and Capital Risk Barclays PLC 61 -- 63 of 109 -- • £51.8bn decrease in PFE on derivatives primarily driven by increased netting eligibility due to the introduction of SA-CCR • £39.8bn decrease due to an £84.3bn increase in the qualifying central bank claims exemption primarily due to the matching of allowable liabilities rather than deposits introduced under the UK leverage framework review, partially offset by a £44.6bn increase in cash • £20.0bn decrease in trading portfolio assets primarily due to decreases in Equities The average UK Leverage Ratio decreased to 4.7% (December 2021: 4.9%) primarily due to a £2.1bn decrease in average T1 capital largely as a result of regulatory changes effective from 1 January 2022 and the redemption of AT1 instruments in Q122. Treasury and Capital Risk Barclays PLC 62 -- 64 of 109 -- MREL MREL requirements including buffers1,2,3,4 Total requirement (£m) based on Requirement as a percentage of: Restated1 Restated1 As at 30.06.22 As at 31.03.22 As at 31.12.21 As at 30.06.22 As at 31.03.22 As at 31.12.21 Requirement based on RWAs (minimum requirement) 98,096 94,947 77,302 28.5% 28.9% 24.6% Requirement based on UK leverage exposure3 91,532 89,025 93,975 8.0% 7.9% 6.9% Restated1 Own funds and eligible liabilities1,3 As at 30.06.22 As at 31.03.22 As at 31.12.21 £m £m £m CET1 capital 46,691 45,269 47,327 AT1 capital instruments and related share premium accounts5 12,297 11,059 12,179 T2 capital instruments and related share premium accounts5 8,355 8,272 8,626 Eligible liabilities 39,137 37,886 39,889 Total Barclays PLC (the Parent company) own funds and eligible liabilities 106,480 102,486 108,021 Total RWAs 344,516 328,830 314,136 Total UK leverage exposure4 1,151,214 1,123,531 1,356,191 Restated1 Own funds and eligible liabilities ratios as a percentage of:1 As at 30.06.22 As at 31.03.22 As at 31.12.21 Total RWAs 30.9% 31.2% 34.4% Total UK leverage exposure4 9.2% 9.1% 8.0% As at 30 June 2022, Barclays PLC (the Parent company) held £106.5bn of own funds and eligible liabilities equating to 30.9% of RWAs. This was in excess of the Group's MREL requirement, excluding the PRA buffer, to hold £98.1bn of own funds and eligible liabilities equating to 28.5% of RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer. 1 Capital and leverage metrics as at 31 December 2021 have been restated to reflect the impact of the Over-issuance of Securities. See Basis of preparation on page 56 for further details. 2 Minimum requirement excludes the confidential institution-specific PRA buffer. 3 CET1, T1 and T2 capital, and RWAs are calculated applying IFRS 9 transitional arrangements. 4 As at 31 December 2021, MREL requirements were on a CRR leverage basis which, from 1 January 2022, was no longer applicable for UK banks. 5 Includes other AT1 capital regulatory adjustments and deductions of £60m (December 2021: £80m), and other T2 credit risk adjustments and deductions of £87m (December 2021: £87m). Treasury and Capital Risk Barclays PLC 63 -- 65 of 109 -- The Directors (the names of whom are set out below) are required to prepare the financial statements on a going concern basis unless it is not appropriate to do so. In making this assessment, the directors have considered information relating to present and future conditions. Each of the Directors confirm that to the best of their knowledge, the condensed consolidated interim financial statements set out on pages 67 to 72 have been prepared in accordance with International Accounting Standard 34, ‘Interim Financial Reporting’, as adopted by the UK, and that the interim management report herein includes a fair review of the information required by Disclosure Guidance and Transparency Rules 4.2.7R and 4.2.8R namely: • an indication of important events that have occurred during the six months ended 30 June 2022 and their impact on the condensed consolidated interim financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year • any related party transactions in the six months ended 30 June 2022 that have materially affected the financial position or performance of Barclays during that period and any changes in the related party transactions described in the last Annual Report that could have a material effect on the financial position or performance of Barclays in the six months ended 30 June 2022 Signed on 27 July 2022 on behalf of the Board by C.S. Venkatakrishnan Anna Cross Group Chief Executive Group Finance Director Barclays PLC Board of Directors Chairman Executive Directors Non-Executive Directors Nigel Higgins C.S. Venkatakrishnan Mike Ashley Anna Cross Robert Berry Tim Breedon CBE Mohamed A. El-Erian Dawn Fitzpatrick Mary Francis CBE Crawford Gillies Brian Gilvary Diane Schueneman Julia Wilson Statement of Directors' Responsibilities Barclays PLC 64 -- 66 of 109 -- Conclusion We have been engaged by Barclays PLC ("the company" or "the group") to review the condensed set of financial statements in the Interim Results Announcement for the six months ended 30 June 2022 which comprises: • the condensed consolidated income statement and condensed consolidated statement of comprehensive income for the period then ended; • the condensed consolidated balance sheet as at 30 June 2022; • the condensed consolidated statement of changes in equity for the period then ended; • the condensed consolidated cash flow statement for the period then ended; and • the related explanatory notes. Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the Interim Results Announcement for the six months ended 30 June 2022 is not prepared, in all material respects, in accordance with IAS 34 Interim Financial Reporting as adopted for use in the UK and the Disclosure Guidance and Transparency Rules (“the DTR”) of the UK’s Financial Conduct Authority (“the UK FCA”). Basis for conclusion We conducted our review in accordance with International Standard on Review Engagements (UK) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity (“ISRE (UK) 2410”) issued for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. We read the other information contained in the Interim Results Announcement and consider whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Conclusions relating to going concern Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for conclusion section of this report, nothing has come to our attention that causes us to believe that the directors have inappropriately adopted the going concern basis of accounting, or that the directors have identified material uncertainties relating to going concern that have not been appropriately disclosed. This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410. However, future events or conditions may cause the group to cease to continue as a going concern, and the above conclusions are not a guarantee that the group will continue in operation. Directors’ responsibilities The Interim Results Announcement is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA. As disclosed in note 1, the Basis of preparation, the annual financial statements of the Barclays Group are prepared in accordance with UK-adopted international accounting standards. The directors are responsible for preparing the condensed set of financial statements included in the Interim Results Announcement in accordance with IAS 34 as adopted for use in the UK. In preparing the condensed set of financial statements, the directors are responsible for assessing the group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or to cease operations, or have no realistic alternative but to do so. Our responsibility Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the Interim Results Announcement based on our review. Our conclusion, including our conclusions relating to going concern, are based on procedures that are less extensive than audit procedures, as described in the Basis for conclusion section of this report. Independent Review Report to Barclays PLC Barclays PLC 65 -- 67 of 109 -- The purpose of our review work and to whom we owe our responsibilities This report is made solely to the company in accordance with the terms of our engagement to assist the company in meeting the requirements of the DTR of the UK FCA. Our review has been undertaken so that we might state to the company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or for the conclusions we have reached. Stuart Crisp for and on behalf of KPMG LLP Chartered Accountants 15 Canada Square London, E14 5GL 27 July 2022 Independent Review Report to Barclays PLC Barclays PLC 66 -- 68 of 109 -- Condensed consolidated income statement (unaudited) Restated2 Notes1 Half year ended 30.06.22 Half year ended 30.06.21 £m £m Interest and similar income 7,134 5,279 Interest and similar expense (2,371) (1,376) Net interest income 4,763 3,903 Fee and commission income 3 4,726 4,682 Fee and commission expense 3 (1,302) (976) Net fee and commission income 3 3,424 3,706 Net trading income 5,013 3,482 Net investment income (116) 152 Other income 120 72 Total income 13,204 11,315 Credit impairment (charges)/releases (341) 742 Net operating income 12,863 12,057 Staff costs 4 (4,583) (4,334) Infrastructure, administration and general expenses 5 (2,687) (2,798) Litigation and conduct 15 (1,857) (176) Operating expenses (9,127) (7,308) Share of post-tax results of associates and joint ventures (3) 154 Profit on disposal of subsidiaries, associates and joint ventures — (1) Profit before tax 3,733 4,902 Tax charge 6 (823) (742) Profit after tax 2,910 4,160 Attributable to: Equity holders of the parent 2,475 3,752 Other equity instrument holders 414 389 Total equity holders of the parent 2,889 4,141 Non-controlling interests 7 21 19 Profit after tax 2,910 4,160 Earnings per share p p Basic earnings per ordinary share 8 14.8 21.9 Diluted earnings per ordinary share 8 14.5 21.3 1 For Notes to the Financial Statements see pages 73 to 100. 2 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Condensed Consolidated Financial Statements Barclays PLC 67 -- 69 of 109 -- Condensed consolidated statement of comprehensive income (unaudited) Restated2 Half year ended 30.06.22 Half year ended 30.06.21 Notes1 £m £m Profit after tax 2,910 4,160 Other comprehensive income/(loss) that may be recycled to profit or loss:3 Currency translation reserve 19 1,703 (495) Fair value through other comprehensive income reserve 19 (913) (365) Cash flow hedging reserve 19 (3,818) (911) Other comprehensive loss that may be recycled to profit (3,028) (1,771) Other comprehensive income/(loss) not recycled to profit or loss:3 Retirement benefit remeasurements 16 1,090 103 Fair value through other comprehensive income reserve 19 154 115 Own credit 19 855 (47) Other comprehensive income not recycled to profit 2,099 171 Other comprehensive loss for the period (929) (1,600) Total comprehensive income for the period 1,981 2,560 Attributable to: Equity holders of the parent 1,960 2,541 Non-controlling interests 21 19 Total comprehensive income for the period 1,981 2,560 1 For Notes to the Financial Statements see pages 73 to 100. 2 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. 3 Reported net of tax. Condensed Consolidated Financial Statements Barclays PLC 68 -- 70 of 109 -- Condensed consolidated balance sheet (unaudited) Restated2 As at 30.06.22 As at 31.12.21 Assets Notes1 £m £m Cash and balances at central banks 283,136 238,574 Cash collateral and settlement balances 132,623 92,542 Loans and advances at amortised cost 12 395,824 361,451 Reverse repurchase agreements and other similar secured lending 1,639 3,227 Trading portfolio assets 127,004 147,035 Financial assets at fair value through the income statement 212,723 191,972 Derivative financial instruments 10 344,855 262,572 Financial assets at fair value through other comprehensive income 63,194 61,753 Investments in associates and joint ventures 911 999 Goodwill and intangible assets 13 8,245 8,061 Property, plant and equipment 3,582 3,555 Current tax assets 551 261 Deferred tax assets 6 5,044 4,619 Retirement benefit assets 16 5,233 3,879 Other assets 4,666 3,785 Total assets 1,589,230 1,384,285 Liabilities Deposits at amortised cost 12 568,670 519,433 Cash collateral and settlement balances 124,724 79,371 Repurchase agreements and other similar secured borrowing 28,566 28,352 Debt securities in issue 115,906 98,867 Subordinated Liabilities 14 11,871 12,759 Trading portfolio liabilities 76,638 54,169 Financial liabilities designated at fair value 255,136 250,960 Derivative financial instruments 10 321,396 256,883 Current tax liabilities 449 689 Deferred tax liabilities 6 5 37 Retirement benefit liabilities 16 309 311 Other liabilities 11,538 10,505 Provisions 15 3,426 1,908 Total liabilities 1,518,634 1,314,244 Equity Called up share capital and share premium 17 4,508 4,536 Other reserves 19 (218) 1,770 Retained earnings 52,980 50,487 Shareholders' equity attributable to ordinary shareholders of the parent 57,270 56,793 Other equity instruments 18 12,357 12,259 Total equity excluding non-controlling interests 69,627 69,052 Non-controlling interests 7 969 989 Total equity 70,596 70,041 Total liabilities and equity 1,589,230 1,384,285 1 For Notes to the Financial Statements see pages 73 to 100. 2 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Condensed Consolidated Financial Statements Barclays PLC 69 -- 71 of 109 -- Condensed consolidated statement of changes in equity (unaudited) Restated1 Restated1 Restated1 Called up share capital and share premium2 Other equity instruments2 Other reserves2 Retained earnings Total Non- controlling interests3 Total equity Half year ended 30.06.22 £m £m £m £m £m £m £m Balance as at 1 January 2022 4,536 12,259 1,770 50,487 69,052 989 70,041 Profit after tax — 414 — 2,475 2,889 21 2,910 Currency translation movements — — 1,703 — 1,703 — 1,703 Fair value through other comprehensive income reserve — — (759) — (759) — (759) Cash flow hedges — — (3,818) — (3,818) — (3,818) Retirement benefit remeasurements — — — 1,090 1,090 — 1,090 Own credit — — 855 — 855 — 855 Total comprehensive income for the period — 414 (2,019) 3,565 1,960 21 1,981 Employee share schemes and hedging thereof 33 — — 417 450 — 450 Issue and redemption of other equity instruments — 115 — 25 140 (20) 120 Other equity instruments coupon paid — (414) — — (414) — (414) Partial disposal of ABSA holding — — (39) 39 — — — Vesting of employee share schemes — — 7 (464) (457) — (457) Dividends paid — — — (664) (664) (21) (685) Repurchase of shares (61) — 61 (432) (432) — (432) Other movements — (17) 2 7 (8) — (8) Balance as at 30 June 2022 4,508 12,357 (218) 52,980 69,627 969 70,596 Half year ended 31.12.2021 Balance as at 1 July 2021 4,568 11,167 2,856 48,401 66,992 1,064 68,056 Profit after tax — 415 — 2,453 2,868 28 2,896 Currency translation movements — — 364 — 364 — 364 Fair value through other comprehensive income reserve — — (38) — (38) — (38) Cash flow hedges — — (1,517) — (1,517) — (1,517) Retirement benefit remeasurements — — — 540 540 — 540 Own credit — — 33 — 33 — 33 Total comprehensive income for the period — 415 (1,158) 2,993 2,250 28 2,278 Employee share schemes and hedging thereof 35 — — (54) (19) — (19) Issue and redemption of other equity instruments — 1,078 — 6 1,084 (75) 1,009 Other equity instruments coupon paid — (415) — — (415) — (415) Vesting of employee share schemes — — (3) (13) (16) — (16) Dividends paid — — — (339) (339) (28) (367) Repurchase of shares (67) — 67 (500) (500) — (500) Other movements — 14 8 (7) 15 — 15 Balance as at 31 December 2021 4,536 12,259 1,770 50,487 69,052 989 70,041 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. 2 Details of share capital, other equity instruments and other reserves are shown on pages 89 to 90. 3 Details of non-controlling interests are shown on page 78. Condensed Consolidated Financial Statements Barclays PLC 70 -- 72 of 109 -- Condensed consolidated statement of changes in equity (unaudited) Restated1 Restated1 Restated1 Called up share capital and share premium2 Other equity instruments2 Other reserves2 Retained earnings Total Non- controlling interests3 Total equity Half year ended 30.06.2021 £m £m £m £m £m £m £m Balance as at 1 January 2021 4,637 11,172 4,461 45,527 65,797 1,085 66,882 Profit after tax — 389 — 3,752 4,141 19 4,160 Currency translation movements — — (495) — (495) — (495) Fair value through other comprehensive income reserve — — (250) — (250) — (250) Cash flow hedges — — (911) — (911) — (911) Retirement benefit remeasurements — — — 103 103 — 103 Own credit — — (47) — (47) — (47) Total comprehensive income for the period — 389 (1,703) 3,855 2,541 19 2,560 Employee share schemes and hedging thereof 25 — — 289 314 — 314 Other equity instruments coupon paid — (389) — — (389) — (389) Vesting of employee share schemes — — 4 (397) (393) — (393) Dividends paid — — — (173) (173) (16) (189) Repurchase of shares (94) — 94 (700) (700) — (700) Other movements — (5) — — (5) (24) (29) Balance as at 30 June 2021 4,568 11,167 2,856 48,401 66,992 1,064 68,056 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. 2 Details of share capital, other equity instruments and other reserves are shown on pages 89 to 90. 3 Details of non-controlling interests are shown on page 78. Condensed Consolidated Financial Statements Barclays PLC 71 -- 73 of 109 -- Condensed consolidated cash flow statement (unaudited) Restated1 Half year ended 30.06.22 Half year ended 30.06.21 £m £m Profit before tax 3,733 4,902 Adjustment for non-cash items (7,115) 6,977 Net (increase)/decrease in loans and advances at amortised cost (17,667) 432 Net increase in deposits at amortised cost 49,237 19,859 Net increase in debt securities in issue 19,748 13,041 Changes in other operating assets and liabilities 14,719 (5,559) Corporate income tax paid (401) (712) Net cash from operating activities 62,254 38,940 Net cash from investing activities (14,939) (3,389) Net cash from financing activities (5,500) (2,562) Effect of exchange rates on cash and cash equivalents 7,047 (5,535) Net increase in cash and cash equivalents 48,862 27,454 Cash and cash equivalents at beginning of the period 259,206 210,142 Cash and cash equivalents at end of the period 308,068 237,596 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Condensed Consolidated Financial Statements Barclays PLC 72 -- 74 of 109 -- 1. Basis of preparation These condensed consolidated interim financial statements ("the financial statements") for the six months ended 30 June 2022 have been prepared in accordance with the Disclosure Guidance and Transparency Rules (DTR) of the UK’s Financial Conduct Authority (FCA) and IAS 34, Interim Financial Reporting, as published by the International Accounting Standards Board (IASB) and adopted by the UK. The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2021. The annual financial statements for the year ended 31 December 2021 were prepared in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and in accordance with International Financial Reporting Standards (IFRS) and interpretations (IFRICs) as issued by the IASB and adopted by the UK. The accounting policies and methods of computation used in these condensed consolidated interim financial statements are the same as those used in the Barclays PLC Annual Report 2021. 1. Going concern The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent company have the resources to continue in business for a period of at least 12 months from approval of the interim financial statements. In making this assessment, the Directors have considered a wide range of information relating to present and future conditions and includes a review of a working capital report (WCR). The WCR is used by the Directors to assess the future performance of the business and that it has the resources in place that are required to meet its ongoing regulatory requirements. The WCR also includes an assessment of the impact of internally generated stress testing scenarios on the liquidity and capital requirement forecasts. The stress tests used were based upon an assessment of reasonably possible downside economic scenarios that the Group could experience. The WCR indicated that the Group had sufficient capital in place to support its future business requirements and remained above its regulatory minimum requirements in the internal stress scenarios. 2. Other disclosures The Credit risk disclosures on pages 27 to 48 form part of these interim financial statements. Restatement of financial statements The comparatives in these condensed consolidated interim financial statements for the six months ended 30 June 2022 (the financial statements) have been restated to reflect both a provision and contingent liability disclosure in respect of the impact of an over-issuance of securities (the Over-issuance of Securities) in excess of the maximum aggregate offering price registered under Barclays Bank PLC’s shelf registration statement on Form F-3, as declared effective by the SEC in August 2019 (2019 F-3) and Barclays Bank PLC’s predecessor shelf registration statement on Form F-3 filed in 2018 (Predecessor Shelf). Due to a historic SEC settlement order, at the time the 2019 F-3 was filed and the Predecessor Shelf was amended, Barclays Bank PLC had ceased to be a “well-known seasoned issuer” (or WKSI) and had become an “ineligible issuer”, as defined in Rule 405 under the Securities Act of 1933, as amended (Securities Act), thus being required to register upfront a certain amount of securities with the SEC. In March 2022, Barclays Bank PLC became aware that it had issued securities in the US materially in excess of the amount it had registered with the SEC under the 2019 F-3 and subsequently became aware that securities had also been issued in excess of the amount it had registered with the SEC under the Predecessor Shelf. The securities that were issued in this period comprise structured notes and exchange traded notes (ETNs). As such, certain offers and sales of these securities were not made in compliance with the Securities Act, giving rise to rights of rescission for certain purchasers of the securities. Under Section 12(a)(1) of the Securities Act, certain purchasers of unregistered securities have a right to recover, upon the tender of such security, the consideration paid for such security with interest, less the amount of any income received, or damages if the purchaser no longer owns the security (the Rescission Price). As a result, Barclays Bank PLC has elected to make a rescission offer to eligible purchasers of the relevant affected securities at the Rescission Price (the Rescission Offer). A proportion of the expected costs associated with the rights of rescission of certain investors are attributable to Barclays PLC’s financial statements for the year ended 31 December 2021. Accordingly, the comparatives in these financial statements have been restated. The restatement impacts the consolidated income statement, the consolidated statement of Financial Statement Notes Barclays PLC 73 -- 75 of 109 -- comprehensive income, the consolidated balance sheet, the consolidated statement of changes in equity, and the consolidated cash flow statement for the year ended 31 December 2021, as well as quarterly and half yearly financial information that is presented within this document. There was no material effect on Barclays PLC’s previously reported financial statements for the year ended 31 December 2020 and 2019. The table below reflects each of the consolidated financial statement line items that were affected by the restatement: Impact on the consolidated income statement As reported Restatement As restated Half year ended 30.06.21 £m £m £m Litigation and conduct (99) (77) (176) Operating expenses (7,231) (77) (7,308) Profit before tax 4,979 (77) 4,902 Taxation (759) 17 (742) Profit after tax 4,220 (60) 4,160 Year ended 31.12.21 £m £m £m Litigation and conduct (177) (220) (397) Operating expenses (14,439) (220) (14,659) Profit before tax 8,414 (220) 8,194 Taxation (1,188) 50 (1,138) Profit after tax 7,226 (170) 7,056 Impact on the consolidated statement of comprehensive income Half year ended 30.06.21 £m £m £m Profit after tax 4,220 (60) 4,160 Total comprehensive income for the period 2,620 (60) 2,560 Year ended 31.12.21 £m £m £m Profit after tax 7,226 (170) 7,056 Total comprehensive income for the period 5,008 (170) 4,838 Impact on the cash flow statement Half year ended 30.06.21 £m £m £m Profit before tax 4,979 (77) 4,902 Adjustment for non-cash items 6,900 77 6,977 Impact on the consolidated balance sheet As at 31.12.21 £m £m £m Current tax liabilities 739 (50) 689 Provisions 1,688 220 1,908 Total liabilities 1,314,074 170 1,314,244 Retained earnings 50,657 (170) 50,487 Total equity 70,211 (170) 70,041 Financial Statement Notes Barclays PLC 74 -- 76 of 109 -- 2. Segmental reporting Analysis of results by business Barclays UK Barclays International Head Office Barclays Group Half year ended 30.06.22 £m £m £m £m Total income 3,373 9,940 (109) 13,204 Credit impairment (charges)/releases (48) (310) 17 (341) Net operating income/(expenses) 3,325 9,630 (92) 12,863 Operating costs (2,083) (5,042) (145) (7,270) Litigation and conduct (25) (1,832) — (1,857) Total operating expenses (2,108) (6,874) (145) (9,127) Other net income/(expenses)1 — 13 (16) (3) Profit/(loss) before tax 1,217 2,769 (253) 3,733 As at 30.06.22 £bn £bn £bn £bn Total assets 318.8 1,250.6 19.8 1,589.2 Restated2 Restated2 Barclays UK Barclays International Head Office Barclays Group Half year ended 30.06.21 £m £m £m £m Total income 3,199 8,218 (102) 11,315 Credit impairment releases 443 293 6 742 Net operating income/(expenses) 3,642 8,511 (96) 12,057 Operating costs (2,114) (4,606) (412) (7,132) Litigation and conduct (22) (161) 7 (176) Total operating expenses (2,136) (4,767) (405) (7,308) Other net income1 — 22 131 153 Profit/(loss) before tax 1,506 3,766 (370) 4,902 As at 31.12.21 £bn £bn £bn £bn Total assets 321.2 1,044.1 19.0 1,384.3 1 Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates and joint ventures and gains on acquisitions. 2 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Split of income by geographic region1 Half year ended 30.06.22 Half year ended 30.06.21 £m £m United Kingdom 7,972 5,895 Europe 1,311 1,222 Americas 3,200 3,608 Africa and Middle East 31 20 Asia 690 570 Total 13,204 11,315 1 The geographical analysis is based on the location of the office where the transactions are recorded. Financial Statement Notes Barclays PLC 75 -- 77 of 109 -- 3. Net fee and commission income Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from Contracts with Customers: Barclays UK Barclays International Head Office Total Half year ended 30.06.22 £m £m £m £m Fee type Transactional1 515 1,448 — 1,963 Advisory 83 511 — 594 Brokerage and execution 125 762 — 887 Underwriting and syndication — 1,102 — 1,102 Other 29 80 2 111 Total revenue from contracts with customers 752 3,903 2 4,657 Other non-contract fee income — 69 — 69 Fee and commission income1 752 3,972 2 4,726 Fee and commission expense (147) (1,153) (2) (1,302) Net fee and commission income 605 2,819 — 3,424 Barclays UK Barclays International Head Office Total Half year ended 30.06.21 £m £m £m £m Fee type Transactional 408 1,181 — 1,589 Advisory 83 459 1 543 Brokerage and execution 109 553 — 662 Underwriting and syndication — 1,715 — 1,715 Other 35 73 3 111 Total revenue from contracts with customers 635 3,981 4 4,620 Other non-contract fee income — 62 — 62 Fee and commission income 635 4,043 4 4,682 Fee and commission expense1 (108) (861) (7) (976) Net fee and commission income 527 3,182 (3) 3,706 1 Barclays has corrected the presentation of the scheme fees incurred when Barclays acts as an “acquirer” as part of the payment transaction cycle. From 2022 onwards, the scheme fees reported under "Barclays International" are presented within fees and commission income under "Transactional" fee type, which had previously been recognised in fees and commission expense. The reclassification into Fee and Commission income is a reduction of £103m for H122. The comparatives have not been restated as the effect is not considered material although the effect would have been a reduction of H121: £88m with no impact on Net fee and commission income. There is no impact on Net assets or Cash flows reported. Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees. These include interchange and merchant fee income generated from credit and bank card usage. Advisory fees are generated from wealth management services and investment banking advisory services related to mergers, acquisitions and financial restructurings. Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter markets and assisting clients in clearing transactions. Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement and administration of a loan syndication. These include commitment fees to provide loan financing. Financial Statement Notes Barclays PLC 76 -- 78 of 109 -- 4. Staff costs Half year ended 30.06.22 Half year ended 30.06.21 Compensation costs £m £m Upfront bonus charge 705 824 Deferred bonus charge 280 262 Other incentives 44 6 Performance costs 1,029 1,092 Salaries 2,278 2,117 Social security costs 377 336 Post-retirement benefits 282 275 Other compensation costs 241 223 Total compensation costs 4,207 4,043 Other resourcing costs Outsourcing 268 171 Redundancy and restructuring (15) 23 Temporary staff costs 53 55 Other 70 42 Total other resourcing costs 376 291 Total staff costs 4,583 4,334 Barclays Group compensation costs as a % of total income 31.9% 35.7% No material awards have yet been granted in relation to the 2022 bonus pool as decisions regarding incentive awards are not taken by the Remuneration Committee until the performance for the full year can be assessed. The current year bonus charge for the first six months represents an accrual for estimated costs in accordance with accounting requirements. One of the primary considerations when evaluating the accrual is Group and business level returns, aligning colleague and shareholder interests. The Group has entered into physically settled forward contracts to hedge the settlement of certain share-based payment schemes. The present value of the fixed forward price to be paid under these outstanding contracts is £287m and has been recorded in retained earnings. 5. Infrastructure, administration and general expenses Half year ended 30.06.22 Half year ended 30.06.21 Infrastructure costs £m £m Property and equipment 744 709 Depreciation and amortisation 863 832 Lease payments 14 20 Impairment of property, equipment and intangible assets 21 304 Total infrastructure costs 1,642 1,865 Administration and general expenses Consultancy, legal and professional fees 288 262 Marketing and advertising 206 163 Other administration and general expenses 551 508 Total administration and general expenses 1,045 933 Total infrastructure, administration and general expenses 2,687 2,798 Financial Statement Notes Barclays PLC 77 -- 79 of 109 -- 6. Tax The tax charge for H122 was £823m (restated1 H121: £742m), representing an effective tax rate (ETR) of 22.0% (restated1 H121: 15.1%). The ETR for H122 includes a charge recognised for the re-measurement of the Group’s UK deferred tax assets (DTAs) due to the enactment of legislation in Q122 which will result in the UK banking surcharge rate being reduced from 8% to 3% effective from 1 April 2023. The ETR excluding the impact of this downward re-measurement of UK DTAs was 12.8%, which includes a 5.8% benefit relating to adjustments in respect of prior years. Included in the H122 tax charge is a credit of £110m (H121: £104m) in respect of payments made on AT1 instruments that are classified as equity for accounting purposes. The H121 ETR included a benefit recognised for the re-measurement of the Group’s UK DTAs as a result of the enactment of legislation to increase the UK corporation tax rate to 25% effective from 1 April 2023. The re-measurement of UK DTAs has resulted in the Group's DTAs decreasing by £318m with a tax charge in the income statement of £346m and a tax credit within other comprehensive income of £28m. In October 2021, the OECD and G20 Inclusive Framework on Base Erosion and Profit Shifting announced plans to introduce a global minimum tax rate of 15%. The model rules were released by the OECD in December 2021 with further guidance published in March 2022. Draft legislation published by the UK government on 20 July 2022 to implement the global minimum tax regime is expected to apply for accounting periods beginning on or after 31 December 2023. The Group is reviewing the published OECD model rules and guidance and will review further guidance as well as new legislation to be released by governments implementing this new tax regime as it is published to assess the potential impact of new legislation. In the USA, the proposed Build Back Better Act was passed by the House of Representatives in 2021 but it was not passed by the Senate and it is uncertain whether various proposals contained in the Act will progress further. The Act included proposals to implement material changes to international tax provisions, including amendments to the Base Erosion and Anti-Abuse Tax and the imposition of an alternative minimum tax based on accounting profits. It is unclear at this time whether any of these proposals could have a significant impact on the Group if enacted. The Group will continue to monitor developments and assess the potential impact of any future legislative changes ultimately enacted. 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. As at 30.06.22 As at 31.12.21 Deferred tax assets and liabilities £m £m UK 3,046 2,183 USA 1,530 2,006 Other territories 468 430 Deferred tax assets 5,044 4,619 Deferred tax liabilities (5) (37) Analysis of deferred tax assets Temporary differences 3,871 3,399 Tax losses 1,173 1,220 Deferred tax assets 5,044 4,619 7. Non-controlling interests Profit attributable to non-controlling interests Equity attributable to non-controlling interests Half year ended 30.06.22 Half year ended 30.06.21 As at 30.06.22 As at 31.12.21 £m £m £m £m Barclays Bank PLC issued: - Preference shares 15 13 529 529 - Upper T2 instruments 6 3 438 458 Other non-controlling interests — 3 2 2 Total 21 19 969 989 Financial Statement Notes Barclays PLC 78 -- 80 of 109 -- 8. Earnings per share Restated1 Half year ended 30.06.22 Half year ended 30.06.21 £m £m Profit attributable to ordinary equity holders of the parent 2,475 3,752 m m Basic weighted average number of shares in issue 16,684 17,140 Number of potential ordinary shares 428 467 Diluted weighted average number of shares 17,112 17,607 p p Basic earnings per ordinary share 14.8 21.9 Diluted earnings per ordinary share 14.5 21.3 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. 9. Dividends on ordinary shares A half year dividend for 2022 of 2.25p (H121: 2p) per ordinary share will be paid on 16 September 2022 to shareholders on the register on 12 August 2022. Half year ended 30.06.22 Half year ended 30.06.21 Per share Total Per share Total Dividends paid during the period p £m p £m Full year dividend paid during period 4.0 664 1.0 173 For qualifying American Depositary Receipt (ADR) holders, the half year dividend of 2.25p per ordinary share becomes 9.0p per American Depositary Share (representing 4 shares). The depositary bank will post the half year dividend on 16 September 2022 to ADR holders on the record at close of business on 12 August 2022. The Directors have confirmed their intention to initiate a share buyback of up to £500m after the balance sheet date. The share buyback is expected to commence in the third quarter of 2022. The financial statements for the six months ended 30 June 2022 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are repurchased by the Company. Financial Statement Notes Barclays PLC 79 -- 81 of 109 -- 10. Derivative financial instruments Contract notional amount Fair value Assets Liabilities As at 30.06.22 £m £m £m Foreign exchange derivatives 6,732,093 135,207 (123,662) Interest rate derivatives 44,275,712 130,628 (116,541) Credit derivatives 1,640,043 8,128 (8,228) Equity and stock index and commodity derivatives 2,510,981 70,066 (71,830) Derivative assets/(liabilities) held for trading 55,158,829 344,029 (320,261) Derivatives in hedge accounting relationships Derivatives designated as cash flow hedges 139,040 701 (21) Derivatives designated as fair value hedges 107,809 106 (1,054) Derivatives designated as hedges of net investments 4,097 19 (60) Derivative assets/(liabilities) designated in hedge accounting relationships 250,946 826 (1,135) Total recognised derivative assets/(liabilities) 55,409,775 344,855 (321,396) As at 31.12.21 Foreign exchange derivatives 5,824,856 76,140 (74,437) Interest rate derivatives 38,816,432 125,846 (114,803) Credit derivatives 1,272,104 5,682 (6,561) Equity and stock index and commodity derivatives 1,899,382 54,010 (59,946) Derivative assets/(liabilities) held for trading 47,812,774 261,678 (255,747) Derivatives in hedge accounting relationships Derivatives designated as cash flow hedges 114,313 798 (3) Derivatives designated as fair value hedges 102,815 59 (1,129) Derivatives designated as hedges of net investments 2,423 37 (4) Derivative assets/(liabilities) designated in hedge accounting relationships 219,551 894 (1,136) Total recognised derivative assets/(liabilities) 48,032,325 262,572 (256,883) The IFRS netting posted against derivative assets was £55bn including £12bn of cash collateral netted (December 2021: £24bn including £4bn cash collateral netted) and £55bn for liabilities including £12bn of cash collateral netted (December 2021: £24bn including £4bn of cash collateral netted). Derivative asset exposures would be £306bn (December 2021: £237bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for which the Group holds cash collateral of £40bn (December 2021: £35bn). Similarly, derivative liabilities would be £293bn (December 2021: £235bn) lower reflecting counterparty netting and cash collateral placed of £26bn (December 2021: £32bn). In addition, non-cash collateral of £13bn (December 2021: £6bn) was held in respect of derivative assets and £3bn (December 2021: £2bn) was placed in respect of derivative liabilities. Collateral amounts are limited to net on balance sheet exposure so as to not include over-collateralisation. Financial Statement Notes Barclays PLC 80 -- 82 of 109 -- 11. Fair value of financial instruments This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual Report 2021 which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the accounting policies adopted or the valuation methodologies used. Valuation The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification: Valuation technique using Quoted market prices Observable inputs Significant unobservable inputs (Level 1) (Level 2) (Level 3) Total As at 30.06.22 £m £m £m £m Trading portfolio assets 58,419 64,329 4,256 127,004 Financial assets at fair value through the income statement 1,115 202,026 9,582 212,723 Derivative financial instruments 11,653 329,329 3,873 344,855 Financial assets at fair value through other comprehensive income 22,455 40,696 43 63,194 Investment property — — 5 5 Total assets 93,642 636,380 17,759 747,781 Trading portfolio liabilities (47,870) (28,686) (82) (76,638) Financial liabilities designated at fair value (193) (254,496) (447) (255,136) Derivative financial instruments (12,674) (304,343) (4,379) (321,396) Total liabilities (60,737) (587,525) (4,908) (653,170) As at 31.12.21 Trading portfolio assets 80,926 63,828 2,281 147,035 Financial assets at fair value through the income statement 5,093 177,167 9,712 191,972 Derivative financial instruments 6,150 252,412 4,010 262,572 Financial assets at fair value through other comprehensive income 22,009 39,706 38 61,753 Investment property — — 7 7 Total assets 114,178 533,113 16,048 663,339 Trading portfolio liabilities (27,529) (26,613) (27) (54,169) Financial liabilities designated at fair value (174) (250,376) (410) (250,960) Derivative financial instruments (6,571) (244,253) (6,059) (256,883) Total liabilities (34,274) (521,242) (6,496) (562,012) Financial Statement Notes Barclays PLC 81 -- 83 of 109 -- The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type: As at 30.06.22 As at 31.12.21 Assets Liabilities Assets Liabilities £m £m £m £m Interest rate derivatives 1,573 (1,849) 1,091 (1,351) Foreign exchange derivatives 786 (560) 376 (374) Credit derivatives 234 (615) 323 (709) Equity derivatives 1,280 (1,355) 2,220 (3,625) Corporate debt 1,171 (13) 1,205 (21) Reverse repurchase and repurchase agreements 178 (188) 13 (172) Non-asset backed loans 8,660 — 6,405 — Asset backed securities 291 — 558 — Equity cash products 422 (3) 393 — Private equity investments 1,297 (8) 1,095 (6) Other1 1,867 (317) 2,369 (238) Total 17,759 (4,908) 16,048 (6,496) 1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. Assets and liabilities reclassified between Level 1 and Level 2 During the period, there were no material transfers between Level 1 and Level 2 (period ended 31 December 2021: no material transfers between Level 1 and Level 2). Level 3 movement analysis The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the period. Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant. Financial Statement Notes Barclays PLC 82 -- 84 of 109 -- Level 3 movement analysis Total gains and (losses) in the period recognised in the income statement Total gains or (losses) recognised in OCI Transfers As at 01.01.22 Purchases Sales Issues Settle- ments Trading income Other income In Out As at 30.06.22 £m £m £m £m £m £m £m £m £m £m £m Corporate debt 389 90 (144) — (17) 54 — — 43 (11) 404 Non-asset backed loans 758 2,448 (459) — — 11 — — 50 (113) 2,695 Asset backed securities 454 72 (80) — (297) (20) — — 100 (66) 163 Equity cash products 303 21 (56) — — 24 — — 52 (17) 327 Other 377 326 (42) — (5) 56 — — 39 (84) 667 Trading portfolio assets 2,281 2,957 (781) — (319) 125 — — 284 (291) 4,256 Non-asset backed loans 5,647 1,847 (757) — (484) (334) — — 52 (9) 5,962 Equity cash products 90 — — — — 3 2 — — — 95 Private equity investments 1,095 99 (16) — (1) 84 (26) — 59 (4) 1,290 Other 2,880 4,817 (5,579) — (156) 11 182 — 99 (19) 2,235 Financial assets at fair value through the income statement 9,712 6,763 (6,352) — (641) (236) 158 — 210 (32) 9,582 Private equity investments — — — — — — — 1 6 — 7 Asset backed securities 38 — — — — — — (2) — — 36 Assets at fair value through other comprehensive income 38 — — — — — — (1) 6 — 43 Investment property 7 — (1) — — — (1) — — — 5 Trading portfolio liabilities (27) (35) 3 — — (29) — — — 6 (82) Financial liabilities designated at fair value (410) (5) — (13) 47 (22) — — (81) 37 (447) Interest rate derivatives (260) 25 — — (4) (305) (9) — 271 6 (276) Foreign exchange derivatives 2 — — — (9) 273 — — (65) 25 226 Credit derivatives (386) (36) 5 — 60 (99) — — 20 55 (381) Equity derivatives (1,405) (83) — — 171 980 (1) — (9) 272 (75) Net derivative financial instruments1 (2,049) (94) 5 — 218 849 (10) — 217 358 (506) Total 9,552 9,586 (7,126) (13) (695) 687 147 (1) 636 78 12,851 1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,873m and derivative financial liabilities were £4,379m. Financial Statement Notes Barclays PLC 83 -- 85 of 109 -- Level 3 movement analysis As at 01.01.21 Purchases Sales Issues Settle- ments Total gains and (losses) in the period recognised in the income statement Total gains or (losses) recognised in OCI Transfers As at 30.06.21 Trading income Other income In Out £m £m £m £m £m £m £m £m £m £m £m Corporate debt 151 305 (87) — — 25 — — 40 (11) 423 Non-asset backed loans 709 620 (131) — (84) 13 — — 124 (106) 1,145 Asset backed securities 686 112 (294) — — (10) — — 43 (48) 489 Equity cash products 214 13 (17) — — 32 — — 29 (9) 262 Other 103 21 — — (51) (1) — — 162 (1) 233 Trading portfolio assets 1,863 1,071 (529) — (135) 59 — — 398 (175) 2,552 Non-asset backed loans 5,580 698 (299) — (687) (119) — — 69 (48) 5,194 Equity cash products 326 160 (194) — — (171) 18 — 1 — 140 Private equity investments 874 106 (9) — (8) (5) 92 — — (71) 979 Other 1,726 2,291 (2,389) — (162) (19) 1 — 16 — 1,464 Financial assets at fair value through the income statement 8,506 3,255 (2,891) — (857) (314) 111 — 86 (119) 7,777 Non-asset backed loans 106 — — — — — — — — (106) — Asset backed securities 47 4 — — (5) — — 2 — — 48 Assets at fair value through other comprehensive income 153 4 — — (5) — — 2 — (106) 48 Investment property 10 — (2) — — — — — — — 8 Trading portfolio liabilities (28) (3) 14 — — (7) — — — 7 (17) Financial liabilities designated at fair value (355) — — — 98 7 (2) — (78) 18 (312) Interest rate derivatives (2) 9 — — 33 (121) 4 — 21 (297) (353) Foreign exchange derivatives 1 — — — 58 (6) — — 3 (34) 22 Credit derivatives (155) (117) 2 — (5) 12 (1) — 1 (1) (264) Equity derivatives (1,614) (315) (1) — (32) (221) (1) — 28 808 (1,348) Net derivative financial instruments1 (1,770) (423) 1 — 54 (336) 2 — 53 476 (1,943) Total 8,379 3,904 (3,407) — (845) (591) 111 2 459 101 8,113 1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £3,657m and derivative financial liabilities were £5,600m. Financial Statement Notes Barclays PLC 84 -- 86 of 109 -- Unrealised gains and losses on Level 3 financial assets and liabilities The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and liabilities held at the period end. Half year ended 30.06.22 Half year ended 30.06.21 Income statement Other compre hensive income Total Income statement Other compre hensive income Total Trading income Other income Trading income Other income £m £m £m £m £m £m £m £m Trading portfolio assets 121 — — 121 35 — — 35 Financial assets at fair value through the income statement (165) (22) — (187) (201) 114 — (87) Financial assets at fair value through other comprehensive income — — (1) (1) — — — — Investment properties — (1) — (1) — — — — Trading portfolio liabilities (35) — — (35) (6) — — (6) Financial liabilities designated at fair value (14) — — (14) 7 — — 7 Net derivative financial instruments 862 (1) — 861 (367) — — (367) Total 769 (24) (1) 744 (532) 114 — (418) Valuation techniques and sensitivity analysis Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative models. Current year valuation and sensitivity methodologies are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2021. Sensitivity analysis of valuations using unobservable inputs As at 30.06.22 As at 31.12.21 Favourable changes Unfavourable changes Favourable changes Unfavourable changes Income statement Equity Income statement Equity Income statement Equity Income statement Equity £m £m £m £m £m £m £m £m Interest rate derivatives 75 — (108) — 51 — (79) — Foreign exchange derivatives 15 — (22) — 20 — (28) — Credit derivatives 111 — (115) — 111 — (103) — Equity derivatives 107 — (112) — 187 — (195) — Corporate debt 36 — (35) — 38 — (28) — Non-asset backed loans 298 — (334) — 165 — (256) — Equity cash products 73 — (129) — 42 — (61) — Private equity investments 272 1 (286) (1) 246 — (236) — Other1 27 — (36) — 20 — (19) — Total 1,014 1 (1,177) (1) 880 — (1,005) — 1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and investment property. The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact of using alternative models, would be to increase fair values by up to £1,015m (December 2021: £880m) or to decrease fair values by up to £1,178m (December 2021: £1,005m) with substantially all the potential effect impacting profit and loss rather than reserves. Financial Statement Notes Barclays PLC 85 -- 87 of 109 -- Significant unobservable inputs The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level 3 are consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2021. Fair value adjustments Key balance sheet valuation adjustments are quantified below: As at 30.06.22 As at 31.12.21 £m £m Exit price adjustments derived from market bid-offer spreads (539) (506) Uncollateralised derivative funding (82) (127) Derivative credit valuation adjustments (388) (212) Derivative debit valuation adjustments 208 91 • Exit price adjustments derived from market bid-offer spreads increased by £33m to £539m as a result of movements in market bid offer spreads. • Uncollateralised derivative funding decreased by £45m to £82m as a result of reduction in uncollateralised funding exposure due to increases in interest rates which offset impact of wider funding spreads. • Derivative credit valuation adjustments increased by £176m to £388m as a result of widening input counterparty credit spreads • Derivative debit valuation adjustments increased by £117m to £208m as a result of widening input own credit spreads Portfolio exemption The Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of financial assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at the measurement date. Unrecognised gains as a result of the use of valuation models using unobservable inputs The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, is £117m (December 2021: £133m) for financial instruments measured at fair value and £221m (December 2021: £230m) for financial instruments carried at amortised cost. There are additions and FX gains of £19m (December 2021: £59m) and amortisation and releases of £35m (December 2021: £42m) for financial instruments measured at fair value and additions of £nil (December 2021: £nil) and amortisation and releases of £9m (December 2021: £17m) for financial instruments carried at amortised cost. Third party credit enhancements Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the Federal Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and other banks pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9 fair value option includes this third party credit enhancement. The on balance sheet value of these brokered certificates of deposit amounted to £3,065m (December 2021: £790m). Financial Statement Notes Barclays PLC 86 -- 88 of 109 -- Comparison of carrying amounts and fair values for assets and liabilities not held at fair value Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost are consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2021. The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s balance sheet. As at 30.06.22 As at 31.12.21 Carrying amount Fair value Carrying amount Fair value Financial assets £m £m £m £m Loans and advances at amortised cost 395,824 396,475 361,451 362,424 Reverse repurchase agreements and other similar secured lending 1,639 1,639 3,227 3,227 Financial liabilities Deposits at amortised cost (568,670) (568,715) (519,433) (519,436) Repurchase agreements and other similar secured borrowing (28,566) (28,569) (28,352) (28,358) Debt securities in issue (115,906) (115,777) (98,867) (100,657) Subordinated liabilities (11,871) (11,799) (12,759) (13,334) 12. Loans and advances and deposits at amortised cost As at 30.06.22 As at 31.12.21 £m £m Loans and advances at amortised cost to banks 12,532 9,698 Loans and advances at amortised cost to customers 337,220 319,922 Debt securities at amortised cost 46,072 31,831 Total loans and advances at amortised cost 395,824 361,451 Deposits at amortised cost from banks 29,891 17,819 Deposits at amortised cost from customers 538,779 501,614 Total deposits at amortised cost 568,670 519,433 13. Goodwill and intangible assets Goodwill and intangible assets are allocated to business operations according to business segments as follows: As at 30.06.22 As at 31.12.21 Goodwill Intangibles Total Goodwill Intangibles Total £m £m £m £m £m £m Barclays UK 3,560 1,247 4,807 3,560 1,233 4,793 Barclays International 308 3,079 3,387 291 2,930 3,221 Head Office 44 7 51 42 5 47 Total 3,912 4,333 8,245 3,893 4,168 8,061 The Group performed an impairment review to assess the recoverability of its goodwill and intangible asset balances as at 31 December 2021. The outcome of this review is disclosed on pages 382-385 of the Barclays PLC Annual Report 2021. No impairment was recognised as a result of the review as value in use exceeded carrying amount. A review of the Group's goodwill and intangible assets as at 30 June 2022 did not identify the presence of impairment. Financial Statement Notes Barclays PLC 87 -- 89 of 109 -- 14. Subordinated liabilities Half year ended 30.06.22 Year ended 31.12.21 £m £m Opening balance as at 1 January 12,759 16,341 Issuances 259 1,890 Redemptions (1,180) (4,807) Other 33 (665) Closing balance 11,871 12,759 Issuances of £259m comprise £128m USD Floating Rate Notes, £89m ZAR Floating Rate Notes and £42m EUR Floating Rate Notes issued externally by Barclays subsidiaries. Redemptions of £1,180m comprise £1,039m notes issued externally by Barclays Bank PLC, £74m USD Floating Rate Notes issued externally by a Barclays subsidiary and £67m GBP Undated Subordinated Loan Notes (secured) issued externally by a Barclays securitisation special purpose vehicle (SPV). £1,039m notes issued externally by Barclays Bank PLC comprise £838m EUR 6.625% Fixed Rate Subordinated Notes, £147m USD 6.86% Callable Perpetual Core Tier One Notes, £42m EUR Subordinated Floating Rate Notes and £12m GBP 6% Callable Perpetual Core Tier One Notes. Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments. 15. Provisions Restated1 As at 30.06.22 As at 31.12.21 £m £m Customer redress 1,985 530 Legal, competition and regulatory matters 418 226 Redundancy and restructuring 216 326 Undrawn contractually committed facilities and guarantees 526 542 Onerous contracts — 5 Sundry provisions 281 279 Total 3,426 1,908 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Over-issuance of securities As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation to the Over-issuance of Securities (see Basis of preparation on page 73 for more information), out of which £1,592m (December 2021: £220m) is due to the over-issuance of structured notes (within Customer redress) and £165m (December 2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential SEC resolution (within Legal, competition and regulatory matters). The amount of the provision in relation to the rescission rights of investors in over-issued structured notes is determined by (among other things) the market value of the structured notes subject to the Rescission Offer, participation rates in such Rescission Offer, prevailing interest rates, and movements in foreign exchange rates. The majority of the structured notes subject to the Rescission Offer provide an equity linked return to investors. As such, the value of these notes is highly sensitive to movements in the price of individual securities and a range of indices. The increase in the provision of £1,372m predominantly reflects a reduction in the market value of the structured notes and additional accrued interest that would be payable to investors on rescission. The US equity markets have been volatile during the first half of 2022, with significant reductions in the value of US equity indices such as the S&P 500 from the year end 2021 levels, which has led to a reduction in the market value of the structured notes, and increased the size of the provision. The provision does not include the impact of market hedges that have been entered into subsequent to the year-end and were initiated from the end of the first quarter of 2022 to reduce the net volatility to the income statement. When Financial Statement Notes Barclays PLC 88 -- 90 of 109 -- determining these market hedges, consideration was given to changes in the rescission costs which would arise from volatility in the market along with the positioning of the Markets business. The structured notes also accrue interest on a monthly basis (at current prevailing interest rates and participation rate assumptions this is c£34m a month) until the Rescission Price has been paid. The provision also assumes that not all structured note investors whose securities are out of the money will accept the Rescission Offer. If all investors were to accept the Rescission Offer, the provision would increase by c£60m. The remaining increase in the provision of £165m results from Barclays PLC’s estimate of the potential SEC resolution. 16. Retirement benefits As at 30 June 2022, the Group’s IAS 19 net pension surplus across all schemes was £4.9bn (December 2021: £3.6bn). The UK Retirement Fund (UKRF), which is the Group’s main scheme, had an IAS 19 net pension surplus of £5.2bn (December 2021: £3.8bn). The movement for the UKRF was driven by an overall increase in AA corporate bond yields (used for discounting future liabilities), a reduction in long-term expected price inflation assumption and the payment of deficit reduction contributions. These movements were partially offset by the fall in the value of UKRF's assets and the impact of high recent inflation on the liabilities. UKRF funding valuations The latest annual update as at 30 September 2021 showed the funding position had improved to a surplus of £0.6bn from a deficit of £0.9bn shown at 30 September 2020. The improvement was mainly due to £0.7bn of deficit reduction contributions and favourable asset returns, partially offset by higher expected long term price inflation. The deficit recovery plan agreed at the last triennial valuation requires deficit reduction contributions from Barclays Bank PLC of £294m in 2022 and £286m in 2023. The deficit reduction contributions are in addition to the regular contributions to meet the Group’s share of the cost of benefits accruing over each year. £147m of the 2022 deficit reduction contributions were paid in April, with the remaining £147m due in September. The next triennial actuarial valuation of the UKRF is due to be completed in 2023 with an effective date of 30 September 2022. During 2019 and 2020, the UKRF, the Group’s main pension scheme, subscribed for non-transferable listed senior fixed rate notes for £1.25bn issued by entities consolidated within the Group under IFRS 10. As a result of these transactions, the CET1 impact of the 2019 and 2020 deficit contributions was deferred until 2023, 2024 and 2025 upon maturity of the notes. Following the PRA’s statement on 13 April 2022, Barclays is planning to unwind these transactions and to agree the terms and timing of this unwind with the UKRF Trustee as part of the next triennial actuarial valuation as at 30 September 2022. Upon unwind, this would result in a c.30bps reduction to the CET1 ratio potentially being accelerated to Q4 2022 from 2023, 2024 and 2025. 17. Called up share capital Ordinary share capital Share premium Total share capital and share premium Half year ended 30.06.22 £m £m £m Opening balance as at 1 January 4,188 348 4,536 Issue of shares under employee share schemes 6 27 33 Repurchase of shares (61) — (61) Closing balance 4,133 375 4,508 Called up share capital comprises 16,531m (December 2021: 16,752m) ordinary shares of 25p each. The decrease is mainly due to the repurchase of 244m shares as part of the £1.0bn share buyback announced in the FY21 results, partially offset by an increase due to the issuance of shares under employee share schemes. Financial Statement Notes Barclays PLC 89 -- 91 of 109 -- 18. Other equity instruments Half year ended 30.06.22 Year ended 31.12.21 £m £m Opening balance as at 1 January 12,259 11,172 Issuances 1,247 1,078 Redemptions (1,132) — Securities held by the Group (17) 9 Closing balance 12,357 12,259 Other equity instruments of £12,357m (December 2021: £12,259m) comprise AT1 securities issued by Barclays PLC. There was one issuance and one redemption in the six months to 30 June 2022. The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option of Barclays PLC, in whole on (i) the initial call date, or on any fifth anniversary after the initial call date or (ii) any day falling in a named period ending on the initial reset date, or on any fifth anniversary after the initial reset date. In addition, the AT1 securities are redeemable, at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any redemptions require the prior consent of the PRA. All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the fully loaded CET1 ratio of the Group fall below 7%. 19. Other reserves As at 30.06.22 As at 31.12.21 £m £m Currency translation reserve 4,443 2,740 Fair value through other comprehensive income reserve (1,081) (283) Cash flow hedging reserve (4,671) (853) Own credit reserve (103) (960) Other reserves and treasury shares 1,194 1,126 Total (218) 1,770 Currency translation reserve The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net investment in foreign operations, net of the effects of hedging. As at 30 June 2022, there was a credit balance of £4,443m (December 2021: £2,740m credit) in the currency translation reserve. The £1,703m credit movement principally reflects the weakening of GBP against USD during the period. Fair value through other comprehensive income reserve The fair value through other comprehensive income reserve represents the changes in the fair value of fair value through other comprehensive income investments since initial recognition. As at 30 June 2022, there was a debit balance of £1,081m (December 2021: £283m debit) in the fair value through other comprehensive income reserve. The loss of £798m is principally driven by a loss of £1,237m from the decrease in fair value of bonds due to increasing bond yields, £5m of net gains transferred to the income statement and £39m of gains transferred to retained earnings on sale of 7.45% equity stake in Absa Group Limited. This is partially offset by a gain of £153m due to an increase in the Absa Group Limited share price and a tax credit of £326m. Financial Statement Notes Barclays PLC 90 -- 92 of 109 -- Cash flow hedging reserve The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss. As at 30 June 2022, there was a debit balance of £4,671m (December 2021: £853m debit) in the cash flow hedging reserve. The decrease of £3,818m principally reflects a £4,747m decrease in the fair value of interest rate swaps held for hedging purposes as major interest rate forward curves increased and £429m of gains transferred to the income statement. This is partially offset by a tax credit of £1,358m. Own credit reserve The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve are not recycled to profit or loss in future periods. As at 30 June 2022, there was a debit balance of £103m (December 2021: £960m debit) in the own credit reserve. The movement of £857m principally reflects a £1,258m gain from the widening of Barclays’ funding spreads partially offset by a tax charge of £403m. Other reserves and treasury shares Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays PLC shares held principally in relation to the Group’s various share schemes. As at 30 June 2022, there was a credit balance of £1,194m (December 2021: £1,126m credit) in other reserves and treasury shares. This is driven by an increase of £61m due to the repurchase of 244m shares as part of the £1.0bn share buyback and a £7m increase in the treasury shares balance held in relation to employee share schemes. 20. Contingent liabilities and commitments As at 30.06.22 As at 31.12.21 Contingent liabilities and financial guarantees £m £m Guarantees and letters of credit pledged as collateral security 16,463 15,549 Performance guarantees, acceptances and endorsements 5,877 5,797 Total 22,340 21,346 Commitments Documentary credits and other short-term trade related transactions 1,888 1,584 Standby facilities, credit lines and other commitments 396,038 344,127 Total 397,926 345,711 Further details on contingent liabilities, where it is not practicable to disclose an estimate of the potential financial effect on Barclays relating to legal and competition and regulatory matters can be found in Note 21. 21. Legal, competition and regulatory matters The Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision, or both, depending on the relevant facts and circumstances. The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in accordance with the relevant accounting policies applicable to Note 15, Provisions. We have not disclosed an estimate of the potential financial impact or effect on the Group of contingent liabilities where it is not currently practicable to do so. Various matters detailed in this note seek damages of an unspecified amount. While certain matters specify the damages claimed, such claimed amounts do not necessarily reflect the Group’s potential financial exposure in respect of those matters. Matters are ordered under headings corresponding to the financial statements in which they are disclosed. Financial Statement Notes Barclays PLC 91 -- 93 of 109 -- 1. Barclays PLC and Barclays Bank PLC Investigations into certain advisory services agreements FCA proceedings In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements). The Financial Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to Barclays PLC’s capital raisings in June and November 2008 (the Capital Raisings) and therefore should have been disclosed in the announcements or public documents relating to the Capital Raisings. In 2013, the FCA issued warning notices (the Notices) finding that Barclays PLC and Barclays Bank PLC acted recklessly and in breach of certain disclosure-related listing rules, and that Barclays PLC was also in breach of Listing Principle 3. The financial penalty provided in the Notices is £50m. Barclays PLC and Barclays Bank PLC continue to contest the findings. Following the conclusion of the Serious Fraud Office (SFO) proceedings against certain former Barclays executives resulting in their acquittals, the FCA proceedings, which were stayed, have resumed. A hearing took place before the Regulatory Decisions Committee in the first quarter of 2022 and a decision is expected in the second half of 2022. Investigations into LIBOR and other benchmarks and related civil actions Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial benchmarks, such as LIBOR. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to the alleged manipulation of LIBOR and/or other benchmarks. USD LIBOR civil actions The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially similar and allege, among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial institutions individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities Exchange Act of 1934 and various state laws by manipulating USD LIBOR rates. Putative class actions and individual actions seek unspecified damages with the exception of one lawsuit, in which the plaintiffs are seeking no less than $100m in actual damages and additional punitive damages against all defendants, including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. Barclays Bank PLC has previously settled certain claims. Two class action settlements, where Barclays Bank PLC has respectively paid $7.1m and $20m, have received final court approval. Barclays Bank PLC also settled two further matters for $7.5m, and $1.95m respectively. Sterling LIBOR civil actions In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel banks alleging, among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust Act, CEA and RICO, were consolidated. The defendants’ motion to dismiss the claims was granted in 2018. The plaintiffs have appealed the dismissal. Japanese Yen LIBOR civil actions In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks by a lead plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s Euroyen Tokyo Interbank Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation of the Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed the plaintiff’s antitrust claims, and, in 2020, the court dismissed the plaintiff’s remaining CEA claims. The plaintiff has appealed the lower court’s dismissal of such claims. In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY against Barclays PLC, Barclays Bank PLC and BCI. Barclays and the plaintiffs have reached a settlement of $17.75m for both actions, which is subject to court approval. Financial Statement Notes Barclays PLC 92 -- 94 of 109 -- SIBOR/SOR civil action In 2016, a putative class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants, alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR). The plaintiffs and remaining defendants (which includes Barclays Bank PLC) have reached a joint settlement to resolve this matter for $91m, which has received preliminary court approval. A final court approval hearing has been scheduled for November 2022. The financial impact of Barclays’ share of the joint settlement is not expected to be material to the Group’s operating results, cash flows or financial position. ICE LIBOR civil actions In 2019, several putative class actions were filed in the SDNY against a panel of banks, including Barclays PLC, Barclays Bank PLC, BCI, other financial institution defendants and Intercontinental Exchange Inc. and certain of its affiliates (ICE), asserting antitrust claims that defendants manipulated USD LIBOR through defendants’ submissions to ICE. These actions have been consolidated. The defendants’ motion to dismiss was granted in 2020 and the plaintiffs appealed. In February 2022, the dismissal was affirmed on appeal. The plaintiffs have not sought U.S. Supreme Court review. This matter is now concluded. In August 2020, an ICE LIBOR-related action was filed by a group of individual plaintiffs in the US District Court for the Northern District of California on behalf of individual borrowers and consumers of loans and credit cards with variable interest rates linked to USD ICE LIBOR. The plaintiffs' motion seeking, among other things, preliminary and permanent injunctions to enjoin the defendants from continuing to set LIBOR or enforce any financial instrument that relies in whole or in part on USD LIBOR was denied. The defendants have moved to dismiss the case. Non-US benchmarks civil actions There remains one claim, issued in 2017, against Barclays Bank PLC and other banks in the UK in connection with alleged manipulation of LIBOR. Proceedings have also been brought in a number of other jurisdictions in Europe, Argentina and Israel relating to alleged manipulation of LIBOR and EURIBOR. Additional proceedings in other jurisdictions may be brought in the future. Credit Default Swap civil action A putative antitrust class action is pending in New Mexico federal court against Barclays Bank PLC, BCI and various other financial institutions. The plaintiffs, the New Mexico State Investment Council and certain New Mexico pension funds, allege that the defendants conspired to manipulate the benchmark price used to value Credit Default Swap (CDS) contracts at settlement (i.e. the CDS final auction price). The plaintiffs allege violations of US antitrust laws and the CEA, and unjust enrichment under state law. The defendants have moved to dismiss the case. Foreign Exchange investigations and related civil actions In 2015, the Group reached settlements totalling approximately $2.38bn with various US federal and state authorities and the FCA in relation to investigations into certain sales and trading practices in the Foreign Exchange market. The European Commission announced two settlements in May 2019 and the Group paid penalties totalling approximately €210m. In June 2019, the Swiss Competition Commission announced two settlements and the Group paid penalties totalling approximately CHF27m. In December 2021, the European Commission announced a final settlement which required the Group to pay penalties totalling approximately €54m, which amount has been provided for in previous periods. The financial impact of any ongoing investigations is not expected to be material to the Group’s operating results, cash flows or financial position. Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to alleged manipulation of Foreign Exchange markets. FX opt out civil action In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign Exchange markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs who opted out of the Consolidated FX Action filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants. Some of the plaintiffs' claims were dismissed in 2020. Financial Statement Notes Barclays PLC 93 -- 95 of 109 -- Retail basis civil action In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf of a proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The SDNY has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court subsequently dismissed all Retail Basis Claims against the Group and all other defendants. The plaintiffs have filed an amended complaint. Non-US FX civil actions Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays Execution Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK, a number of other jurisdictions in Europe, Israel, Brazil and Australia. Additional proceedings may be brought in the future. The above-mentioned proceedings include two purported class actions filed against Barclays PLC, Barclays Bank PLC, BX, BCI and other financial institutions in the UK Competition Appeal Tribunal (CAT) in 2019 following the settlements with the European Commission described above. The CAT refused to certify these claims in the first quarter of 2022 although the claimants are seeking permission to appeal. Also in 2019, a separate claim was filed in the UK in the High Court of Justice (High Court), and subsequently transferred to the CAT, by various banks and asset management firms against Barclays Bank PLC and other financial institutions alleging breaches of European and UK competition laws related to FX trading. Metals related civil actions A number of US civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd. manipulated the prices of gold and gold derivative contracts in violation of the Antitrust Act and other federal laws. The parties have reached a joint settlement to resolve this matter for $50m, which has received preliminary court approval, with the final court approval hearing scheduled for August 2022. The financial impact of Barclays’ share of the joint settlement is not expected to be material to the Group’s operating results, cash flows or financial position. A separate US civil complaint by a proposed class of plaintiffs against a number of banks, including Barclays Bank PLC, BCI and BX, alleging manipulation of the price of silver in violation of the CEA, the Antitrust Act and state antitrust and consumer protection laws, has been dismissed as against the Barclays entities. The plaintiffs have the option to seek the court’s permission to appeal. Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc. and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices. US residential mortgage related civil actions There are two pending US Residential Mortgage-Backed Securities (RMBS) related civil actions arising from unresolved repurchase requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level representations and warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in 2007. In one action, the Barclays defendants’ motion for summary judgment was granted in June 2022 and the plaintiffs’ R&W breach claim was dismissed. The plaintiffs may appeal. The other repurchase action is pending. Barclays Bank PLC has reached settlements to resolve two other repurchase actions, which have received final court approval. Payment of the settlement amount of one of those repurchase actions was completed in the first quarter of 2022, and the other will be completed in the third quarter of 2022. The financial impact of the settlements is not expected to be material to the Group’s operating results, cash flows or financial position. In 2020, a civil litigation claim was filed in the New Mexico First Judicial District Court by the State of New Mexico against six banks, including BCI, on behalf of two New Mexico state pension funds and the New Mexico State Investment Council relating to legacy RMBS purchases. As to BCI, the complaint alleges that the funds purchased approximately $22m in RMBS underwritten by BCI. The parties have reached a joint settlement to resolve this matter for $32.5m. The settlement was paid in April 2022. The financial impact of BCI’s share of the joint settlement is not material to the Group’s operating results, cash flows or financial position. Government and agency securities civil actions Treasury auction securities civil actions Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial institutions under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to Financial Statement Notes Barclays PLC 94 -- 96 of 109 -- boycott such trading platforms. The court dismissed the consolidated action in March 2021. The plaintiffs filed an amended complaint. The defendants’ motion to dismiss the amended complaint was granted in March 2022. The plaintiffs are appealing this decision. In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging that defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA and state common law. Supranational, Sovereign and Agency bonds civil actions Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC, BCI, BX, Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital Canada, Inc. and other financial institutions alleging that the defendants conspired to fix prices and restrain competition in the market for US dollar-denominated Supranational, Sovereign and Agency bonds. In one of the actions filed in the SDNY, the court granted the defendants’ motion to dismiss the plaintiffs’ complaint. The dismissal was affirmed on appeal; however, the district court subsequently informed the parties of a potential conflict. The motion to dismiss were assigned to a new district court judge and the plaintiffs have moved to vacate the dismissal order. The plaintiffs have voluntarily dismissed the other SDNY action. In the Federal Court of Canada action, the plaintiffs reached settlements with a small number of banks in 2020 (not including Barclays Capital Canada, Inc.). The plaintiffs have commenced the class certification process. There is no court scheduled deadline and the action remains at an early stage. Variable Rate Demand Obligations civil actions Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have been filed by private plaintiffs on behalf of the states of Illinois and California. Three putative class action complaints have been consolidated in the SDNY. In the consolidated SDNY class action, certain of the plaintiffs’ claims were dismissed in November 2020 and defendants’ motion for partial dismissal of the amended consolidated complaint was granted in part and denied in part in June 2022. In the California action, the plaintiffs’ claims were dismissed in June 2021. The plaintiffs have appealed the dismissal. Odd-lot corporate bonds antitrust class action In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The complaint alleges a conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. The plaintiffs demand unspecified money damages. The defendants’ motion to dismiss was granted in 2021 and the plaintiffs have appealed the dismissal. The district court subsequently informed the parties of a potential conflict and the case was reassigned to a new district court judge. The plaintiffs have filed a motion seeking a ruling that would vacate the dismissal and allow the plaintiffs to file an amended complaint if the appeals court remands the case for further proceedings. Interest rate swap and credit default swap US civil actions Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate swaps (IRS) are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The complaints allege the defendants conspired to prevent the development of exchanges for IRS and demand unspecified money damages. In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including Barclays PLC, Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an IRS platform. In 2017, Tera Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct alleged in the IRS cases also caused the plaintiff to suffer harm with respect to the Credit Default Swaps market. In 2018 and 2019, respectively, the court dismissed certain claims in both cases for unjust enrichment and tortious interference but denied motions to dismiss the federal and state antitrust claims, which remain pending. BDC Finance L.L.C. In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York (NY Supreme Court), demanding damages of $298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of total return swaps governed by an ISDA Master Agreement (the Master Agreement). Following a trial, the court ruled in 2018 that Barclays Bank PLC was not a defaulting party, which was affirmed on appeal. In April 2021, the trial court entered judgement in favour of Barclays Bank PLC for $3.3m and as yet to be determined legal fees and costs. BDC appealed. In Financial Statement Notes Barclays PLC 95 -- 97 of 109 -- January 2022, the appellate court reversed the trial court’s summary judgment decision in favour of Barclays Bank PLC and remanded the case to the lower court for further proceedings, with the trial scheduled to commence in the fourth quarter of 2022. In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings, L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays Bank PLC’s conduct relating to the Master Agreement, asserting claims for violation of the Connecticut Unfair Trade Practices Act and tortious interference with business and prospective business relations. This case is currently stayed. Civil actions in respect of the US Anti-Terrorism Act There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District Court in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar- denominated transactions for the Iranian Government and various Iranian banks, which in turn funded acts of terrorism that injured or killed the plaintiffs or the plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and mental anguish under the provisions of the US Anti-Terrorism Act, which allow for the trebling of any proven damages. The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. The plaintiffs have appealed in one action. The remaining actions are stayed pending a decision on the appeal. Out of the two actions in the SDNY, the court also granted the defendants’ motion to dismiss the first action, which is stayed pending a decision on the EDNY appeal. The second SDNY action is stayed, pending any appeal on the dismissal of the first. Shareholder derivative action In November 2020, a purported Barclays shareholder filed a putative derivative action in New York state court against BCI and a number of current and former members of the Board of Directors of Barclays PLC and senior executives or employees of the Group. The shareholder filed the claim on behalf of nominal defendant Barclays PLC, alleging that the individual defendants harmed the company through breaches of their duties, including under the Companies Act 2006. The plaintiff seeks damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of these alleged breaches. An amended complaint was filed in April 2021, which BCI and certain other defendants moved to dismiss. The motion to dismiss was granted in April 2022. The plaintiffs are appealing the decision. Derivative transactions civil action In 2021, Vestia (a Dutch housing association) brought a claim against Barclays Bank PLC in the UK in the High Court in relation to a series of derivative transactions entered into with Barclays Bank PLC between 2008 and 2011, seeking damages of £329m. Barclays Bank PLC is defending the claim and has made a counterclaim. Timeshare loans, skilled person review, and associated matters In August 2020, the FCA granted an application by Clydesdale Financial Services Limited (CFS), which trades as Barclays Partner Finance and houses Barclays’ point-of-sale finance business, for a validation order with respect to certain loans to customers brokered between April 2014 and April 2016 by ASL, a timeshare operator, which did not, at the point of sale, hold the necessary broker licence. As a condition to the validation order, the FCA required CFS to undertake a skilled person review of the assessment of affordability processes for the loans brokered by ASL (ASL Loans) as well as CFS’ policies and procedures for assessing affordability and oversight of brokers more generally, and dictated a remediation methodology in the event that ASL Loans did not pass the affordability test. CFS voluntarily agreed to remediate the ASL Loans, in accordance with the FCA’s methodology and the remediation exercise is substantively complete. The remaining scope of the skilled person review is also complete. The skilled person made a number of observations, some of which were adverse, about both current and historic affordability practices as well as current oversight practices. CFS is not required to conduct a full back book review but, following a review of certain cohorts of loans to determine historic affordability and/or broker oversight practices that may have caused customer harm, where harm is identified, CFS’ intention is to remediate. To date CFS has identified a number of areas for remediation but the scoping exercise is ongoing. Separately, and notwithstanding this, CFS decided in March 2022 to extend the proactive remediation of ASL Loans beyond those brokered between April 2014 to April 2016 to include the full portfolio of ASL Loans brokered between 2006 and 2018. In the first quarter of 2022, a customer remediation provision of £181m has been recognised in relation to the remediation of the ASL Loans originated outside the April 2014 to April 2016 period. This provision represents the best estimate as at 30 June 2022. CFS continues to review complaints about other legacy partner finance loans, however, it is not currently possible to predict the outcome of this review or the financial impact on the Group. Financial Statement Notes Barclays PLC 96 -- 98 of 109 -- Over-issuance of securities in the US Barclays Bank PLC maintains a US shelf registration statement with the Securities and Exchange Commission (SEC) in order to issue securities to US investors. In May 2017, Barclays Bank PLC was the subject of an SEC settlement order as a result of which it lost its status as a “well-known seasoned issuer” (or WKSI) and was required to register a specified amount of securities to be issued under any US shelf registration statements filed with the SEC. On 10 March 2022, executive management became aware that Barclays Bank PLC had issued securities materially in excess of the set amount under its 2019 US shelf registration statement (2019 F-3) and subsequently became aware that securities had also been issued in excess of the set amount under the predecessor US shelf registration statement (the Predecessor Shelf). The securities that have been over-issued comprise structured notes and exchange traded notes (ETNs). Securities issued in excess of the amount registered are considered to be “unregistered securities” for the purposes of US securities laws, with certain purchasers of those securities having a right to recover, upon the tender of such security to Barclays Bank PLC, the consideration paid for such security with interest, less the amount of any income received, or to recover damages from Barclays Bank PLC if the purchaser no longer owns the security and had sold the security at a loss (the Rescission Price). Barclays Bank PLC is expected to launch a rescission offer on 1 August 2022, by which Barclays Bank PLC will offer to repurchase the relevant affected securities for the rescission price (the Rescission Offer). Although the Rescission Offer is expected to reduce liability with respect to potential private civil claims, it will not necessarily prevent such claims from being asserted against Barclays Bank PLC and/or its affiliates, including claims under applicable US federal securities laws. Further, the Rescission Offer does not bar the SEC and other regulators from pursuing enforcement actions against Barclays Bank PLC and its affiliates, which are expected to result in fines, penalties and/or other sanctions. The Group is engaged with, and responding to inquiries and requests for information from, various regulators, including the SEC. The SEC’s investigation into this matter is at an advanced stage and the Group has had preliminary discussions with the staff of the SEC's Division of Enforcement about resolving this matter. As at 30 June 2022, Barclays PLC has recognised a balance sheet provision of £1,757m (December 2021: £220m) in relation to this matter, out of which £1,592m (December 2021: £220m) relates to the over-issuance of structured notes and £165m (December 2021: nil) relates to liabilities that could be incurred arising out of ongoing discussions in respect of a potential SEC resolution. A contingent liability exists in relation to the over-issuance of ETNs due to evidentiary challenges and the high level of trading in the securities. A contingent liability also exists in relation to any potential civil claims or enforcement actions taken against Barclays Bank PLC and/or its affiliates, but Barclays Bank PLC is unable to assess the likelihood of liabilities that may arise out of such claims or actions. Any liabilities, claims or actions in connection with the over-issuance of securities under its 2019 F-3 and the Predecessor Shelf could have an adverse effect on Barclays Bank PLC’s and the Group’s business, financial condition, results of operations and reputation as a frequent issuer in the securities markets. Investigation into the use of unapproved communications platforms In July 2022, Barclays Bank PLC and BCI reached an agreement in principle with the staff of the SEC's Division of Enforcement and the staff of the Commodity Futures Trading Commission (CFTC) in connection with investigations by the SEC and the CFTC of Barclays Bank PLC, BCI and other financial institutions as part of a financial industry sweep regarding compliance with record-keeping obligations in connection with business-related communications sent over unapproved electronic messaging platforms. The SEC and the CFTC found that Barclays Bank PLC and BCI failed to comply with their respective record keeping rules, where such communications were sent or received by employees over electronic messaging channels that had not been approved by the bank for business use by employees. The proposed resolution with the SEC and the CFTC, will include Barclays Bank PLC and BCI paying a combined $125m civil monetary penalty to the SEC and a $75m civil monetary penalty to the CFTC. There will also be non-financial components to the settlements which have yet to be finalised and agreed with the SEC and CFTC. Subject to final agreement of the terms of the settlements and related documentation, as well as the SEC's and CFTC's approval, the civil monetary penalties are expected to be paid during the third quarter of 2022. 2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have retrospective effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect to attribute an amount of approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s decision has been appealed to the First Tier Tribunal (Tax Chamber). Financial Statement Notes Barclays PLC 97 -- 99 of 109 -- Local authority civil actions concerning LIBOR Following settlement by Barclays Bank PLC of various governmental investigations concerning certain benchmark interest rate submissions referred to above in ‘Investigations into LIBOR and other benchmarks and related civil actions’, in the UK, certain local authorities brought claims in 2018 against Barclays Bank PLC and Barclays Bank UK PLC asserting that they entered into loans between 2006 and 2008 in reliance on misrepresentations made by Barclays Bank PLC in respect of its conduct in relation to LIBOR. Barclays Bank PLC and Barclays Bank UK PLC were successful in their applications to strike out the claims. The claims have been settled on terms such that the parties have agreed not to pursue these claims further and to bear their own costs. The financial impact of the settlements is not material to the Group’s operating results, cash flows or financial position. 3. Barclays PLC Alternative trading systems In 2020, a claim was brought against Barclays PLC in the UK in the High Court by various shareholders regarding Barclays PLC’s share price based on the allegations contained within a complaint by the New York State Attorney General (NYAG) in 2014. Such claim was settled in 2016, as previously disclosed. The more recent claim seeks unquantified damages and Barclays is defending the claim. The NYAG complaint was filed against Barclays PLC and BCI in the NY Supreme Court alleging, among other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX, BCI’s SEC-registered alternative trading system. General The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other overseas jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary course of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection, consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual property, money laundering, financial crime, employment, environmental and other statutory and common law issues. The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities in which the Group is or has been engaged. The Group is cooperating with the relevant authorities and keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis. At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material adverse effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters (including formerly active matters or those matters arising after the date of this note) will not be material to Barclays PLC’s results, operations or cash flow for a particular period, depending on, among other things, the amount of the loss resulting from the matter(s) and the amount of profit otherwise reported for the reporting period. 22. Related party transactions Related party transactions in the half year ended 30 June 2022 were similar in nature to those disclosed in the Barclays PLC Annual Report 2021. No related party transactions that have taken place in the half year ended 30 June 2022 have materially affected the financial position or the performance of the Group during this period. 23. Interest rate benchmark reform Following the financial crisis, the reform and replacement of benchmark interest rates such as LIBOR became a priority for global regulators. The FCA and other global regulators instructed market participants to prepare for the cessation of GBP, EUR, CHF, JPY LIBOR and the 1-week and 2-month USD settings of LIBOR after the end of 2021, The remaining USD LIBOR settings are scheduled to cease immediately after 30 June 2023. How the Group is managing the transition to alternative benchmark rates Barclays established a Group-wide LIBOR Transition Programme, further detail on the transition programme is available in the Barclays PLC Annual Report 2021 (Page 417). This Programme oversaw transition for GBP, EUR, CHF and JPY LIBOR exposures and continues to work to transition the remaining residual of unremediated exposures off of synthetic rates, in addition to overseeing USD LIBOR transition in preparation for the 30 June 2023 cessation. Financial Statement Notes Barclays PLC 98 -- 100 of 109 -- The majority of GBP, EUR, CHF and JPY exposures have now transitioned off of LIBOR and good progress has been made with the unremediated exposures reported at year-end 2021. A small residual population of GBP, EUR and JPY contracts remain unremediated at the end of H1 2022. The majority of these have now reset onto GBP and JPY Synthetic LIBOR rates. We continue to work with clients to bilaterally transition these trades and have raised potential risks regarding note holder consent for securitised products and Local Authority consent for Public Finance Initiative (PFI) loan deals with our regulators. The Barclays Group-wide LIBOR Transition Programme has also commenced focus on the transition of USD LIBOR exposures impacted by the 30 June 2023 cessation timeline. As with GBP, EUR, CHF and JPY LIBOR, USD LIBOR transition approaches will vary by product and nature of counterparty. H122 saw focused efforts to transition uncommitted lending exposure with further wide scale client engagement for other products due to commence in H222. Both active conversion of exposures and inclusion of fallback provisions will be leveraged for bilateral derivative and non-derivatives products. For cleared derivatives, Barclays is working with central clearing counterparties (CCPs) on transition which is expected to follow a market wide, standardised approach to reform similar to the CCP-led conversions in 2021. The Group met the Q121 Federal Reserve Bank of New York milestone to cease new use of US dollar LIBOR, with limited exceptions. The Group has put in place controls so that any exceptions or exemptions are approved. 24. Barclays PLC parent company balance sheet As at 30.06.22 As at 31.12.21 Assets £m £m Investment in subsidiaries 63,633 62,528 Loans and advances to subsidiaries 20,369 22,072 Financial assets at fair value through the income statement 24,052 25,091 Derivative financial instruments 5 4 Other assets 235 68 Total assets 108,294 109,763 Liabilities Deposits at amortised cost 545 488 Debt securities in issue 22,389 25,658 Subordinated liabilities 10,070 9,301 Financial liabilities designated at fair value 16,888 16,319 Derivative financial instruments 540 43 Other liabilities 104 117 Total liabilities 50,536 51,926 Equity Called up share capital 4,133 4,188 Share premium account 375 348 Other equity instruments 12,347 12,241 Other reserves 616 555 Retained earnings 40,287 40,505 Total equity 57,758 57,837 Total liabilities and equity 108,294 109,763 Investment in subsidiaries The investment in subsidiaries of £63,633m (December 2021: £62,528m) predominantly relates to investments in the ordinary shares of Barclays Bank PLC of £36,340m (December 2021: £35,590m) and their AT1 securities of £9,849m (December 2021: £9,493m), as well as investments in the ordinary shares of Barclays Bank UK PLC of £14,245m (December 2021: £14,245m) and their AT1 securities of £2,570m (December 2021: £2,570m). Barclays PLC considers the carrying value of its investment in subsidiaries to be fully recoverable. Loans and advances to subsidiaries During the period, loans and advances to subsidiaries decreased by £1,703m to £20,369m (December 2021: £22,072m). The decrease was driven by the maturity of £2,296m intragroup loans to Barclays Bank PLC and the maturity of £836m Financial Statement Notes Barclays PLC 99 -- 101 of 109 -- intragroup loans to Barclays Bank UK PLC. There was also a £397m share buyback which took place in Q222. This was partially offset by a foreign exchange impact of £1,326m due to depreciation of GBP against major currencies (although the FX impact is offset across the balance sheet liabilities) and £1,010m dividend receipts from Barclays Bank UK PLC. Financial assets and liabilities designated at fair value Financial liabilities designated at fair value of £16,888m (December 2021: £16,319m) comprise material issuances during the period of €2,250m Fixed Rate Resetting Senior Callable Notes and $400m Zero Coupon Callable Notes. The proceeds raised through these transactions were used to invest in subsidiaries of Barclays PLC which are included within the financial assets designated at fair value through the income statement balance of £24,052m (December 2021: £25,091m). Subordinated liabilities and debt securities in issue During the period, subordinated liabilities have increased to £10,070m (December 2021: £9,301m) largely driven by foreign exchange impact of £819m due to depreciation of GBP against major currencies. Debt securities in issue of £22,389m (December 2021: £25,658m) have reduced in the year due to the maturity of senior issuances. Called up share capital and share premium Called up share capital and share premium of Barclays PLC is £4,508m (December 2021: £4,536m). The decrease in the year is primarily due to 244m shares repurchased with a total nominal value of £61m. This decrease was offset by £33m of shares issued under employee share schemes. Other equity instruments Other equity instruments comprises AT1 securities issued by Barclays PLC. The increase in the year of £106m is driven by one issuance (principal amount of £1,250m) and one redemption (principal amount of $1,500m). Other reserves As at 30 June 2022, there was a balance of £616m (December 2021: £555m) in other reserves. The increase is due to the repurchase of shares as part of the share buyback. Management of internal investments, loans and advances Barclays PLC retains the discretion to manage the nature of its internal investments in subsidiaries according to their regulatory and business needs. Barclays PLC may invest capital and funding into Barclays Bank PLC, Barclays Bank UK PLC and other Group subsidiaries such as Barclays Execution Services Limited and the US Intermediate Holding Company (IHC). Financial Statement Notes Barclays PLC 100 -- 102 of 109 -- The Group’s management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Non-IFRS performance measures glossary Measure Definition Loan: deposit ratio Loans and advances at amortised cost divided by deposits at amortised cost. The components of the calculation have been included on the page 52. Period end allocated tangible equity Allocated tangible equity is calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group’s tangible shareholders’ equity and the amounts allocated to businesses. Average tangible shareholders’ equity Calculated as the average of the previous month’s period end tangible equity and the current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period. Average allocated tangible equity Calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. Return on average tangible shareholders’ equity Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on pages 102 to 104. Return on average allocated tangible equity Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on pages 102 to 105. Cost: income ratio Total operating expenses divided by total income. Loan loss rate Quoted in basis points and represents total annualised impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 27. Quoted as zero when credit impairment is a net release. Net interest margin Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 24. Tangible net asset value per share Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 106. Appendix: Non-IFRS Performance Measures Barclays PLC 101 -- 103 of 109 -- Returns Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.5% (2021: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group’s average tangible shareholders’ equity and the amounts allocated to businesses. Profit/(loss) attributable to ordinary equity holders of the parent Average tangible equity Return on average tangible equity Half year ended 30.06.22 £m £bn % Barclays UK 854 10.0 17.0 Corporate and Investment Bank 1,895 31.8 11.9 Consumer, Cards and Payments 188 4.4 8.5 Barclays International 2,083 36.2 11.5 Head Office (462) 2.7 n/m Barclays Group 2,475 48.9 10.1 Half year ended 30.06.211 Barclays UK 1,019 9.9 20.6 Corporate and Investment Bank 2,252 28.3 15.9 Consumer, Cards and Payments 386 4.0 19.1 Barclays International 2,638 32.3 16.3 Head Office 95 4.3 n/m Barclays Group 3,752 46.5 16.1 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Appendix: Non-IFRS Performance Measures Barclays PLC 102 -- 104 of 109 -- Half year ended 30.06.22 Barclays UK Corporate and Investment Bank Consumer, Cards and Payments Barclays International Head Office Barclays Group Return on average tangible shareholders' equity £m £m £m £m £m £m Attributable profit/(loss) 854 1,895 188 2,083 (462) 2,475 £bn £bn £bn £bn £bn £bn Average shareholders' equity 13.6 31.8 5.3 37.1 6.3 57.0 Average goodwill and intangibles (3.6) — (0.9) (0.9) (3.6) (8.1) Average tangible shareholders' equity 10.0 31.8 4.4 36.2 2.7 48.9 Return on average tangible shareholders' equity 17.0% 11.9% 8.5% 11.5% n/m 10.1% Half year ended 30.06.211 Barclays UK Corporate and Investment Bank Consumer, Cards and Payments Barclays International Head Office Barclays Group Return on average tangible shareholders' equity £m £m £m £m £m £m Attributable profit 1,019 2,252 386 2,638 95 3,752 £bn £bn £bn £bn £bn £bn Average shareholders' equity 13.5 28.3 4.6 32.9 8.0 54.4 Average goodwill and intangibles (3.6) — (0.6) (0.6) (3.7) (7.9) Average tangible shareholders' equity 9.9 28.3 4.0 32.3 4.3 46.5 Return on average tangible shareholders' equity 20.6% 15.9% 19.1% 16.3% n/m 16.1% Performance measures excluding the Over-issuance of Securities Profit attributable to ordinary equity holders of the parent Half year ended 30.06.22 £m Attributable profit 2,475 Post-tax impact of the Over-issuance of Securities 581 Profit attributable to ordinary equity holders of the parent excluding the Over-issuance of Securities 3,056 Return on average tangible shareholders' equity £bn Average tangible shareholders' equity 48.9 Return on average tangible shareholders' equity excluding the Over-issuance of Securities 12.5 % 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Appendix: Non-IFRS Performance Measures Barclays PLC 103 -- 105 of 109 -- Barclays Group Return on average tangible shareholders' equity Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320 £m £m £m £m £m £m £m £m Attributable profit 1,071 1,404 1,079 1,374 2,048 1,704 220 611 £bn £bn £bn £bn £bn £bn £bn £bn Average shareholders' equity 57.1 56.9 56.1 56.5 54.4 54.4 55.7 56.4 Average goodwill and intangibles (8.1) (8.1) (8.1) (8.2) (7.9) (7.9) (8.1) (8.1) Average tangible shareholders' equity 49.0 48.8 48.0 48.3 46.5 46.5 47.6 48.3 Return on average tangible shareholders' equity 8.7% 11.5% 9.0% 11.4% 17.6% 14.7% 1.8% 5.1% Barclays UK Return on average allocated tangible equity Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320 £m £m £m £m £m £m £m £m Attributable profit 458 396 420 317 721 298 160 113 £bn £bn £bn £bn £bn £bn £bn £bn Average allocated equity 13.6 13.7 13.6 13.6 13.5 13.5 13.4 13.7 Average goodwill and intangibles (3.6) (3.6) (3.6) (3.6) (3.6) (3.6) (3.6) (3.6) Average allocated tangible equity 10.0 10.1 10.0 10.0 9.9 9.9 9.8 10.1 Return on average allocated tangible equity 18.4% 15.6% 16.8% 12.7% 29.1% 12.0% 6.5% 4.5% 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Appendix: Non-IFRS Performance Measures Barclays PLC 104 -- 106 of 109 -- Barclays International Return on average allocated tangible equity Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320 £m £m £m £m £m £m £m £m Attributable profit 783 1,300 818 1,191 1,207 1,431 441 782 £bn £bn £bn £bn £bn £bn £bn £bn Average allocated equity 38.2 36.0 33.8 32.7 33.0 32.8 31.1 31.2 Average goodwill and intangibles (0.9) (0.9) (0.9) (0.9) (0.6) (0.5) (0.6) (0.6) Average allocated tangible equity 37.3 35.1 32.9 31.8 32.4 32.3 30.5 30.6 Return on average allocated tangible equity 8.4% 14.8% 9.9% 14.9% 14.9% 17.7% 5.8% 10.2% Corporate and Investment Bank Return on average allocated tangible equity Q222 Q122 Q4211 Q3211 Q2211 Q121 Q420 Q320 £m £m £m £m £m £m £m £m Attributable profit 579 1,316 695 1,085 989 1,263 413 627 £bn £bn £bn £bn £bn £bn £bn £bn Average allocated equity 32.7 30.8 28.7 27.8 28.4 28.2 26.3 26.4 Average goodwill and intangibles — — — — — — — — Average allocated tangible equity 32.7 30.8 28.7 27.8 28.4 28.2 26.3 26.4 Return on average allocated tangible equity 7.1% 17.1% 9.7% 15.6% 14.0% 17.9% 6.3% 9.5% Consumer, Cards and Payments Return on average allocated tangible equity Q222 Q122 Q421 Q321 Q221 Q121 Q420 Q320 £m £m £m £m £m £m £m £m Attributable profit/(loss) 204 (16) 123 106 218 168 28 155 £bn £bn £bn £bn £bn £bn £bn £bn Average allocated equity 5.5 5.2 5.1 4.9 4.6 4.6 4.8 4.8 Average goodwill and intangibles (0.9) (0.9) (0.9) (0.9) (0.6) (0.5) (0.6) (0.6) Average allocated tangible equity 4.6 4.3 4.2 4.0 4.0 4.1 4.2 4.2 Return on average allocated tangible equity 17.8% (1.5)% 11.7% 10.5% 21.8% 16.5% 2.7% 14.7% 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Appendix: Non-IFRS Performance Measures Barclays PLC 105 -- 107 of 109 -- Tangible net asset value per share As at 30.06.22 Restated1 As at 31.12.21 Restated1 As at 30.06.21 £m £m £m Total equity excluding non-controlling interests 69,627 69,052 66,992 Other equity instruments (12,357) (12,259) (11,167) Goodwill and intangibles (8,245) (8,061) (8,196) Tangible shareholders' equity attributable to ordinary shareholders of the parent 49,025 48,732 47,629 m m m Shares in issue 16,531 16,752 16,998 p p p Tangible net asset value per share 297 291 280 1 2021 financial metrics have been restated to reflect the impact of the Over-issuance of Securities. See Restatement of financial statements (Note 1) on page 73 for more information. Appendix: Non-IFRS Performance Measures Barclays PLC 106 -- 108 of 109 -- Results timetable1 Date Ex-dividend date 11 August 2022 Dividend record date 12 August 2022 Cut off time of 5:00pm (UK time) for the receipt of Dividend Re- investment Programme (DRIP) Application Form Mandate 26 August 2022 Dividend payment date 16 September 2022 Q322 Results Announcement 26 October 2022 For qualifying US and Canadian resident ADR holders, the half year dividend of 2.25p per ordinary share becomes 9.0p per ADS (representing four shares). The ex-dividend, dividend record and dividend payment dates for ADR holders are as shown above % Change3 Exchange rates2 30.06.22 31.12.21 30.06.21 31.12.21 30.06.21 Period end - USD/GBP 1.22 1.35 1.38 (10)% (12)% 6 month average - USD/GBP 1.30 1.36 1.39 (4)% (6)% 3 month average - USD/GBP 1.26 1.35 1.40 (7)% (10)% Period end - EUR/GBP 1.16 1.19 1.17 (3)% (1)% 6 month average - EUR/GBP 1.19 1.17 1.15 2% 3% 3 month average - EUR/GBP 1.18 1.18 1.16 — 2% Share price data Barclays PLC (p) 153.12 187.00 171.12 Barclays PLC number of shares (m)4 16,531 16,752 16,998 For further information please contact Investor relations Media relations Chris Manners +44 (0) 20 7773 2136 Tom Hoskin +44 (0) 20 7116 4755 More information on Barclays can be found on our website: home.barclays Registered office 1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. Registrar Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. Tel: 0371 384 20555 from the UK or +44 121 415 7004 from overseas. American Depositary Receipts (ADRs) EQ Shareowner Services P.O. Box 64854 St. Paul, MN 55164-0854 United States of America shareowneronline.com Toll Free Number: +1 800-990-1135 Outside the US +1 651-453-2128 Delivery of ADR certificates and overnight mail EQ Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. 1 Note that this date is provisional and subject to change. 2 The average rates shown above are derived from daily spot rates during the year. 3 The change is the impact to GBP reported information. 4 The number of shares of 16,531m is different from the 16,509m quoted in the 1 July 2022 RNS because the share buyback transactions executed on the 29 and 30 June 2022 did not settle until 1 July 2022 and 4 July 2022. 5 Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales. Shareholder Information Barclays PLC 107 -- 109 of 109 --